# EDGAR Filing Document

**Accession Number:** 0000715072
**File Stem:** 0000715072-25-000234
**Filing Date:** 2025-11
**Character Count:** 327327
**Document Hash:** 705069802ae5b132ebd2e95077fff940
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000715072-25-000234.hdr.sgml**: 20251107

**ACCESSION NUMBER**: 0000715072-25-000234

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 113

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251107

**DATE AS OF CHANGE**: 20251107

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** RENASANT CORP
- **CENTRAL INDEX KEY:** 0000715072
- **STANDARD INDUSTRIAL CLASSIFICATION:** STATE COMMERCIAL BANKS [6022]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 640676974
- **STATE OF INCORPORATION:** MS
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-13253
- **FILM NUMBER:** 251461593

**BUSINESS ADDRESS:**
- **STREET 1:** 209 TROY STREET
- **CITY:** TUPELO
- **STATE:** MS
- **ZIP:** 38804-4827
- **BUSINESS PHONE:** (662) 680-1001

**MAIL ADDRESS:**
- **STREET 1:** P.O. BOX 709
- **CITY:** TUPELO
- **STATE:** MS
- **ZIP:** 38802-0709

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PEOPLES HOLDING CO
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'? rnst-20250930

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

________________________________________________________

**FORM 10-Q** 

________________________________________________________

**(Mark One)** 

☒ **Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**For the quarterly period ended September 30, 2025** 

**Or**

☐ **Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**For the transition period from <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>**

**Commission file number: 001-13253** 

________________________________________________________

**RENASANT CORPORATION**

**(Exact name of registrant as specified in its charter)**

________________________________________________________

---

| | |
|:---|:---|
| **Mississippi** | **64-0676974** |
| **(State or other jurisdiction of** | **(I.R.S. Employer** |
| **incorporation or organization)** | **Identification No.)** |

---

---

| | | | |
|:---|:---|:---|:---|
| **209 Troy Street,** | **Tupelo,** | **Mississippi** | **38804-4827** |
| **(Address of principal executive offices)** | **(Address of principal executive offices)** | **(Address of principal executive offices)** | **(Zip Code)** |

---

**(662) 680-1001** 

**(Registrant's telephone number, including area code)**

________________________________________________________

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common stock, $5.00 par value per share | RNST | The New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;No ☒

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

As of October 31, 2025, 95,021,382 shares of the registrant's common stock, par value $5.00 per share, were outstanding.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Form 10-Q

For the Quarterly Period Ended September 30, 2025

CONTENTS

---

| | | |
|:---|:---|:---|
| | | Page |
| PART I | <u>[Financial Information](#icd1fb2c5bace4247a2ab058bf222a535_10)</u> |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 1. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Financial Statements (Unaudited)](#icd1fb2c5bace4247a2ab058bf222a535_13)</u> |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Consolidated Balance Sheets</u> | <u>[1](#icd1fb2c5bace4247a2ab058bf222a535_16)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Income](#icd1fb2c5bace4247a2ab058bf222a535_19)</u> | <u>[2](#icd1fb2c5bace4247a2ab058bf222a535_19)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Comprehensive Income](#icd1fb2c5bace4247a2ab058bf222a535_22)</u> | <u>[3](#icd1fb2c5bace4247a2ab058bf222a535_22)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Changes in Shareholders' Equity](#icd1fb2c5bace4247a2ab058bf222a535_25)</u> | <u>[4](#icd1fb2c5bace4247a2ab058bf222a535_25)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Cash Flows](#icd1fb2c5bace4247a2ab058bf222a535_28)</u> | <u>[6](#icd1fb2c5bace4247a2ab058bf222a535_28)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Notes to Consolidated Financial Statements](#icd1fb2c5bace4247a2ab058bf222a535_31)</u> | <u>[8](#icd1fb2c5bace4247a2ab058bf222a535_31)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 2. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#icd1fb2c5bace4247a2ab058bf222a535_94)</u> | <u>[56](#icd1fb2c5bace4247a2ab058bf222a535_94)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 3. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Quantitative and Qualitative Disclosures about Market Risk](#icd1fb2c5bace4247a2ab058bf222a535_124)</u> | <u>[83](#icd1fb2c5bace4247a2ab058bf222a535_124)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 4. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Controls and Procedures](#icd1fb2c5bace4247a2ab058bf222a535_127)</u> | <u>[83](#icd1fb2c5bace4247a2ab058bf222a535_127)</u> |
| PART II | <u>[Other Information](#icd1fb2c5bace4247a2ab058bf222a535_130)</u> |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 1A. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Risk Factors](#icd1fb2c5bace4247a2ab058bf222a535_133)</u> | <u>[84](#icd1fb2c5bace4247a2ab058bf222a535_133)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 2. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Unregistered Sales of Equity Securities and Use of Proceeds](#icd1fb2c5bace4247a2ab058bf222a535_136)</u> | <u>[84](#icd1fb2c5bace4247a2ab058bf222a535_136)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 5. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Other Information](#icd1fb2c5bace4247a2ab058bf222a535_139)</u> | <u>[85](#icd1fb2c5bace4247a2ab058bf222a535_139)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 6. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Exhibits](#icd1fb2c5bace4247a2ab058bf222a535_142)</u> | <u>[85](#icd1fb2c5bace4247a2ab058bf222a535_142)</u> |
| <u>[SIGNATURES](#icd1fb2c5bace4247a2ab058bf222a535_145)</u> | <u>[SIGNATURES](#icd1fb2c5bace4247a2ab058bf222a535_145)</u> | <u>[86](#icd1fb2c5bace4247a2ab058bf222a535_145)</u> |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

**PART I. FINANCIAL INFORMATION**

**Item 1. FINANCIAL STATEMENTS**

Renasant Corporation and Subsidiaries

Consolidated Balance Sheets

*(In Thousands, Except Share Data)*

---

| | | |
|:---|:---|:---|
| | **(Unaudited)**<br>**September 30,<br>2025** |<br>**December 31, 2024** |
| **Assets** | | |
| Cash and due from banks | $284485 | $198408 |
| Interest-bearing balances with banks | 799300 | 893624 |
| Cash and cash equivalents | 1083785 | 1092032 |
| Securities held to maturity (fair value of $976,690 and $1,002,544, respectively) | 1051884 | 1126112 |
| Securities available for sale, at fair value (amortized cost of $2,599,397 and $968,927, respectively) | 2512650 | 831013 |
| Loans held for sale, at fair value | 286779 | 246171 |
| Loans held for investment, net of unearned income | 19025521 | 12885020 |
| Allowance for credit losses on loans | (297591) | (201756) |
| Loans, net | 18727930 | 12683264 |
| Premises and equipment, net | 471213 | 279796 |
| Other real estate owned, net | 10578 | 8673 |
| Goodwill | 1411711 | 988898 |
| Other intangible assets, net | 155077 | 14105 |
| Bank-owned life insurance | 488920 | 391810 |
| Mortgage servicing rights, net | 65466 | 72991 |
| Other assets | 460172 | 300003 |
| **Total assets** | $26726165 | $18034868 |
| **Liabilities and shareholders' equity** |  |  |
| **Liabilities** |  |  |
| Deposits |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Noninterest-bearing | $5238431 | $3403981 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest-bearing | 16186124 | 11168631 |
| Total deposits | 21424555 | 14572612 |
| Short-term borrowings | 606063 | 108018 |
| Long-term debt | 558878 | 430614 |
| Other liabilities | 310891 | 245306 |
| **Total liabilities** | 22900387 | 15356550 |
| **Shareholders' equity** |  |  |
| Preferred stock, $0.01 par value – 5,000,000 shares authorized; no shares issued and outstanding |  |  |
| Common stock, $5.00 par value – 250,000,000 and 150,000,000 shares authorized, respectively; 97,722,397 and 66,484,225 shares issued, respectively; 95,020,881 and 63,565,690 shares outstanding, respectively | 488612 | 332421 |
| Treasury stock, at cost – 2,701,516 and 2,918,535 shares, respectively | (90297) | (97196) |
| Additional paid-in capital | 2389033 | 1491847 |
| Retained earnings | 1139600 | 1093854 |
| Accumulated other comprehensive loss, net of taxes | (101170) | (142608) |
| **Total shareholders' equity** | 3825778 | 2678318 |
| **Total liabilities and shareholders' equity** | $26726165 | $18034868 |

---

*See Notes to Consolidated Financial Statements.&nbsp;&nbsp;&nbsp;&nbsp;*

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Consolidated Statements of Income (Unaudited)

*(In Thousands, Except Share Data)*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Interest income** |  |  |  |  |
| Loans | $312785 | $206867 | $818792 | $603492 |
| Securities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Taxable | 27108 | 9212 | 62996 | 27975 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tax-exempt | 3109 | 1092 | 7746 | 3439 |
| Other | 8096 | 11872 | 25792 | 27527 |
| **Total interest income** | 351098 | 229043 | 915326 | 662433 |
| **Interest expense** |  |  |  |  |
| Deposits | 115573 | 90787 | 306880 | 261021 |
| Borrowings | 12005 | 7258 | 31870 | 22098 |
| **Total interest expense** | 127578 | 98045 | 338750 | 283119 |
| **Net interest income** | 223520 | 130998 | 576576 | 379314 |
| Provision for credit losses on loans | 9650 | 1210 | 87100 | 8148 |
| Provision for (recovery of) credit losses on unfunded commitments | 800 | (275) | 9422 | (1475) |
| **Provision for credit losses** | 10450 | 935 | 96522 | 6673 |
| **Net interest income after provision for credit losses** | 213070 | 130063 | 480054 | 372641 |
| **Noninterest income** |  |  |  |  |
| Service charges on deposit accounts | 13416 | 10438 | 37398 | 31230 |
| Fees and commissions | 4167 | 4116 | 14604 | 12009 |
| Insurance commissions |  |  |  | 5474 |
| Wealth management revenue | 8217 | 5835 | 22629 | 17188 |
| Mortgage banking income | 9017 | 8447 | 28427 | 29515 |
| Gain on sale of insurance agency |  | 53349 |  | 53349 |
| Gain on debt extinguishment |  |  |  | 56 |
| BOLI income | 4235 | 2858 | 10547 | 8250 |
| Other | 6974 | 4256 | 17150 | 12371 |
| **Total noninterest income** | 46026 | 89299 | 130755 | 169442 |
| **Noninterest expense** |  |  |  |  |
| Salaries and employee benefits | 98982 | 71307 | 270481 | 213508 |
| Data processing | 5541 | 4133 | 15068 | 11885 |
| Net occupancy and equipment | 18415 | 11415 | 47528 | 34648 |
| Other real estate owned | 328 | 56 | 1170 | 268 |
| Professional fees | 3435 | 3189 | 10542 | 9732 |
| Advertising and public relations | 5254 | 3677 | 14041 | 12370 |
| Intangible amortization | 8674 | 1160 | 18638 | 3558 |
| Communications | 3955 | 2176 | 9172 | 6312 |
| Merger and conversion related expenses | 17494 | 11273 | 38764 | 11273 |
| Other | 21752 | 13597 | 55506 | 43317 |
| **Total noninterest expense** | 183830 | 121983 | 480910 | 346871 |
| Income before income taxes | 75266 | 97379 | 129899 | 195212 |
| Income taxes | 15478 | 24924 | 27575 | 44502 |
| **Net income** | $59788 | $72455 | $102324 | $150710 |
| **Basic earnings per share** | $0.63 | $1.18 | $1.21 | $2.60 |
| **Diluted earnings per share** | $0.63 | $1.18 | $1.20 | $2.59 |

---

*See Notes to Consolidated Financial Statements.*

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Consolidated Statements of Comprehensive Income (Unaudited)

*(In Thousands)*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Net income | $59788 | $72455 | $102324 | $150710 |
| Other comprehensive income, net of tax: |  |  |  |  |
| Securities available for sale: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized holding gains on securities | 11585 | 23441 | 38313 | 19275 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of unrealized holding losses on securities transferred to the held to maturity category | 2237 | 2331 | 6615 | 7190 |
| Total securities available for sale | 13822 | 25772 | 44928 | 26465 |
| Derivative instruments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized holding losses on derivative instruments | (1026) | (828) | (3713) | (1539) |
| Total derivative instruments | (1026) | (828) | (3713) | (1539) |
| Defined benefit pension and post-retirement benefit plans: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of net actuarial loss recognized in net periodic pension cost | 75 | 78 | 223 | 236 |
| Total defined benefit pension and post-retirement benefit plans | 75 | 78 | 223 | 236 |
| Other comprehensive income, net of tax | 12871 | 25022 | 41438 | 25162 |
| Comprehensive income | $72659 | $97477 | $143762 | $175872 |

---

*See Notes to Consolidated Financial Statements.*

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Consolidated Statements of Changes in Shareholders' Equity

(Unaudited)

*(In Thousands, Except Share Data)*

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | **Treasury Stock** | **Additional Paid-In Capital** | **Retained Earnings** | **Accumulated Other Comprehensive Income (Loss)** | **Total** |
| **Nine Months Ended September 30, 2025** | **Shares** | **Amount** | **Treasury Stock** | **Additional Paid-In Capital** | **Retained Earnings** | **Accumulated Other Comprehensive Income (Loss)** | **Total** |
| **Balance at January 1, 2025** | 63565690 | $332421 | $(97196) | $1491847 | $1093854 | $(142608) | $2678318 |
| Net income |  |  |  |  | 41518 |  | 41518 |
| Other comprehensive income |  |  |  |  |  | 20987 | 20987 |
| Comprehensive income |  |  |  |  |  |  | 62505 |
| Cash dividends ($0.22 per share) |  |  |  |  | (14270) |  | (14270) |
| Issuance of common stock for stock-based compensation awards | 173777 |  | 5550 | (8778) |  |  | (3228) |
| Stock-based compensation expense |  |  |  | 3780 |  |  | 3780 |
| **Balance at March 31, 2025** | 63739467 | $332421 | $(91646) | $1486849 | $1121102 | $(121621) | $2727105 |
| Net income |  | $— | $— | $— | $1018 | $— | $1018 |
| Other comprehensive income |  |  |  |  |  | 7580 | 7580 |
| Comprehensive income |  |  |  |  |  |  | 8598 |
| Cash dividends ($0.22 per share) |  |  |  |  | (21155) |  | (21155) |
| Common stock issued in connection with an acquisition | 31238172 | 156191 |  | 903720 |  |  | 1059911 |
| Issuance of common stock for stock-based compensation awards | 41672 |  | 1398 | (1307) |  |  | 91 |
| Stock-based compensation expense |  |  |  | 4304 |  |  | 4304 |
| **Balance at June 30, 2025** | 95019311 | $488612 | $(90248) | $2393566 | $1100965 | $(114041) | $3778854 |
| Net income |  |  |  |  | $59788 |  | $59788 |
| Other comprehensive income |  |  |  |  |  | 12871 | 12871 |
| Comprehensive income |  |  |  |  |  |  | 72659 |
| Cash dividends ($0.22 per share) |  |  |  |  | (21153) |  | (21153) |
| Measurement period adjustment related to common stock issued in connection with an acquisition |  |  |  | (9090) |  |  | (9090) |
| Issuance of common stock for stock-based compensation awards | 1570 |  | (49) | (886) |  |  | (935) |
| Stock-based compensation expense |  |  |  | 5443 |  |  | 5443 |
| **Balance at September 30, 2025** | 95020881 | $488612 | $(90297) | $2389033 | $1139600 | $(101170) | $3825778 |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | **Treasury Stock** | **Additional Paid-In Capital** | **Retained Earnings** | **Accumulated Other Comprehensive Income (Loss)** | **Total** |
| **Nine Months Ended September 30, 2024** | **Shares** | **Amount** | **Treasury Stock** | **Additional Paid-In Capital** | **Retained Earnings** | **Accumulated Other Comprehensive Income (Loss)** | **Total** |
| **Balance at January 1, 2024** | 56142207 | $296483 | $(105249) | $1308281 | $952124 | $(154256) | $2297383 |
| Net income |  |  |  |  | 39409 |  | 39409 |
| Other comprehensive loss |  |  |  |  |  | (2687) | (2687) |
| Comprehensive income |  |  |  |  |  |  | 36722 |
| Cash dividends ($0.22 per share) |  |  |  |  | (12653) |  | (12653) |
| Issuance of common stock for stock-based compensation awards | 162653 |  | 5566 | (8660) |  |  | (3094) |
| Stock-based compensation expense |  |  |  | 3992 |  |  | 3992 |
| **Balance at March 31, 2024** | 56304860 | $296483 | $(99683) | $1303613 | $978880 | $(156943) | $2322350 |
| Net income |  | $— | $— | $— | $38846 | $— | $38846 |
| Other comprehensive income |  |  |  |  |  | 2827 | 2827 |
| Comprehensive income |  |  |  |  |  |  | 41673 |
| Cash dividends ($0.22 per share) |  |  |  |  | (12640) |  | (12640) |
| Issuance of common stock for stock-based compensation awards | 63064 |  | 2149 | (2205) |  |  | (56) |
| Stock-based compensation expense |  |  |  | 3374 |  |  | 3374 |
| **Balance at June 30, 2024** | 56367924 | $296483 | $(97534) | $1304782 | $1005086 | $(154116) | $2354701 |
| Net income |  |  |  |  | $72455 |  | $72455 |
| Other comprehensive income |  |  |  |  |  | 25022 | 25022 |
| Comprehensive income |  |  |  |  |  |  | 97477 |
| Cash dividends ($0.22 per share) |  |  |  |  | (14217) |  | (14217) |
| Common stock issued in public offering | 7187500 | 35938 |  | 181062 |  |  | 217000 |
| Issuance of common stock for stock-based compensation awards | 8604 |  | 283 | (439) |  |  | (156) |
| Stock-based compensation expense |  |  |  | 3273 |  |  | 3273 |
| **Balance at September 30, 2024** | 63564028 | $332421 | $(97251) | $1488678 | $1063324 | $(129094) | $2658078 |

---

*See Notes to Consolidated Financial Statements.*

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Consolidated Statements of Cash Flows (Unaudited)

*(In Thousands)*

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** |
| **Operating activities** |  |  |
| Net income | $102324 | $150710 |
| Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision for credit losses | 96522 | 6673 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation, amortization and accretion | 13167 | 23780 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax (benefit) expense | (4103) | 2494 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of MSR | (1467) | (3472) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of insurance agency |  | (53349) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Funding of mortgage loans held for sale | (1220267) | (1053190) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales of mortgage loans held for sale | 1198088 | 954133 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gains on sales of mortgage loans held for sale | (15086) | (14233) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Debt prepayment benefit |  | (56) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Gains) losses on sales of premises and equipment | (347) | 11 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 13527 | 10639 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in other assets | 251 | (8108) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decrease in other liabilities | (18278) | (1712) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided by operating activities** | 164331 | 14320 |
| **Investing activities** |  |  |
| Purchases of securities available for sale | (1058969) | (60656) |
| Proceeds from sales of securities available for sale | 686485 | 177185 |
| Proceeds from call/maturities of securities available for sale | 203429 | 66310 |
| Proceeds from call/maturities of securities held to maturity | 78918 | 76170 |
| Proceeds from sale of MSR | 9353 | 23011 |
| Net increase in loans | (929248) | (283266) |
| Purchases of premises and equipment | (30337) | (10408) |
| Proceeds from sales of premises and equipment | 1366 | 339 |
| Net cash received from sale of insurance agency |  | 55333 |
| Proceeds from surrender of bank-owned life insurance | 56255 |  |
| Net change in FHLB stock | (6130) | 2443 |
| Proceeds from sales of other assets | 12605 | 1466 |
| Net cash received in acquisition of businesses | 261483 |  |
| Other, net | 3836 | 656 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash (used in) provided by investing activities** | (710954) | 48583 |
| **Financing activities** |  |  |
| Net increase (decrease) in noninterest-bearing deposits | 46584 | (53874) |
| Net increase in interest-bearing deposits | 348575 | 486840 |
| Net increase (decrease) in short-term borrowings | 199795 | (198845) |
| Repayment of long-term debt |  | (245) |
| Cash paid for dividends | (56578) | (39510) |
| Proceeds from equity offering |  | 217000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided by financing activities** | 538376 | 411366 |
| **Net (decrease) increase in cash and cash equivalents** | (8247) | 474269 |
| **Cash and cash equivalents at beginning of period** | 1092032 | 801351 |
| **Cash and cash equivalents at end of period** | $1083785 | $1275620 |
| **Supplemental disclosures** |  |  |
| Cash paid for interest | $324630 | $286930 |
| Cash paid for income taxes | $21281 | $27412 |
| Noncash transactions: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transfers of loans to other real estate owned | $4057 | $3286 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock issued in acquisition of businesses | $1050821 | $— |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Recognition of operating right-of-use assets | $13282 | $2503 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Recognition of operating lease liabilities | $13282 | $2503 |

---

*See Notes to Consolidated Financial Statements.*

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

**Note 1 – Summary of Significant Accounting Policies**

*(In Thousands)*

<u>Nature of Operations</u>: Renasant Corporation (referred to herein as the "Company") owns and operates Renasant Bank ("Renasant Bank" or the "Bank"), Park Place Capital Corporation and Continental Republic Capital, LLC (doing business as "Republic Business Credit"). On July 1, 2024, the Bank sold substantially all of the assets of its subsidiary, Renasant Insurance, Inc. Through its subsidiaries, the Company offers a diversified range of financial, wealth management and fiduciary services to its retail and commercial customers from offices located throughout the Southeast and offers factoring and asset-based lending on a nationwide basis.

<u>Basis of Presentation</u>: The accompanying unaudited consolidated financial statements of the Company and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair statement of the results for the interim periods presented have been included. For further information regarding the Company's significant accounting policies, refer to the audited consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 filed with the Securities and Exchange Commission (the "SEC").

<u>Use of Estimates</u>: The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates, and such differences may be material. Material estimates that are particularly susceptible to change include the allowance for credit losses and the fair value of assets acquired and liabilities assumed as part of a business acquisition.

<u>Impact of Recently-Issued Accounting Standards and Pronouncements</u>:

In November 2024, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2024-03, *"Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses"* ("ASU 2024-03"), which amends the disclosure requirements in the notes to financial statements of specified information about certain costs and expenses. ASU 2024-03 will be effective January 1, 2027 and is not expected to have a significant impact on the Company's financial statements.

In December 2023, FASB issued ASU 2023-09, *"Income Taxes (Topic 740): Improvements to Income Tax Disclosures"* ("ASU 2023-09"), which enhances the transparency and decision usefulness of income tax disclosures. ASU 2023-09 requires disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid. Entities will also be required to disclose income/(loss) from continuing operations before income tax expense/(benefit) disaggregated between domestic and foreign, as well as income tax expense/(benefit) from continuing operations disaggregated by federal, state and foreign. ASU 2023-09 was effective January 1, 2025 and did not have a significant impact on our financial statements.

In November 2023, FASB issued ASU 2023-07, *"Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures"* ("ASU 2023-07"), which amends the disclosure requirements related to segment reporting primarily through enhanced disclosure about significant segment expenses and by requiring disclosure of segment information on an annual and interim basis. ASU 2023-07 was effective January 1, 2024 and did not have a significant impact on the Company's financial statements or segment disclosures.

**Note 2 – Mergers and Acquisitions**

*(Dollar Amounts In Thousands, Except Share Data)*

*Acquisition of The First Bancshares, Inc. ("The First")*

Effective April 1, 2025, the Company completed its acquisition by merger of The First, the parent company of The First Bank, in a transaction valued at approximately $1,052,690. The Company issued 30,811,851 shares of common stock and paid approximately $1,869, net of tax benefit, to The First stock option holders for 100% of the voting equity interest in The First. At closing, The First merged with and into the Company, with the Company the surviving corporation in the merger; immediately thereafter, The First Bank merged with and into Renasant Bank, with Renasant Bank the surviving banking corporation in the

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

merger. Before the merger, The First operated 116 banking locations throughout Louisiana, Mississippi, Alabama, Georgia and Florida. The Company incurred transaction costs of $17,494 and $38,764 during the three and nine months ended September 30, 2025. The Company incurred transaction costs of $4,746 during the three and nine months ended September 30, 2024. These transaction costs are reported in the line item "Merger and conversion related expenses" in the Consolidated Statements of Income.

The transaction was accounted for using the acquisition method of accounting and, accordingly, assets acquired and liabilities assumed were recorded at estimated fair values as of the acquisition date. The Company recorded approximately $582,423 in intangible assets which consist of goodwill of $422,813 and a core deposit intangible of $159,610. Goodwill resulted from a combination of revenue enhancements from expansion in existing markets and efficiencies resulting from operational synergies. The calculation of goodwill is subject to change as additional information becomes available during the measurement period. As a result of the various measurement period adjustments identified during the third quarter of 2025, the estimated fair value of goodwill as of the acquisition date decreased by $8,071, from $430,884 to $422,813. The fair value of the core deposit intangible is being amortized over its estimated useful life, currently expected to be approximately 10 years. The goodwill is not deductible for income tax purposes.

The Company assumed the outstanding short-term borrowings and long-term debt of The First. Short-term borrowings consisted of $298,250 in short-term advances from the Federal Home Loan Bank. Long-term debt consisted of $95,262 and $25,653 in subordinated notes and junior subordinated debentures, respectively.

The following table summarizes the calculation of the purchase price in connection with the Company's merger with The First.

---

| | |
|:---|:---|
| **Purchase Price:** | |
| Shares issued to common shareholders, excluding unvested restricted stock awards | 30811851 |
| Purchase price per share | $33.93 |
| Value of stock paid | $1045446 |
| Fair value of converted unvested restricted stock awards for pre-combination service | 5375 |
| Cash settlement for stock options, net of tax benefit | 1869 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total purchase price | $1052690 |

---

The following table summarizes the fair value on April 1, 2025 of assets acquired and liabilities assumed on that date in connection with the merger with The First.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **As Reported by The First** | **Preliminary Adjustments** | **Measurement Period Adjustments** | **Fair Value of Net Assets Acquired at Date of Acquisition** |
| Cash and cash equivalents | $263352 | $— | $— | $263352 |
| Securities | 1528975 | (71772) | 174 | 1457377 |
| Loans, including loans held for sale | 5327056 | (152153) | (1511) | 5173392 |
| Premises and equipment | 174770 | (1596) |  | 173174 |
| Bank-owned life insurance | 146601 |  |  | 146601 |
| Other real estate owned | 8413 | 2696 |  | 11109 |
| Core deposit intangible | 56899 | 102711 |  | 159610 |
| Other assets | 169500 | 3859 | 379 | 173738 |
| Total assets | $7675566 | $(116255) | $(958) | $7558353 |
| Deposits | $6456784 | $(7391) | $— | 6449393 |
| Borrowings | 422067 | (2902) |  | 419165 |
| Other liabilities | 75760 | (15903) | 61 | 59918 |
| Total liabilities | $6954611 | $(26196) | $61 | $6928476 |
| Net identifiable assets acquired over liabilities assumed | $720955 | $(90059) | $(1019) | $629877 |
| Goodwill<sup>(1)</sup> | 272520 | 158364 | (8071) | 422813 |
| Net assets acquired over liabilities assumed | $993475 | $68305 | $(9090) | $1052690 |

---

(1) The goodwill resulting from the merger has been assigned to the Community Banks operating segment.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

The following table presents additional information related to the acquired loan portfolio at the acquisition date:

---

| | |
|:---|:---|
| | **April 1, 2025** |
| **Purchased Credit-Deteriorated ("PCD") loans:** | |
| Par value | $168511 |
| Allowance for credit losses at acquisition | (25003) |
| Non-credit discount | (4021) |
| Purchase price | $139487 |
| **Non-PCD loans:** |  |
| Fair value | $5032996 |
| Gross contractual amounts receivable | 5233447 |
| Estimate of contractual cash flows not expected to be collected | 62190 |

---

*Supplemental Pro Forma Combined Condensed Consolidated Results of Operations*

The following unaudited pro forma combined condensed consolidated financial information presents the results of operations for the three and nine months ended September 30, 2025 and 2024 of the Company as though the merger with The First had been completed as of January 1, 2024. The unaudited pro forma information combines the historical results of The First with the Company's historical consolidated results and applies the impact of purchase accounting adjustments such as loan discount accretion, deposit amortization and intangible assets amortization as if the merger was completed as of January 1, 2024. It excludes $20,479 of merger-related expenses and $66,612 of Day 1 acquisition provision expense from the second quarter of 2025 and instead includes such expenses in the first quarter of 2024. The pro forma information is not necessarily indicative of what would have occurred had the acquisition taken place on January 1, 2024. The pro forma information does not include the effect of any cost-saving or revenue-enhancing strategies. Other than the aforementioned $20,479 in merger-related expenses, which were attributed to the first quarter of 2024, merger expenses are reflected in the period in which they were incurred.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
| | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Net interest income - pro forma | $214571 | $210037 | $639871 | $620429 |
| Noninterest income - pro forma | $46026 | $99012 | $139289 | $200096 |
| Noninterest expense - pro forma | $183830 | $175935 | $548533 | $516469 |
| Net income - pro forma | $50839 | $98877 | $173055 | $175698 |
| Earnings per share - pro forma: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.54 | $1.07 | $1.83 | $1.96 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.53 | $1.06 | $1.81 | $1.95 |

---

The Company has determined it is impracticable to disclose stand-alone revenues and earnings for legacy The First since April 1, 2025 due to the merging of certain processes during the second quarter of 2025.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

**Note 3 – Securities**

*(In Thousands, Except Number of Securities)*

The amortized cost and fair value of securities available for sale were as follows as of the dates presented in the tables below.

There was no allowance for credit losses allocated to any of the Company's available for sale securities as of September 30, 2025 or December 31, 2024.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Amortized<br>Cost** | **Gross<br>Unrealized<br>Gains** | **Gross<br>Unrealized<br>Losses** | **Fair<br>Value** |
| **September 30, 2025** | | | | |
| Obligations of states and political subdivisions | $270696 | $5318 | $(2365) | $273649 |
| Residential mortgage backed securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises | 710105 | 3709 | (17508) | 696306 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises | 739005 | 2978 | (59903) | 682080 |
| Commercial mortgage backed securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises | 100337 | 221 | (799) | 99759 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises | 414781 | 2639 | (18669) | 398751 |
| Other debt securities | 364473 | 871 | (3239) | 362105 |
|  | $2599397 | $15736 | $(102483) | $2512650 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Amortized<br>Cost** | **Gross<br>Unrealized<br>Gains** | **Gross<br>Unrealized<br>Losses** | **Fair<br>Value** |
| **December 31, 2024** | | | | |
| Obligations of states and political subdivisions | $20266 | $57 | $(2269) | $18054 |
| Residential mortgage backed securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises | 185292 | 81 | (24468) | 160905 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises | 475311 | 75 | (86870) | 388516 |
| Commercial mortgage backed securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises | 11373 |  | (751) | 10622 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises | 146510 | 41 | (21595) | 124956 |
| Other debt securities | 130175 | 440 | (2655) | 127960 |
|  | $968927 | $694 | $(138608) | $831013 |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

The amortized cost and fair value of securities held to maturity were as follows as of the dates presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Amortized<br>Cost** | **Gross<br>Unrealized<br>Gains** | **Gross<br>Unrealized<br>Losses** | **Fair<br>Value** |
| **September 30, 2025** | | | | |
| Obligations of states and political subdivisions | $280536 | $26 | $(33585) | $246977 |
| Residential mortgage backed securities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises | 336382 |  | (11384) | 324998 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises | 327592 |  | (19529) | 308063 |
| Commercial mortgage backed securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises | 16944 |  | (2185) | 14759 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises | 42372 |  | (6129) | 36243 |
| Other debt securities | 48090 |  | (2440) | 45650 |
|  | $1051916 | $26 | $(75252) | $976690 |
| Allowance for credit losses - held to maturity securities | (32) |  |  |  |
| Held to maturity securities, net of allowance for credit losses | $1051884 |  |  |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Amortized<br>Cost** | **Gross<br>Unrealized<br>Gains** | **Gross<br>Unrealized<br>Losses** | **Fair<br>Value** |
| **December 31, 2024** | | | | |
| Obligations of states and political subdivisions | $284542 | $3 | $(42491) | $242054 |
| Residential mortgage backed securities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises | 372414 |  | (25251) | 347163 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises | 354882 |  | (41506) | 313376 |
| Commercial mortgage backed securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises | 16961 |  | (2958) | 14003 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises | 43662 |  | (7317) | 36345 |
| Other debt securities | 53683 |  | (4080) | 49603 |
|  | $1126144 | $3 | $(123603) | $1002544 |
| Allowance for credit losses - held to maturity securities | (32) |  |  |  |
| Held to maturity securities, net of allowance for credit losses | $1126112 |  |  |  |

---

Securities sold are presented in the tables below for the periods presented. On April 1, 2025, the Company acquired available for sale securities with a fair value of $1,457,377 as part of the merger with The First. Shortly after merger, certain securities from this portfolio were sold at carrying value, resulting in no gain or loss on the sale; no other securities were sold in the first nine months of 2025. With respect to the securities sold during the nine months ended September 30, 2024, the Company intended to sell these securities as of December 31, 2023, and completed the sale in January 2024. Therefore, the Company impaired the securities and recognized the loss in net income as of December 31, 2023.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | | |
|:---|:---|:---|:---|
| | **Carrying Value Immediately Prior to Sale** | **Net Proceeds** | **Gain/(Loss)** |
| **Nine months ended September 30, 2025** | | | |
| Obligations of other U.S. Government agencies and corporations | $34394 | $34394 | $— |
| Obligations of states and political subdivisions | 327509 | 327509 |  |
| Residential mortgage backed securities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises | 275910 | 275910 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises | 2437 | 2437 |  |
| Commercial mortgage backed securities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises | 6541 | 6541 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises | 6480 | 6480 |  |
| Other debt securities | 33214 | 33214 |  |
|  | $686485 | $686485 | $— |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Carrying Value Immediately Prior to Sale** | **Net Proceeds** | **Impairment (Recognized in December 2023)** |
| **Nine months ended September 30, 2024** | | | |
| Obligations of states and political subdivisions | $12301 | $11360 | $(941) |
| Residential mortgage backed securities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises | 107389 | 95922 | (11467) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises | 48300 | 43990 | (4310) |
| Commercial mortgage backed securities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises | 28547 | 25913 | (2634) |
|  | $196537 | $177185 | $(19352) |

---

At September 30, 2025 and December 31, 2024, securities with a carrying value of $1,210,564 and $818,344, respectively, were pledged to secure government, public and trust deposits. Securities with a carrying value of $13,639 and $16,935 were pledged as collateral for short-term borrowings and derivative instruments, respectively, at September 30, 2025. Securities with a carrying value of $13,083 and $12,443 were pledged as collateral for short-term borrowings and derivative instruments, respectively, at December 31, 2024.

The amortized cost and fair value of securities at September 30, 2025 by contractual maturity are shown below. Expected maturities will differ from contractual maturities because issuers may call or prepay obligations with or without call or prepayment penalties.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Held to Maturity** | **Held to Maturity** | **Available for Sale** | **Available for Sale** |
| | **Amortized<br>Cost** | **Fair<br>Value** | **Amortized<br>Cost** | **Fair<br>Value** |
| Due within one year | $420 | $420 | $9797 | $9815 |
| Due after one year through five years | 5649 | 5427 | 76154 | 76555 |
| Due after five years through ten years | 180726 | 161444 | 121374 | 121260 |
| Due after ten years | 93741 | 79686 | 119660 | 121614 |
| Residential mortgage backed securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises | 336382 | 324998 | 710105 | 696306 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises | 327592 | 308063 | 739005 | 682080 |
| Commercial mortgage backed securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises | 16944 | 14759 | 100337 | 99759 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises | 42372 | 36243 | 414781 | 398751 |
| Other debt securities | 48090 | 45650 | 308184 | 306510 |
|  | $1051916 | $976690 | $2599397 | $2512650 |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

The following tables present the age of gross unrealized losses and fair value by investment category for which an allowance for credit losses has not been recorded as of the dates presented:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Less than 12 Months** | **Less than 12 Months** | **Less than 12 Months** | **12 Months or More** | **12 Months or More** | **12 Months or More** | **Total** | **Total** | **Total** |
| | **#** | **Fair<br>Value** | **Unrealized<br>Losses** | **#** | **Fair<br>Value** | **Unrealized<br>Losses** | **#** | **Fair<br>Value** | **Unrealized<br>Losses** |
| **Available for Sale:** | | | | | | | | | |
| **September 30, 2025** | | | | | | | | | |
| Obligations of states and political subdivisions | 19 | $33281 | $(702) | 7 | $13309 | $(1663) | 26 | $46590 | $(2365) |
| Residential mortgage backed securities: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises | 5 | 122812 | (1316) | 36 | 137171 | (16192) | 41 | 259983 | (17508) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises | 3 | 27820 | (155) | 37 | 306995 | (59748) | 40 | 334815 | (59903) |
| Commercial mortgage backed securities: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises | 9 | 71211 | (396) | 2 | 5581 | (403) | 11 | 76792 | (799) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises | 9 | 28319 | (40) | 25 | 102483 | (18629) | 34 | 130802 | (18669) |
| Other debt securities | 16 | 269566 | (1983) | 10 | 18286 | (1256) | 26 | 287852 | (3239) |
| Total | 61 | $553009 | $(4592) | 117 | $583825 | $(97891) | 178 | $1136834 | $(102483) |
| **December 31, 2024** |  |  |  |  |  |  |  |  |  |
| Obligations of states and political subdivisions |  | $— | $— | 7 | $12841 | $(2269) | 7 | $12841 | $(2269) |
| Residential mortgage backed securities: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises | 7 | 11051 | (259) | 34 | 141321 | (24208) | 41 | 152372 | (24467) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises | 3 | 48879 | (482) | 37 | 311964 | (86389) | 40 | 360843 | (86871) |
| Commercial mortgage backed securities: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises | 2 | 5248 | (122) | 2 | 5375 | (629) | 4 | 10623 | (751) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises | 2 | 7681 | (39) | 25 | 104326 | (21556) | 27 | 112007 | (21595) |
| Other debt securities | 2 | 22357 | (218) | 17 | 30801 | (2437) | 19 | 53158 | (2655) |
| Total | 16 | $95216 | $(1120) | 122 | $606628 | $(137488) | 138 | $701844 | $(138608) |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Less than 12 Months** | **Less than 12 Months** | **Less than 12 Months** | **12 Months or More** | **12 Months or More** | **12 Months or More** | **Total** | **Total** | **Total** |
| | **#** | **Fair<br>Value** | **Unrealized<br>Losses** | **#** | **Fair<br>Value** | **Unrealized<br>Losses** | **#** | **Fair<br>Value** | **Unrealized<br>Losses** |
| **Held to Maturity:** | | | | | | | | | |
| **September 30, 2025** | | | | | | | | | |
| Obligations of states and political subdivisions | 6 | $15151 | $(1272) | 119 | $229928 | $(32313) | 125 | $245079 | $(33585) |
| Residential mortgage backed securities: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises |  |  |  | 66 | 324998 | (11384) | 66 | 324998 | (11384) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises |  |  |  | 18 | 308063 | (19529) | 18 | 308063 | (19529) |
| Commercial mortgage backed securities: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises |  |  |  | 1 | 14758 | (2185) | 1 | 14758 | (2185) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises |  |  |  | 9 | 36285 | (6129) | 9 | 36285 | (6129) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other debt securities |  |  |  | 10 | 45854 | (2440) | 10 | 45854 | (2440) |
| Total | 6 | $15151 | $(1272) | 223 | $959886 | $(73980) | 229 | $975037 | $(75252) |
| **December 31, 2024** |  |  |  |  |  |  |  |  |  |
| Obligations of states and political subdivisions |  | $— | $— | 128 | $240394 | $(42491) | 128 | $240394 | $(42491) |
| Residential mortgage backed securities: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises |  |  |  | 69 | 347154 | (25251) | 69 | 347154 | (25251) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises |  |  |  | 18 | 313376 | (41506) | 18 | 313376 | (41506) |
| Commercial mortgage backed securities: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage backed securities issued by U.S. Government agencies or sponsored enterprises |  |  |  | 1 | 14002 | (2958) | 1 | 14002 | (2958) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises |  |  |  | 9 | 36345 | (7317) | 9 | 36345 | (7317) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other debt securities |  |  |  | 10 | 49603 | (4080) | 10 | 49603 | (4080) |
| Total |  | $— | $— | 235 | $1000874 | $(123603) | 235 | $1000874 | $(123603) |

---

The Company evaluates its available for sale investment securities in an unrealized loss position on a quarterly basis. If the Company intends to sell the security or it is more likely than not that it will be required to sell before recovery, the entire unrealized loss is recorded as a loss within noninterest income in the Consolidated Statements of Income along with a corresponding adjustment to the amortized cost basis of the security. If the Company does not intend to sell the security and it is not more likely than not that it will be required to sell the security before recovery of its amortized cost basis, the Company evaluates if any of the unrealized loss is related to a potential credit loss. The amount related to credit loss, if any, is recognized in earnings as a provision for credit loss and a corresponding allowance for credit losses is established; each is calculated as the difference between the estimate of the discounted future contractual cash flows and the amortized cost basis of the security. A number of qualitative and quantitative factors are considered by management in the estimate of the discounted future contractual cash flows, including the financial condition of the underlying issuer, current and projected deferrals or defaults and credit ratings by nationally recognized statistical rating agencies. The remaining difference between the fair value and the

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

amortized cost basis of the security is considered the amount related to other market factors and is recognized in other comprehensive income, net of tax.

As of September 30, 2025, the Company did not intend to sell any of the securities in an unrealized loss position, and it is not more likely than not that the Company will be required to sell any such security prior to the recovery of its amortized cost basis, which may be maturity. Furthermore, more than 90% of available for sale securities have the explicit backing of the U.S. government or a guarantee from a U.S. government sponsored enterprise that has perceived credit risk the same as the U.S. government. Performance of these securities has been in line with broader market price performance, indicating that increases in market-based, risk-free rates, and not credit-related factors, are driving losses. When determining the fair value of the contractual cash flows for municipal and corporate securities, the Company considers historical experience with credit sensitive securities, current market conditions, the financial condition of the underlying issuer, current credit ratings, ratings changes and outlook, explicit and implicit guarantees, or insurance programs. Based upon its review of these factors as of September 30, 2025, the Company determined that all such losses resulted from factors not deemed credit-related. As a result, no credit-related impairment was recognized in current earnings, and all unrealized losses for available for sale securities were recorded in other comprehensive income (loss). See Note 13, "Other Comprehensive Income" for more information on the Company's unrealized losses on securities.

The allowance for credit losses on held to maturity securities was $32 at each of September 30, 2025 and December 31, 2024. The Company monitors the credit quality of debt securities held to maturity using bond investment grades assigned by nationally recognized statistical ratings agencies. Updated investment grades are obtained as they become available from agencies. As of September 30, 2025, all of the debt securities held to maturity were rated A or higher by the ratings agencies.

**Note 4 – Loans**

*(In Thousands, Except Number of Loans)*

For purposes of this Note 4, all references to "loans" mean loans excluding loans held for sale.

The following is a summary of loans and leases as of the dates presented:

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31, 2024** |
| Commercial, financial, agricultural | $2760490 | $1885817 |
| Lease financing | 78964 | 95071 |
| Real estate – construction: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Residential | 404651 | 256655 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commercial | 1122839 | 836998 |
| Total real estate – construction | 1527490 | 1093653 |
| Real estate – 1-4 family mortgage: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primary | 3061356 | 2428076 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Home equity | 739786 | 544158 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rental/investment | 841515 | 402938 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development | 239955 | 113705 |
| Total real estate – 1-4 family mortgage | 4882612 | 3488877 |
| Real estate – commercial mortgage: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Owner-occupied | 3321186 | 1894679 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-owner occupied | 6120677 | 4226937 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development | 223212 | 114452 |
| Total real estate – commercial mortgage | 9665075 | 6236068 |
| Installment loans to individuals | 115675 | 90014 |
| Gross loans | 19030306 | 12889500 |
| Unearned income | (4785) | (4480) |
| Loans, net of unearned income | $19025521 | $12885020 |

---

*Past Due and Nonaccrual Loans*

Loans are considered past due if the required principal and interest payments have not been received as of the date such payments were due. Generally, the recognition of interest on loans is discontinued at the time the loan is 90 days past due unless the credit is well-secured and in process of collection. Consumer and other retail loans are typically charged-off no later than the time the loan is 120 days past due. In all cases, loans are placed on nonaccrual status or charged-off at an earlier date if collection of principal or interest is considered doubtful. Loans may be placed on nonaccrual status regardless of whether or not such loans are considered past due. For loans that are placed on nonaccrual status or charged-off, all interest accrued for the current year but not collected is reversed against interest income. The interest on these loans is accounted for on the cash-basis or cost-recovery method, until qualifying for return to accrual status. Loans are returned to accrual status when all the principal and interest amounts contractually due are brought current and future payments are reasonably assured. No interest income was recognized on nonaccrual loans for the three and nine months ended September 30, 2025 and 2024.

The following tables provide an aging of past due accruing and nonaccruing loans, segregated by class, as of the dates presented:

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Accruing Loans** | **Accruing Loans** | **Accruing Loans** | **Accruing Loans** | **Nonaccruing Loans** | **Nonaccruing Loans** | **Nonaccruing Loans** | **Nonaccruing Loans** | |
| | **30-89 Days<br>Past Due** | **90 Days<br>or More<br>Past Due** | **Current<br>Loans** | **Total<br>Loans** | **30-89 Days<br>Past Due** | **90 Days<br>or More<br>Past Due** | **Current<br>Loans** | **Total<br>Loans** |<br>**Total<br>Loans** |
| **September 30, 2025** | | | | | | | | | |
| Commercial, financial, agricultural | $4430 | $138 | $2723231 | $2727799 | $(260) | $6946 | $26005 | $32691 | $2760490 |
| Lease financing | 215 |  | 78111 | 78326 |  | 638 |  | 638 | 78964 |
| Real estate – construction: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Residential | 441 |  | 401685 | 402126 |  | 241 | 2284 | 2525 | 404651 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commercial | 2708 |  | 1118008 | 1120716 |  |  | 2123 | 2123 | 1122839 |
| Total real estate – construction | 3149 |  | 1519693 | 1522842 |  | 241 | 4407 | 4648 | 1527490 |
| Real estate – 1-4 family mortgage: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primary | 26510 | 46 | 2982691 | 3009247 | 2351 | 42865 | 6893 | 52109 | 3061356 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Home equity | 4852 |  | 732374 | 737226 | 414 | 1875 | 271 | 2560 | 739786 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rental/investment | 2235 | 103 | 836590 | 838928 | 238 | 1442 | 907 | 2587 | 841515 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development | 177 |  | 239729 | 239906 |  | 44 | 5 | 49 | 239955 |
| Total real estate – 1-4 family mortgage | 33774 | 149 | 4791384 | 4825307 | 3003 | 46226 | 8076 | 57305 | 4882612 |
| Real estate – commercial mortgage: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Owner-occupied | 5278 |  | 3286031 | 3291309 | 3964 | 3950 | 21963 | 29877 | 3321186 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-owner occupied | 649 | 485 | 6074884 | 6076018 | 9241 | 7361 | 28057 | 44659 | 6120677 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development | 332 |  | 222161 | 222493 | 82 | 585 | 52 | 719 | 223212 |
| Total real estate – commercial mortgage | 6259 | 485 | 9583076 | 9589820 | 13287 | 11896 | 50072 | 75255 | 9665075 |
| Installment loans to individuals | 827 | 20 | 114609 | 115456 | 89 | 104 | 26 | 219 | 115675 |
| Unearned income |  |  | (4785) | (4785) |  |  |  |  | (4785) |
| Loans, net of unearned income | $48654 | $792 | $18805319 | $18854765 | $16119 | $66051 | $88586 | $170756 | $19025521 |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Accruing Loans** | **Accruing Loans** | **Accruing Loans** | **Accruing Loans** | **Nonaccruing Loans** | **Nonaccruing Loans** | **Nonaccruing Loans** | **Nonaccruing Loans** | |
| | **30-89 Days<br>Past Due** | **90 Days<br>or More<br>Past Due** | **Current<br>Loans** | **Total<br>Loans** | **30-89 Days<br>Past Due** | **90 Days<br>or More<br>Past Due** | **Current<br>Loans** | **Total<br>Loans** |<br>**Total<br>Loans** |
| **December 31, 2024** | | | | | | | | | |
| Commercial, financial, agricultural | $807 | $125 | $1883010 | $1883942 | $245 | $734 | $896 | $1875 | $1885817 |
| Lease financing | 27 |  | 90961 | 90988 | 78 | 614 | 3391 | 4083 | 95071 |
| Real estate – construction: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Residential | 2194 |  | 253238 | 255432 |  | 1023 | 200 | 1223 | 256655 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commercial |  | 16 | 836982 | 836998 |  |  |  |  | 836998 |
| Total real estate – construction | 2194 | 16 | 1090220 | 1092430 |  | 1023 | 200 | 1223 | 1093653 |
| Real estate – 1-4 family mortgage: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primary | 29258 |  | 2343781 | 2373039 | 13627 | 25335 | 16075 | 55037 | 2428076 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Home equity | 3186 | 35 | 537568 | 540789 | 941 | 1094 | 1334 | 3369 | 544158 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rental/investment | 573 | 12 | 401977 | 402562 | 136 | 240 |  | 376 | 402938 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development | 25 | 1740 | 111920 | 113685 | 20 |  |  | 20 | 113705 |
| Total real estate – 1-4 family mortgage | 33042 | 1787 | 3395246 | 3430075 | 14724 | 26669 | 17409 | 58802 | 3488877 |
| Real estate – commercial mortgage: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Owner-occupied | 2650 | 365 | 1879350 | 1882365 | 296 | 1000 | 11018 | 12314 | 1894679 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-owner occupied | 326 |  | 4197331 | 4197657 |  |  | 29280 | 29280 | 4226937 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development | 142 | 160 | 111019 | 111321 | 98 | 16 | 3017 | 3131 | 114452 |
| Total real estate – commercial mortgage | 3118 | 525 | 6187700 | 6191343 | 394 | 1016 | 43315 | 44725 | 6236068 |
| Installment loans to individuals | 654 | 11 | 89246 | 89911 | 4 | 42 | 57 | 103 | 90014 |
| Unearned income |  |  | (4480) | (4480) |  |  |  |  | (4480) |
| Loans, net of unearned income | $39842 | $2464 | $12731903 | $12774209 | $15445 | $30098 | $65268 | $110811 | $12885020 |

---

*Collateral Dependent Loans*

Collateral dependent loans are loans for which the repayment is expected to be provided substantially through the operation or sale of the collateral and the borrower is experiencing financial difficulty. These loans do not share common risk characteristics with other loans within the Company's portfolio, and the allowance for credit losses on such loans is evaluated on an individual basis rather than on a collective basis with other pooled loans. The majority of collateral dependent loans consist of commercial purpose loans with collateral comprised of real estate and business assets. Collateral dependent loans were $131,265 and $66,063 at September 30, 2025 and December 31, 2024, respectively. The Company recorded a specific allowance for credit losses on such loans of $27,010 and $15,052 at September 30, 2025 and December 31, 2024, respectively, which reflected the difference between the net realizable value of the collateral and the amortized cost of the loans. The increase in collateral dependent loans from December 31, 2024 is primarily due to acquired collateral dependent loans from The First.

*Certain Modifications to Borrowers Experiencing Financial Difficulty*

Certain modifications of loans made to borrowers experiencing financial difficulty in the form of principal forgiveness, an interest rate reduction, an other-than-insignificant payment delay (including extension of the amortization period), or a term extension, but excluding covenant waivers and modification of contingent acceleration clauses, are required to be disclosed in accordance with ASU 2022-02, *"Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures"* ("ASU 2022-02"). All modifications for the three and nine months ended September 30, 2025 and 2024 and which met the disclosure criteria in ASU 2022-02 were performing in accordance with their modified terms at September 30, 2025 and 2024, respectively. There were unused commitments of $647 and $464 with respect to these loans at September 30, 2025 and September 30, 2024, respectively. Upon the Company's determination that a modification has subsequently become uncollectible, the loan, or portion of the loan, is charged off, the amortized cost basis of the loan is reduced by the uncollectible amount, and the allowance for credit losses is adjusted accordingly. See Note 5, "Allowance for Credit Losses," for more information on the allowance for credit losses.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

The following tables present the amortized cost basis of loans that were experiencing financial difficulty, modified during the three and nine months ended September 30, 2025 and 2024, respectively, by class of financing receivable and by type of modification. The percentage of the amortized cost basis for each class of disclosed modifications as compared to the amortized cost basis of each class of loans is also presented below.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| | **Interest Rate Reduction** | **Term Extension** | **Payment Delay** | **Term Extension and Payment Delay** | **Interest Rate Reduction and Term Extension** | **Total** | **% Total Loans by Class** |
| Commercial, financial, agricultural | $— | $27025 | $— | $101 | $— | $27126 | 0.98% |
| Lease financing |  |  |  |  |  |  |  |
| Real estate – 1-4 family mortgage: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Primary |  |  | 157 | 17 |  | 174 | 0.01 |
| &nbsp;&nbsp;&nbsp;&nbsp;Home equity |  | 39 | 124 |  |  | 163 | 0.02 |
| Total real estate – 1-4 family mortgage |  | 39 | 281 | 17 |  | 337 | 0.01 |
| Real estate – commercial mortgage: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Owner-occupied | 1142 | $— | $— | $— | $142 | $1284 | 0.04 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-owner occupied |  |  |  |  | 357 | 357 | 0.01 |
| &nbsp;&nbsp;&nbsp;&nbsp;Land development |  | 33 |  |  |  | 33 | 0.01 |
| Total real estate – commercial mortgage | 1142 | 33 |  |  | 499 | 1674 | 0.02 |
| Installment loans to individuals |  |  |  | 11 |  | 11 | 0.01 |
| Loans, net of unearned income | $1142 | $27097 | $281 | $129 | $499 | $29148 | 0.15% |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Interest Rate Reduction** | **Term Extension** | **Payment Delay** | **Term Extension and Payment Delay** | **Interest Rate Reduction and Term Extension** | **Interest Rate Reduction, Term Extension and Payment Delay** | **Total** | **% Total Loans by Class** |
| Commercial, financial, agricultural | $— | $27025 | $— | $101 | $— | $— | $27126 | 0.98% |
| Real estate – construction: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Residential |  |  |  | 235 |  |  | 235 | 0.06% |
| Real estate – 1-4 family mortgage: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Primary |  |  | 157 | 17 |  |  | 174 | 0.01 |
| &nbsp;&nbsp;Home equity |  | 39 | 124 |  |  |  | 163 | 0.02 |
| Total real estate – 1-4 family mortgage |  | 39 | 281 | 17 |  |  | 337 | 0.01 |
| Real estate – commercial mortgage: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Owner-occupied | 1142 |  |  |  | 142 |  | 1284 | 0.04 |
| &nbsp;&nbsp;Non-owner occupied |  | 2077 |  |  | 357 |  | 2434 | 0.04 |
| &nbsp;&nbsp;Land development |  | 33 |  |  |  |  | 33 | 0.01 |
| Total real estate – commercial mortgage | 1142 | 2110 |  |  | 499 |  | 3751 | 0.04 |
| Installment loans to individuals |  | 81 | 6 | 13 |  | 2 | 102 | 0.09 |
| Loans, net of unearned income | $1142 | $29255 | $287 | $366 | $499 | $2 | $31551 | 0.17% |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
| | **Term Extension** | **Payment Delay** | **Interest Rate Reduction, Term Extension and Payment Delay** | **Interest Rate Reduction and Payment Delay** | **Total** | **% Total Loans by Class** |
| Commercial, financial, agricultural | $— | $53 | $— | $— | $53 | —% |
| Real estate – 1-4 family mortgage: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Primary | 23 | 1620 |  | 206 | 1849 | 0.08 |
| &nbsp;&nbsp;&nbsp;&nbsp;Home equity | 106 |  |  |  | 106 | 0.02 |
| &nbsp;&nbsp;&nbsp;&nbsp;Rental/investment | 36 | 548 |  |  | 584 | 0.15 |
| Total real estate – 1-4 family mortgage | 165 | 2168 |  | 206 | 2539 |  |
| Real estate – commercial mortgage: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Owner-occupied | 1086 | 206 |  |  | 1292 | 0.07 |
| Installment loans to individuals |  |  | 3 |  | 3 |  |
| Loans, net of unearned income | $1251 | $2427 | $3 | $206 | $3887 | 0.03% |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Interest Rate Reduction** | **Term Extension** | **Payment Delay** | **Term Extension and Payment Delay** | **Interest Rate Reduction and Term Extension** | **Interest Rate Reduction, Term Extension and Payment Delay** | **Interest Rate Reduction and Payment Delay** | **Total** | **% Total Loans by Class** |
| Commercial, financial, agricultural | $1097 | $69 | $53 | $— | $— | $125 |  | $1344 | 0.07% |
| Real estate – 1-4 family mortgage: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Primary |  | 56 | 1806 | 442 |  |  | 206 | 2510 | 0.10 |
| &nbsp;&nbsp;Home equity |  | 106 |  |  |  |  |  | 106 | 0.02 |
| &nbsp;&nbsp;Rental/investment |  | 36 | 548 |  |  |  |  | 584 | 0.15 |
| Total real estate – 1-4 family mortgage |  | 198 | 2354 | 442 |  |  | 206 | 3200 | 0.09 |
| Real estate – commercial mortgage: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Owner-occupied | 6946 | 1266 | 206 |  | 255 |  |  | 8673 | 0.47 |
| &nbsp;&nbsp;Non-owner occupied |  | 2431 | 83 |  |  |  |  | 2514 | 0.06 |
| Total real estate – commercial mortgage | 6946 | 3697 | 289 |  | 255 |  |  | 11187 | 0.19 |
| Installment loans to individuals |  |  | 13 |  |  | 3 |  | 16 | 0.02 |
| Loans, net of unearned income | $8043 | $3964 | $2709 | $442 | $255 | $128 | 206 | $15747 | 0.12% |

---

The following tables present the weighted average financial effect of loan modifications by class of financing receivable for the periods presented.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | |
|:---|:---|
| **Three months ended September 30, 2025**<br>**Loan Type** |<br>**Financial Effect** |
| **Interest Rate Reduction** | |
| Real Estate - Commercial Mortgage - Owner Occupied | Reduced the interest rate 485 basis points |
| **Term Extension** |  |
| Commercial, financial, agricultural | Extended the term 12 months |
| Real estate – 1-4 family mortgage - Home Equity | Extended the term 56 months |
| Real Estate - Commercial Mortgage - Land Development | Extended the term 60 months |
| **Payment Delay** |  |
| Real estate – 1-4 family mortgage - Primary | Delayed the payment 16 months |
| Real estate – 1-4 family mortgage - Home Equity | Delayed the payment 51 months |
| **Combination - Term Extension and Payment Delay** |  |
| Commercial, financial, agricultural | Extended the term and delayed the payment 22 months |
| Real estate – 1-4 family mortgage - Primary | Extended the term and delayed the payment 19 months |
| Installment loans to individuals | Extended the term and delayed the payment 43 months |
| **Combination - Interest Rate Reduction and Term Extension** |  |
| Real Estate - Commercial Mortgage - Owner Occupied | Reduced the interest rate 45 basis points and extended the term 80 months |
| Real Estate - Commercial Mortgage - Non-owner Occupied | Reduced the interest rate 45 basis points and extended the term 81 months |

---

---

| | |
|:---|:---|
| **Nine months ended September 30, 2025**<br>**Loan Type** |<br>**Financial Effect** |
| **Interest Rate Reduction** | |
| Real Estate - Commercial Mortgage - Owner Occupied | Reduced the interest rate 485 basis points |
| **Term Extension** |  |
| Commercial, financial, agricultural | Extended the term 12 months |
| Real estate – 1-4 family mortgage - Home Equity | Extended the term 56 months |
| Real Estate - Commercial Mortgage - Non-owner Occupied | Extended the term 12 months |
| Real Estate - Commercial Mortgage - Land Development | Extended the term 60 months |
| Installment loans to individuals | Extended the term 124 months |
| **Payment Delay** |  |
| Real estate – 1-4 family mortgage - Primary | Delayed the payment 16 months |
| Real estate – 1-4 family mortgage - Home Equity | Delayed the payment 50 months |
| Installment loans to individuals | Delayed the payment 23 months |
| **Combination - Term Extension and Payment Delay** |  |
| Commercial, financial, agricultural | Extended the term and delayed the payment 22 months |
| Real estate – Construction - Residential | Extended the term and delayed the payment 35 months |
| Real estate – 1-4 family mortgage - Primary | Extended the term and delayed the payment 19 months |
| Installment loans to individuals | Extended the term and delayed the payment 45 months |
| **Combination - Interest Rate Reduction and Term Extension** |  |
| Real Estate - Commercial Mortgage - Owner Occupied | Reduced the interest rate 45 basis points and extended the term 80 months |
| Real Estate - Commercial Mortgage - Non-owner Occupied | Reduced the interest rate 45 basis points and extended the term 81 months |
| **Combination - Interest Rate Reduction, Term Extension and Payment Delay** |  |
| Installment loans to individuals | Reduced the interest rate 425 basis points and extended the term and delayed the payment 49 months |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | |
|:---|:---|
| **Three months ended September 30, 2024**<br>**Loan Type** |<br>**Financial Effect** |
| **Term Extension** | |
| Real estate – 1-4 family mortgage - Primary | Extended the term 90 months |
| Real estate – 1-4 family mortgage - Home Equity | Extended the term 16 months |
| Real estate – 1-4 family mortgage - Rental/investment | Extended the term 6 months |
| Real Estate - Commercial Mortgage - Owner Occupied | Extended the term 8 months |
| **Payment Delay** |  |
| Commercial, financial, agricultural | Delayed the payment 8 months |
| Real estate – 1-4 family mortgage - Primary | Delayed the payment 19 months |
| Real estate – 1-4 family mortgage - Rental/investment | Delayed the payment 131 months |
| Real Estate - Commercial Mortgage - Owner Occupied | Delayed the payment 40 months |
| **Combination - Interest Rate Reduction and Payment Delay** |  |
| Real estate – 1-4 family mortgage - Primary | Reduced the interest rate 25 basis points and extended the term 51 months |
| **Combination - Interest Rate Reduction, Term Extension and Payment Delay** |  |
| Installment loans to individuals | Reduced the interest rate 460 basis points and extended the term and delayed the payment 54 months |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | |
|:---|:---|
| **Nine months ended September 30, 2024**<br>**Loan Type** |<br>**Financial Effect** |
| **Interest Rate Reduction** | |
| Commercial, financial, agricultural | Reduced the interest rate 39 basis points |
| Real Estate - Commercial Mortgage - Owner Occupied | Reduced the interest rate 47 basis points |
| **Term Extension** |  |
| Commercial, financial, agricultural | Extended the term 8 months |
| Real estate – 1-4 family mortgage - Primary | Extended the term 51 months |
| Real estate – 1-4 family mortgage - Home Equity | Extended the term 16 months |
| Real estate – 1-4 family mortgage - Rental/investment | Extended the term 6 months |
| Real Estate - Commercial Mortgage - Owner Occupied | Extended the term 8 months |
| Real Estate - Commercial Mortgage - Non-owner Occupied | Extended the term 8 months |
| **Payment Delay** |  |
| Commercial, financial, agricultural | Delayed the payment 8 months |
| Real estate – 1-4 family mortgage - Primary | Delayed the payment 22 months |
| Real estate – 1-4 family mortgage - Rental/investment | Delayed the payment 131 months |
| Real Estate - Commercial Mortgage - Owner Occupied | Delayed the payment 40 months |
| Real Estate - Commercial Mortgage - Non-owner Occupied | Delayed the payment 9 months |
| Installment loans to individuals | Delayed the payment 17 months |
| **Combination - Term Extension and Payment Delay** |  |
| Real estate – 1-4 family mortgage - Primary | Extended the term and delayed the payment 42 months |
| **Combination - Interest Rate Reduction and Term Extension** |  |
| Real Estate - Commercial Mortgage - Owner Occupied | Reduced the interest rate 275 basis points and extended the term 21 months |
| **Combination - Interest Rate Reduction and Payment Delay** |  |
| Real estate – 1-4 family mortgage - Primary | Reduced the interest rate 25 basis points and delayed the payment 51 months |
| **Combination - Interest Rate Reduction, Term Extension and Payment Delay** |  |
| Commercial, financial, agricultural | Reduced the interest rate 181 basis points and extended the term and delayed the payment 59 months |
| Installment loans to individuals | Reduced the interest rate 460 basis points and extended the term and delayed the payment 54 months |

---

*Credit Quality*

For commercial and commercial real estate loans, internal risk-rating grades are assigned by lending, credit administration and loan review personnel, based on an analysis of the financial and collateral strength and other credit attributes underlying each loan. Management analyzes the resulting ratings, as well as other external statistics and factors such as delinquency, to track the migration performance of the portfolio balances of commercial and commercial real estate secured loans. Loan grades range between 10 and 95, with 10 being loans with the least credit risk. Loans within the "Pass" grade (those with a risk rating between 10 and 69) generally have a lower risk of loss and therefore a lower risk factor applied to the loan balances. The "Special Mention" grade (those with a risk rating between 70 and 79) represents a loan where a significant adverse risk-modifying action is anticipated in the near term that, if left uncorrected, could result in deterioration of the credit quality of the loan. Loans that migrate toward the "Classified" grade generally have a higher risk of loss and therefore a higher risk factor applied to those related loan balances.

The following tables present the Company's loan portfolio by year of origination and internal risk-rating grades as of the dates presented:

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | | | |
| | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior** |<br>**Revolving Loans** |<br>**Revolving Loans Converted to Term** |<br>**Total<br>Loans** |
| **September 30, 2025** |  |  |  |  |  |  |  |  |  |
| **Commercial, Financial, Agricultural** | $**453028** | $**292323** | $**213414** | $**242191** | $**141528** | $**121173** | $**1263029** | $**3592** | $**2730278** |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 451970 | 285390 | 192780 | 235332 | 139257 | 115489 | 1206897 | 367 | 2627482 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention | 206 | 2767 | 16032 | 586 | 453 | 3613 | 18562 |  | 42219 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified | 852 | 4166 | 4602 | 6273 | 1818 | 2071 | 37570 | 3225 | 60577 |
| **Lease Financing Receivables** | $**9572** | $**8112** | $**13660** | $**30939** | $**6709** | $**5187** | $**—** | $**—** | $**74179** |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 9560 | 8112 | 13165 | 29059 | 6709 | 5187 |  |  | 71792 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  | 32 |  |  |  |  | 32 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified | 12 |  | 495 | 1848 |  |  |  |  | 2355 |
| **Real Estate - Construction** | $**408714** | $**419441** | $**322877** | $**225680** | $**8252** | $**98** | $**31284** | $**1145** | $**1417491** |
| &nbsp;&nbsp;&nbsp;Residential | 209182 | 72180 | 5989 | 241 |  |  | 7060 |  | 294652 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 207133 | 72180 | 5754 |  |  |  | 7060 |  | 292127 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified | 2049 |  | 235 | 241 |  |  |  |  | 2525 |
| &nbsp;&nbsp;&nbsp;Commercial | 199532 | 347261 | 316888 | 225439 | 8252 | 98 | 24224 | 1145 | 1122839 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 199532 | 347259 | 298658 | 223318 | 8252 | 98 | 24224 | 1145 | 1102486 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified |  | 2 | 18230 | 2121 |  |  |  |  | 20353 |
| **Real Estate - 1-4 Family Mortgage** | $**289327** | $**244798** | $**167011** | $**215772** | $**121131** | $**87795** | $**109877** | $**402** | $**1236113** |
| &nbsp;&nbsp;&nbsp;Primary | 22085 | 18104 | 9154 | 15152 | 12632 | 12130 | 524 | 82 | 89863 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 21754 | 14797 | 8510 | 14514 | 11629 | 10912 | 524 | 82 | 82722 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  | 199 |  | 209 | 449 | 46 |  |  | 903 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified | 331 | 3108 | 644 | 429 | 554 | 1172 |  |  | 6238 |
| &nbsp;&nbsp;&nbsp;Home Equity | 3015 | 814 | 883 | 775 | 758 | 265 | 102888 | 320 | 109718 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 3015 | 814 | 883 | 272 | 758 | 265 | 102559 | 269 | 108835 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  | 503 |  |  | 329 | 51 | 883 |
| &nbsp;&nbsp;&nbsp;Rental/Investment | 187220 | 142595 | 127516 | 183646 | 105543 | 74139 | 2240 |  | 822899 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 186026 | 141898 | 126195 | 182079 | 104506 | 72012 | 2240 |  | 814956 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention | 268 | 175 | 546 | 148 | 93 | 32 |  |  | 1262 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified | 926 | 522 | 775 | 1419 | 944 | 2095 |  |  | 6681 |
| &nbsp;&nbsp;&nbsp;Land Development | 77007 | 83285 | 29458 | 16199 | 2198 | 1261 | 4225 |  | 213633 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 77007 | 80391 | 29458 | 16199 | 2198 | 1261 | 4225 |  | 210739 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  | 2894 |  |  |  |  |  |  | 2894 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |  |
| **Real Estate - Commercial Mortgage** | $**1698474** | $**1414243** | $**1022192** | $**2455287** | $**1317543** | $**1385472** | $**358688** | $**2077** | $**9653976** |
| &nbsp;&nbsp;&nbsp;Owner-Occupied | 377668 | 577015 | 444953 | 589572 | 483072 | 623280 | 225473 |  | 3321033 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 376885 | 563297 | 429598 | 577140 | 469153 | 588653 | 215394 |  | 3220120 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention | 356 | 5366 | 3816 | 1750 | 1514 | 15135 | 9228 |  | 37165 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified | 427 | 8352 | 11539 | 10682 | 12405 | 19492 | 851 |  | 63748 |
| &nbsp;&nbsp;&nbsp;Non-Owner Occupied | 1256303 | 784652 | 558455 | 1840634 | 813648 | 752286 | 112622 | 2077 | 6120677 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 1201694 | 757376 | 554765 | 1716497 | 778906 | 690735 | 111009 |  | 5810982 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention | 38986 | 7731 | 2275 | 66737 | 9412 | 7966 | 138 |  | 133245 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified | 15623 | 19545 | 1415 | 57400 | 25330 | 53585 | 1475 | 2077 | 176450 |
| &nbsp;&nbsp;&nbsp;Land Development | 64503 | 52576 | 18784 | 25081 | 20823 | 9906 | 20593 |  | 212266 |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | | | |
| | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior** |<br>**Revolving Loans** |<br>**Revolving Loans Converted to Term** |<br>**Total<br>Loans** |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 64337 | 50741 | 17988 | 23994 | 20806 | 9605 | 20593 |  | 208064 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention | 139 | 1069 | 750 |  |  | 113 |  |  | 2071 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified | 27 | 766 | 46 | 1087 | 17 | 188 |  |  | 2131 |
| **Installment loans to individuals** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |  |
| **Total loans subject to risk rating** | $**2859115** | $**2378917** | $**1739154** | $**3169869** | $**1595163** | $**1599725** | $**1762878** | $**7216** | $**15112037** |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 2798913 | 2322255 | 1677754 | 3018404 | 1542174 | 1494217 | 1694725 | 1863 | 14550305 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention | 39955 | 20201 | 23419 | 69462 | 11921 | 26905 | 27928 |  | 219791 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified | 20247 | 36461 | 37981 | 82003 | 41068 | 78603 | 40225 | 5353 | 341941 |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | | | |
| | **2024** | **2023** | **2022** | **2021** | **2020** | **Prior** |<br>**Revolving Loans** |<br>**Revolving Loans Converted to Term** |<br>**Total<br>Loans** |
| **December 31, 2024** |  |  |  |  |  |  |  |  |  |
| **Commercial, Financial, Agricultural** | $**292917** | $**208900** | $**228690** | $**113192** | $**66121** | $**54163** | $**898772** | $**2889** | $**1865644** |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 287632 | 206087 | 213209 | 112527 | 64780 | 52756 | 874104 | 2767 | 1813862 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention | 591 | 1613 | 185 | 242 | 107 | 378 | 7006 |  | 10122 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified | 4694 | 1200 | 15296 | 423 | 1234 | 1029 | 17662 | 122 | 41660 |
| **Lease Financing Receivables** | $**12239** | $**22339** | $**39738** | $**9125** | $**3724** | $**3426** | $**—** | $**—** | $**90591** |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 12239 | 17225 | 34637 | 8778 | 2587 | 3246 |  |  | 78712 |
| &nbsp;&nbsp;&nbsp;&nbsp;Watch |  | 1261 | 3254 | 173 | 1137 | 180 |  |  | 6005 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified |  | 3853 | 1847 | 174 |  |  |  |  | 5874 |
| **Real Estate - Construction** | $**353568** | $**243827** | $**382439** | $**18443** | $**—** | $**625** | $**20096** | $**—** | $**1018998** |
| &nbsp;&nbsp;&nbsp;Residential | 162966 | 15455 | 1708 |  |  | 625 | 1246 |  | 182000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 160772 | 14673 | 1467 |  |  | 625 | 1246 |  | 178783 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention | 2194 |  |  |  |  |  |  |  | 2194 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified |  | 782 | 241 |  |  |  |  |  | 1023 |
| &nbsp;&nbsp;&nbsp;Commercial | 190602 | 228372 | 380731 | 18443 |  |  | 18850 |  | 836998 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 190602 | 216051 | 380731 | 18443 |  |  | 18850 |  | 824677 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  | 12321 |  |  |  |  |  |  | 12321 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |  |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | | | |
| | **2024** | **2023** | **2022** | **2021** | **2020** | **Prior** |<br>**Revolving Loans** |<br>**Revolving Loans Converted to Term** |<br>**Total<br>Loans** |
| **Real Estate - 1-4 Family Mortgage** | $**187587** | $**110606** | $**120025** | $**66034** | $**33800** | $**26150** | $**35740** | $**1150** | $**581092** |
| &nbsp;&nbsp;&nbsp;Primary | 10925 | 5336 | 7865 | 4247 | 2463 | 6534 | 1704 | 796 | 39870 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 10925 | 5126 | 7558 | 3979 | 2463 | 5776 | 1704 | 796 | 38327 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  | 143 |  |  |  |  |  | 143 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified |  | 210 | 164 | 268 |  | 758 |  |  | 1400 |
| &nbsp;&nbsp;&nbsp;Home Equity | 966 | 1005 | 7 | 937 |  | 35 | 28976 | 51 | 31977 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 966 | 1005 | 7 | 937 |  |  | 28976 |  | 31891 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  | 35 |  | 51 | 86 |
| &nbsp;&nbsp;&nbsp;Rental/Investment | 96447 | 83682 | 108436 | 59836 | 31029 | 18146 | 4745 | 303 | 402624 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 95903 | 82878 | 108296 | 59553 | 30936 | 17487 | 4745 | 213 | 400011 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention | 180 | 564 | 44 | 52 | 24 |  |  |  | 864 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified | 364 | 240 | 96 | 231 | 69 | 659 |  | 90 | 1749 |
| &nbsp;&nbsp;&nbsp;Land Development | 79249 | 20583 | 3717 | 1014 | 308 | 1435 | 315 |  | 106621 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 79150 | 20583 | 1977 | 1014 | 308 | 1435 | 315 |  | 104782 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention | 99 |  | 1740 |  |  |  |  |  | 1839 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |  |
| **Real Estate - Commercial Mortgage** | $**996574** | $**708788** | $**1807169** | $**1009177** | $**622818** | $**792959** | $**251819** | $**35475** | $**6224779** |
| &nbsp;&nbsp;&nbsp;Owner-Occupied | 373353 | 271445 | 339116 | 275077 | 190911 | 304663 | 137023 | 2969 | 1894557 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 372183 | 261624 | 330018 | 271228 | 188860 | 299578 | 130847 | 2717 | 1857055 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention | 948 | 348 | 388 | 850 | 131 | 1538 |  |  | 4203 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified | 222 | 9473 | 8710 | 2999 | 1920 | 3547 | 6176 | 252 | 33299 |
| &nbsp;&nbsp;&nbsp;Non-Owner Occupied | 576021 | 427715 | 1447377 | 724161 | 428874 | 484792 | 105645 | 32331 | 4226916 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 554095 | 427339 | 1354418 | 718043 | 425291 | 430220 | 105645 | 24360 | 4039411 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention | 4900 | 21 | 77741 | 814 | 1138 | 8254 |  |  | 92868 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified | 17026 | 355 | 15218 | 5304 | 2445 | 46318 |  | 7971 | 94637 |
| &nbsp;&nbsp;&nbsp;Land Development | 47200 | 9628 | 20676 | 9939 | 3033 | 3504 | 9151 | 175 | 103306 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 47134 | 9585 | 17187 | 9735 | 2783 | 3468 | 9151 | 175 | 99218 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention | 66 | 24 | 142 | 31 | 59 |  |  |  | 322 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified |  | 19 | 3347 | 173 | 191 | 36 |  |  | 3766 |
| **Installment loans to individuals** | $**5** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**5** |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 5 |  |  |  |  |  |  |  | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |  |
| **Total loans subject to risk rating** | $**1842890** | $**1294460** | $**2578061** | $**1215971** | $**726463** | $**877323** | $**1206427** | $**39514** | $**9781109** |
| &nbsp;&nbsp;&nbsp;&nbsp;Pass | 1811606 | 1262176 | 2449505 | 1204237 | 718008 | 814591 | 1175583 | 31028 | 9466734 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Mention | 8978 | 16152 | 83637 | 2162 | 2596 | 10350 | 7006 |  | 130881 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified | 22306 | 16132 | 44919 | 9572 | 5859 | 52382 | 23838 | 8486 | 183494 |

---

The following tables present the performing status of the Company's loan portfolio not subject to risk rating as of the dates presented:

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | | | |
| | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior** |<br>**Revolving Loans** |<br>**Revolving Loans Converted to Term** |<br>**Total<br>Loans** |
| **September 30, 2025** |  |  |  |  |  |  |  |  |  |
| **Commercial, Financial, Agricultural** | $**30179** | $**—** | $**33** | $**—** | $**—** | $**—** | $**—** | $**—** | $**30212** |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans | 30179 |  | 33 |  |  |  |  |  | 30212 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  |  |  |  |  |  |  |  |  |
| **Lease Financing Receivables** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  |  |  |  |  |  |  |  |  |
| **Real Estate - Construction** | $**38223** | $**45868** | $**15004** | $**8315** | $**1950** | $**—** | $**—** | $**639** | $**109999** |
| &nbsp;&nbsp;&nbsp;Residential | 38223 | 45868 | 15004 | 8315 | 1950 |  |  | 639 | 109999 |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans | 38223 | 45868 | 15004 | 8315 | 1950 |  |  | 639 | 109999 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Commercial |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  |  |  |  |  |  |  |  |  |
| **Real Estate - 1-4 Family Mortgage** | $**282209** | $**219627** | $**372514** | $**819945** | $**555821** | $**770394** | $**611849** | $**14140** | $**3646499** |
| &nbsp;&nbsp;&nbsp;Primary | 277668 | 217026 | 366790 | 802483 | 546389 | 761137 |  |  | 2971493 |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans | 277243 | 216753 | 360338 | 786987 | 542277 | 740036 |  |  | 2923634 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans | 425 | 273 | 6452 | 15496 | 4112 | 21101 |  |  | 47859 |
| &nbsp;&nbsp;&nbsp;Home Equity |  | 116 | 467 | 716 | 219 | 2694 | 611716 | 14140 | 630068 |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans |  | 116 | 184 | 716 | 145 | 2172 | 611644 | 12664 | 627641 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  |  | 283 |  | 74 | 522 | 72 | 1476 | 2427 |
| &nbsp;&nbsp;&nbsp;Rental/Investment |  |  | 146 | 12797 | 2646 | 3027 |  |  | 18616 |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans |  |  | 146 | 12797 | 2646 | 3027 |  |  | 18616 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Land Development | 4541 | 2485 | 5111 | 3949 | 6567 | 3536 | 133 |  | 26322 |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans | 4541 | 2485 | 5111 | 3905 | 6562 | 3536 | 133 |  | 26273 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  |  |  | 44 | 5 |  |  |  | 49 |
| **Real Estate - Commercial Mortgage** | $**2852** | $**1159** | $**2129** | $**1708** | $**2363** | $**888** | $**—** | $**—** | $**11099** |
| &nbsp;&nbsp;&nbsp;Owner-Occupied |  |  |  |  |  | 153 |  |  | 153 |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans |  |  |  |  |  | 153 |  |  | 153 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Non-Owner Occupied |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Land Development | 2852 | 1159 | 2129 | 1708 | 2363 | 735 |  |  | 10946 |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans | 2852 | 1138 | 2047 | 1605 | 2363 | 735 |  |  | 10740 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  | 21 | 82 | 103 |  |  |  |  | 206 |
| **Installment loans to individuals** | $**37403** | $**18982** | $**10962** | $**7619** | $**4258** | $**13027** | $**23220** | $**204** | $**115675** |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans | 37403 | 18982 | 10907 | 7555 | 4255 | 12910 | 23220 | 204 | 115436 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  |  | 55 | 64 | 3 | 117 |  |  | 239 |
| **Total loans not subject to risk rating** | $**390866** | $**285636** | $**400642** | $**837587** | $**564392** | $**784309** | $**635069** | $**14983** | $**3913484** |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans | 390441 | 285342 | 393770 | 821880 | 560198 | 762569 | 634997 | 13507 | 3862704 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans | 425 | 294 | 6872 | 15707 | 4194 | 21740 | 72 | 1476 | 50780 |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | | | |
| | **2024** | **2023** | **2022** | **2021** | **2020** | **Prior** |<br>**Revolving Loans** |<br>**Revolving Loans Converted to Term** |<br>**Total<br>Loans** |
| **December 31, 2024** |  |  |  |  |  |  |  |  |  |
| **Commercial, Financial, Agricultural** | $**—** | $**—** | $**—** | $**—** | $**—** | $**20173** | $**—** | $**—** | $**20173** |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans |  |  |  |  |  | 20173 |  |  | 20173 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  |  |  |  |  |  |  |  |  |
| **Lease Financing Receivables** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  |  |  |  |  |  |  |  |  |
| **Real Estate - Construction** | $**37714** | $**23301** | $**11210** | $**2056** | $**—** | $**—** | $**108** | $**266** | $**74655** |
| &nbsp;&nbsp;&nbsp;Residential | 37714 | 23301 | 11210 | 2056 |  |  | 108 | 266 | 74655 |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans | 37514 | 23301 | 11210 | 2056 |  |  | 108 | 266 | 74455 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans | 200 |  |  |  |  |  |  |  | 200 |
| &nbsp;&nbsp;&nbsp;Commercial |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  |  |  |  |  |  |  |  |  |
| **Real Estate - 1-4 Family Mortgage** | $**154305** | $**341962** | $**708223** | $**492408** | $**280382** | $**417656** | $**499157** | $**13692** | $**2907785** |
| &nbsp;&nbsp;&nbsp;Primary | 152511 | 340032 | 706868 | 490903 | 279683 | 417316 |  | 893 | 2388206 |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans | 152207 | 336019 | 692470 | 485325 | 269503 | 397394 |  | 893 | 2333811 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans | 304 | 4013 | 14398 | 5578 | 10180 | 19922 |  |  | 54395 |
| &nbsp;&nbsp;&nbsp;Home Equity | 30 |  |  |  |  | 195 | 499157 | 12799 | 512181 |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans | 30 |  |  |  |  | 177 | 499052 | 9553 | 508812 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  |  |  |  |  | 18 | 105 | 3246 | 3369 |
| &nbsp;&nbsp;&nbsp;Rental/Investment |  |  |  | 256 |  | 58 |  |  | 314 |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans |  |  |  | 256 |  | 58 |  |  | 314 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Land Development | 1764 | 1930 | 1355 | 1249 | 699 | 87 |  |  | 7084 |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans | 1764 | 1919 | 1355 | 1240 | 699 | 87 |  |  | 7064 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  | 11 |  | 9 |  |  |  |  | 20 |
| **Real Estate - Commercial Mortgage** | $**2614** | $**2350** | $**1902** | $**2567** | $**1460** | $**396** | $**—** | $**—** | $**11289** |
| &nbsp;&nbsp;&nbsp;Owner-Occupied |  |  |  |  | 121 | 1 |  |  | 122 |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans |  |  |  |  | 121 | 1 |  |  | 122 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Non-Owner Occupied |  |  |  |  | 21 |  |  |  | 21 |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans |  |  |  |  | 21 |  |  |  | 21 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Land Development | 2614 | 2350 | 1902 | 2567 | 1318 | 395 |  |  | 11146 |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans | 2614 | 2350 | 1789 | 2567 | 1317 | 395 |  |  | 11032 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans |  |  | 113 |  | 1 |  |  |  | 114 |
| **Installment loans to individuals** | $**32598** | $**11488** | $**7971** | $**3815** | $**1317** | $**17261** | $**15530** | $**29** | $**90009** |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans | 32561 | 11472 | 7971 | 3802 | 1317 | 17212 | 15529 | 29 | 89893 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans | 37 | 16 |  | 13 |  | 49 | 1 |  | 116 |
| **Total loans not subject to risk rating** | $**227231** | $**379101** | $**729306** | $**500846** | $**283159** | $**455486** | $**514795** | $**13987** | $**3103911** |
| &nbsp;&nbsp;&nbsp;&nbsp;Performing Loans | 226690 | 375061 | 714795 | 495246 | 272978 | 435497 | 514689 | 10741 | 3045697 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Performing Loans | 541 | 4040 | 14511 | 5600 | 10181 | 19989 | 106 | 3246 | 58214 |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

The following tables disclose gross charge-offs by year of origination for the nine months ended September 30, 2025 and year ended December 31, 2024, respectively:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **September 30, 2025** | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior** | **Revolving Loans** | **Total Charge-offs** |
| Commercial, financial, agricultural | $5 | $642 | $869 | $538 | $4972 | $978 | $470 | $8474 |
| Lease financing |  |  | 2356 | 20 | 34 | 26 |  | 2436 |
| Real estate – construction: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Residential |  |  | 107 | 6 |  |  |  | 113 |
| Real estate – 1-4 family mortgage: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primary |  | 106 | 64 | 188 | 64 | 418 |  | 840 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Home equity |  |  |  |  | 241 | 132 |  | 373 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rental/investment |  |  |  |  |  | 1 |  | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development |  |  |  |  |  | 26 |  | 26 |
| Total real estate – 1-4 family mortgage |  | 106 | 64 | 188 | 305 | 577 |  | 1240 |
| Real estate – commercial mortgage: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Owner-occupied |  |  |  |  |  | 1600 | 3941 | 5541 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-owner occupied |  |  |  |  |  | 160 |  | 160 |
| Total real estate – commercial mortgage |  |  |  |  |  | 1760 | 3941 | 5701 |
| Installment loans to individuals |  | 182 | 92 | 34 | 44 | 843 | 3 | 1198 |
| Loans, net of unearned income | $5 | $930 | $3488 | $786 | $5355 | $4184 | $4414 | $19162 |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **December 31, 2024** | **2024** | **2023** | **2022** | **2021** | **2020** | **Prior** | **Revolving Loans** | **Total Charge-offs** |
| Commercial, financial, agricultural | $— | $46 | $152 | $879 | $4 | $2975 | $407 | $4463 |
| Lease financing |  | 336 | 306 |  |  |  |  | 642 |
| Real estate – construction: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Residential |  |  | 145 |  |  |  |  | 145 |
| Real estate – 1-4 family mortgage: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primary |  | 29 | 195 | 35 | 110 | 102 |  | 471 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Home equity |  |  | 329 |  |  | 121 |  | 450 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rental/investment |  |  |  |  |  | 45 |  | 45 |
| Total real estate – 1-4 family mortgage |  | 29 | 524 | 35 | 110 | 268 |  | 966 |
| Real estate – commercial mortgage: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Owner-occupied |  |  | 37 |  |  |  |  | 37 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-owner occupied |  |  |  |  |  | 5693 |  | 5693 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development |  |  |  |  |  | 7 |  | 7 |
| Total real estate – commercial mortgage |  |  | 37 |  |  | 5700 |  | 5737 |
| Installment loans to individuals | 36 | 110 | 69 | 15 | 3 | 1623 |  | 1856 |
| Loans, net of unearned income | $36 | $521 | $1233 | $929 | $117 | $10566 | $407 | $13809 |

---

*Loans Pledged*

The FHLB of Dallas maintains a blanket lien on the Company's loan portfolio to be pledged as collateral for various FHLB products. In addition, the Company also pledges a portion of its non-real estate loan portfolio to the Federal Reserve as collateral at the Discount Window.

**Note 5 – Allowance for Credit Losses**

*(In Thousands)*

*Allowance for Credit Losses on Loans*

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

The allowance for credit losses is an estimate of expected losses inherent within the Company's loans held for investment and is maintained at a level believed adequate by management to absorb credit losses inherent in the entire loan portfolio. Management evaluates the adequacy of the allowance for credit losses on a quarterly basis. Expected credit loss inherent in non-cancellable off-balance-sheet credit exposures is accounted for as a separate liability in the Consolidated Balance Sheets. The allowance for credit losses on loans held for investment, as reported in the Company's Consolidated Balance Sheets, is adjusted by a provision for credit losses, which is reported in earnings, and reduced by net charge-offs. Loan losses are charged against the allowance for credit losses when management believes the uncollectability of a loan balance is confirmed and such losses are reasonably quantifiable. Subsequent recoveries, if any, are credited to the allowance. For more information about the Company's policies and procedures for determining the amount of the allowance for credit losses, please refer to the discussion in Note 1, "Summary of Significant Accounting Policies," in the Notes to the Consolidated Financial Statements in Item 8, Financial Statements and Supplementary Data, in the Company's Annual Report on Form 10-K for the year ended December 31, 2024.

The Company has made an accounting policy election to exclude accrued interest from the measurement of the allowance for credit losses in the Company's loan portfolio. As of September 30, 2025 and December 31, 2024, the Company had accrued interest receivable for loans of $72,216 and $54,395, respectively, which is recorded in the "Other assets" line item on the Consolidated Balance Sheets.

The following tables provide a roll-forward of the allowance for credit losses by loan category and a breakdown of the ending balance of the allowance based on the Company's credit loss methodology for the periods presented:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Commercial** | **Real Estate -<br>Construction** | **Real Estate -<br>1-4 Family<br>Mortgage** | **Real Estate -<br>Commercial<br>Mortgage** | **Lease Financing** | **Installment<br>Loans to Individuals** | **Total** |
| **Three Months Ended September 30, 2025** | | | | | | | |
| Allowance for credit losses: |  |  |  |  |  |  |  |
| Beginning balance | $59676 | $21784 | $65703 | $135572 | $1935 | $6100 | $290770 |
| Initial impact of purchased credit deteriorated ("PCD") loans acquired  | 1890 |  | 505 | (885) |  |  | 1510 |
| Charge-offs | (2557) | (8) | (612) | (1296) | (42) | (539) | (5054) |
| Recoveries | 51 | 6 | 84 | 429 | 90 | 55 | 715 |
| Net charge-offs | (2506) | (2) | (528) | (867) | 48 | (484) | (4339) |
| Provision for (recovery of) credit losses on loans | 1466 | 2171 | 1146 | 5522 | (503) | (152) | 9650 |
| Ending balance | $60526 | $23953 | $66826 | $139342 | $1480 | $5464 | $297591 |
| **Nine Months Ended September 30, 2025** |  |  |  |  |  |  |  |
| Allowance for credit losses: |  |  |  |  |  |  |  |
| Beginning balance | $38527 | $15126 | $47761 | $90204 | $3368 | $6770 | $201756 |
| Initial impact of PCD loans acquired during the period | 9030 | 1997 | 769 | 13205 |  | 2 | 25003 |
| Charge-offs | (8474) | (113) | (1240) | (5701) | (2436) | (1198) | (19162) |
| Recoveries | 1636 | 6 | 154 | 551 | 103 | 444 | 2894 |
| Net charge-offs | (6838) | (107) | (1086) | (5150) | (2333) | (754) | (16268) |
| Provision for (recovery of) credit losses on loans | 19807 | 6937 | 19382 | 41083 | 445 | (554) | 87100 |
| Ending balance | $60526 | $23953 | $66826 | $139342 | $1480 | $5464 | $297591 |
| Nonaccruing loans with no allowance for credit losses | $25041 | $4412 | $4275 | $17480 | $— | $— | $51208 |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Commercial** | **Real Estate -<br>Construction** | **Real Estate -<br>1-4 Family<br>Mortgage** | **Real Estate -<br>Commercial<br>Mortgage** | **Lease Financing** | **Installment Loans to Individuals** | **Total** |
| **Three Months Ended September 30, 2024** | | | | | | | |
| Allowance for credit losses: |  |  |  |  |  |  |  |
| Beginning balance | $44951 | $18896 | $47421 | $77125 | $2515 | $8963 | $199871 |
| Charge-offs | (347) |  | (256) | (10) | (642) | (649) | (1904) |
| Recoveries | 514 |  | 57 | 11 | 8 | 611 | 1201 |
| Net recoveries (charge-offs) | 167 |  | (199) | 1 | (634) | (38) | (703) |
| (Recovery of) provision for credit losses on loans | (2065) | (2240) | (3) | 4961 | 503 | 54 | 1210 |
| Ending balance | $43053 | $16656 | $47219 | $82087 | $2384 | $8979 | $200378 |
| **Nine Months Ended September 30, 2024** |  |  |  |  |  |  |  |
| Allowance for credit losses: |  |  |  |  |  |  |  |
| Beginning balance | $43980 | $18612 | $47283 | $77020 | $2515 | $9168 | $198578 |
| Charge-offs | (882) |  | (546) | (5737) | (642) | (1379) | (9186) |
| Recoveries | 1385 |  | 130 | 116 | 26 | 1181 | 2838 |
| Net recoveries (charge-offs) | 503 |  | (416) | (5621) | (616) | (198) | (6348) |
| Provision for (recovery of) credit losses on loans | (1430) | (1956) | 352 | 10688 | 485 | 9 | 8148 |
| Ending balance | $43053 | $16656 | $47219 | $82087 | $2384 | $8979 | $200378 |
| Nonaccruing loans with no allowance for credit losses | $122 | $— | $6898 | $25016 | $614 | $— | $32650 |

---

The Company recorded a provision for credit losses on loans of $9,650 during the third quarter of 2025, as compared to a provision for credit losses on loans of $1,210 recorded in the third quarter of 2024. The Company's allowance for credit losses model considers economic projections, primarily the national unemployment rate and GDP, over a reasonable and supportable period of two years. The provision for credit losses on loans of $9,650 in the third quarter of 2025 was primarily driven by loan growth and changes in credit metrics that influenced the Company's expectations of future losses, including but not limited to the balance of nonperforming loans, underlying collateral values, and historical levels of charge-offs, all considered in the context of the existing balance of the allowance for credit losses.

<u>Allowance for Credit Losses on Unfunded Loan Commitments</u> 

The Company maintains a separate allowance for credit losses on unfunded loan commitments, which is included in the "Other liabilities" line item on the Consolidated Balance Sheets. For more information about the Company's policies and procedures for determining the amount of the allowance for credit losses on unfunded loan commitments, please refer to the discussion in Note 1, "Significant Accounting Policies," in the Notes to the Consolidated Financial Statements in Item 8, Financial Statements and Supplementary Data, in the Company's Annual Report on Form 10-K for the year ended December 31, 2024.

The following table provides a roll-forward of the allowance for credit losses on unfunded loan commitments for the periods presented.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | |
|:---|:---|:---|
| **Three Months Ended September 30,** | **2025** | **2024** |
| Allowance for credit losses on unfunded loan commitments: |  |  |
| Beginning balance | $23565 | $15718 |
| Provision for (recovery of) credit losses on unfunded loan commitments | 800 | (275) |
| Ending balance | $24365 | $15443 |
| **Nine Months Ended September 30,** | **2025** | **2024** |
| Allowance for credit losses on unfunded loan commitments: |  |  |
| Beginning balance | $14943 | $16918 |
| Provision for (recovery of) credit losses on unfunded loan commitments | 9422 | (1475) |
| Ending balance | $24365 | $15443 |

---

The Company recorded a provision for credit losses on unfunded loan commitments of $800 during the third quarter of 2025, as compared to a recovery of credit losses on unfunded loan commitments of $275 recorded in the third quarter of 2024. The $800 provision for credit losses on unfunded commitments in the third quarter of 2025 was primarily driven by growth in the balance of unfunded loan commitments.

**Note 6 – Other Real Estate Owned**

*(In Thousands)*

The following table provides details of the Company's other real estate owned ("OREO"), net of valuation allowances and direct write-downs, as of the dates presented:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| Residential real estate | $5179 | $2966 |
| Commercial real estate | 3711 | 5681 |
| Residential land development | 15 | 19 |
| Commercial land development | 1673 | 7 |
| Total | $10578 | $8673 |

---

Changes in the Company's OREO were as follows:

---

| | |
|:---|:---|
| | **Total<br>OREO** |
| Balance at January 1, 2025 | $8673 |
| Acquired OREO | 11109 |
| Transfers of loans | 3971 |
| Impairments | (623) |
| Dispositions | (12552) |
| Balance at September 30, 2025 | $10578 |

---

At September 30, 2025 and December 31, 2024, the amortized cost of loans secured by Real Estate - 1-4 Family Mortgage in the process of foreclosure was $9,112 and $505, respectively.

Components of the line item "Other real estate owned" in the Consolidated Statements of Income were as follows for the periods presented:

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Repairs and maintenance | $186 | $62 | $415 | $273 |
| Property taxes and insurance | 95 | 24 | 192 | 76 |
| Impairments | 38 |  | 623 | 67 |
| Net losses (gains) on OREO sales | 12 | (28) | (53) | (143) |
| Rental income | (3) | (2) | (7) | (5) |
| Total | $328 | $56 | $1170 | $268 |

---

**Note 7 – Goodwill and Other Intangible Assets**

*(In Thousands)*

The carrying amounts of goodwill by operating segments for the nine months ended September 30, 2025 and 2024 are set forth in the table below.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2024** | **2024** | **2024** |
| | **Community Banks** | **Total** | **Community Banks** | **Insurance** | **Total** |
| Balance at January 1 | $988898 | $988898 | $988898 | $2767 | $991665 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additions to goodwill from The First merger | 422813 | 422813 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sale of the insurance agency |  |  |  | (2767) | (2767) |
| Balance at September 30 | $1411711 | $1411711 | $988898 | $— | $988898 |

---

The following table provides a summary of finite-lived intangible assets as of the dates presented:

---

| | | | |
|:---|:---|:---|:---|
| | **Gross Carrying<br>Amount** | **Accumulated<br>Amortization** | **Net Carrying<br>Amount** |
| **September 30, 2025** | | | |
| Core deposit intangibles | $242102 | $(89733) | $152369 |
| Customer relationship intangible | 7670 | (4962) | 2708 |
| Total finite-lived intangible assets | $249772 | $(94695) | $155077 |
| **December 31, 2024** |  |  |  |
| Core deposit intangibles | $82492 | $(71881) | $10611 |
| Customer relationship intangible | 7670 | (4176) | 3494 |
| Total finite-lived intangible assets | $90162 | $(76057) | $14105 |

---

Amortization expense for finite-lived intangible assets is presented in the table below.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Amortization expense for: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Core deposit intangibles | $8412 | $862 | $17852 | $2664 |
| &nbsp;&nbsp;&nbsp;&nbsp;Customer relationship intangible | 262 | 298 | 786 | 894 |
| Total intangible amortization | $8674 | $1160 | $18638 | $3558 |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

The remaining weighted average life of finite-lived intangible assets is 9.00 years at September 30, 2025. The estimated amortization expense of finite-lived intangible assets for the year ending December 31, 2025 and the succeeding four years is summarized as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Core Deposit Intangibles** | **Customer Relationship Intangible** | **Total** |
| 2025 | $26055 | $1048 | $27103 |
| 2026 | 30732 | 860 | 31592 |
| 2027 | 27440 | 628 | 28068 |
| 2028 | 23337 | 483 | 23820 |
| 2029 | 18335 | 331 | 18666 |
| Thereafter | 44322 | 144 | $44466 |

---

**Note 8 – Mortgage Servicing Rights**

*(In Thousands)*

The Company retains the right to service certain mortgage loans that it sells to secondary market investors. These mortgage servicing rights ("MSRs") are recognized as a separate asset on the date the corresponding mortgage loan is sold. MSRs are amortized in proportion to and over the period of estimated net servicing income. These servicing rights are carried at the lower of amortized cost or fair value. Fair value is determined using an income approach with various assumptions, including expected cash flows, prepayment speeds, market discount rates, servicing costs, and other factors, and is subject to significant fluctuation as a result of actual prepayment speeds, default rates and losses differing from estimates thereof. For example, an increase in mortgage interest rates or a decrease in actual prepayment speeds may cause positive adjustments to the valuation of the Company's MSRs.

MSRs are evaluated for impairment (or reversals of prior impairments) quarterly based upon the fair value of the rights as compared to the carrying amount. Impairment is recognized through a valuation allowance in the amount that unamortized cost exceeds fair value. If the Company later determines that all or a portion of the impairment no longer exists, a reduction of the valuation allowance may be recorded as an increase to income. Changes in valuation allowances related to servicing rights are reported in "Mortgage banking income" on the Consolidated Statements of Income.

There was no valuation adjustment on MSRs during the nine months ended September 30, 2025 or 2024.

Changes in the Company's MSRs were as follows:

---

| | | |
|:---|:---|:---|
| | **2025** | **2024** |
| Balance at January 1 | $72991 | $91688 |
| Sale of MSRs | (7886) | (19539) |
| Capitalization | 7092 | 6860 |
| Amortization | (6731) | (7019) |
| Balance at September 30 | $65466 | $71990 |

---

Data and key economic assumptions related to the Company's MSRs are as follows as of the dates presented:

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| Unpaid principal balance | $5632116 | $5874481 |
| Weighted-average prepayment speed (CPR) | 10.38% | 8.87% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Estimated impact of a 10% increase | $(2903) | $(3066) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Estimated impact of a 20% increase | (5594) | (5941) |
| Discount rate | 9.96% | 11.09% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Estimated impact of a 10% increase | $(3292) | $(3924) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Estimated impact of a 20% increase | (6337) | (7557) |
| Weighted-average coupon interest rate | 4.54% | 4.13% |
| Weighted-average servicing fee (basis points) | 33.96 | 36.06 |
| Weighted-average remaining maturity (in years) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.5 |

---

The Company recorded servicing fees of $2,841 and $3,594 for the three months ended September 30, 2025 and 2024, respectively, and $9,498 and $11,463 for the nine months ended September 30, 2025 and 2024, respectively, all of which are included in "Mortgage banking income" in the Consolidated Statements of Income.

**Note 9 - Employee Benefit and Deferred Compensation Plans**

*(In Thousands, Except Share Data)*

*Pension and Post-retirement Medical Plans*

The Company sponsors a noncontributory defined benefit pension plan, under which participation and benefit accruals ceased as of December 31, 1996, and it provides retiree medical benefits, consisting of the opportunity to purchase coverage at subsidized rates under the Company's group medical plan.

Information related to the defined benefit pension plan maintained by Renasant Bank ("Pension Benefits") and to the post-retirement health and life plan ("Other Benefits") as of the dates presented is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Pension Benefits** | **Pension Benefits** | **Other Benefits** | **Other Benefits** |
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Interest cost | $237 | $227 | $5 | $5 |
| Expected return on plan assets | (267) | (249) |  |  |
| Recognized actuarial loss (gain) | 121 | 129 | (22) | (23) |
| Net periodic benefit cost (return) | $91 | $107 | $(17) | $(18) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Pension Benefits** | **Pension Benefits** | **Other Benefits** | **Other Benefits** |
| | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Interest cost | $711 | $681 | $15 | $16 |
| Expected return on plan assets | (801) | (745) |  |  |
| Recognized actuarial loss (gain) | 364 | 387 | (66) | (70) |
| Net periodic benefit cost (return) | $274 | $323 | $(51) | $(54) |

---

*Incentive Compensation Plans*

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

The Company maintains the 2020 Long-Term Incentive Compensation Plan, a long-term equity compensation plan that provides for the award of restricted stock and the grant of stock options. The Company awards performance-based restricted stock to executives and other officers and employees and time-based restricted stock to non-employee directors, executives, and other officers and employees.

The following table summarizes the changes in restricted stock as of and for the nine months ended September 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Performance-Based Restricted Stock** | **Weighted Average Grant-Date Fair Value** | **Time-Based Restricted Stock** | **Weighted Average Grant-Date Fair Value** |
| Nonvested at beginning of period | 203115 | $34.32 | 801181 | $35.08 |
| Awarded | 75644 | 36.17 | 343814 | 35.26 |
| Vested |  |  | (273993) | 36.46 |
| Cancelled |  |  | (11401) | 35.18 |
| Nonvested at end of period | 278759 | $34.82 | 859601 | $34.71 |

---

The First maintained a long-term equity compensation plan, and awards outstanding as of the date of the merger were converted into adjusted restricted stock awards in respect to Renasant common stock, subject to the same terms and conditions.

The following table summarizes the changes in converted restricted stock as of September 30, 2025:

---

| | | |
|:---|:---|:---|
| | **Time-Based Restricted Stock** | **Weighted Average Grant-Date Fair Value** |
| Nonvested at beginning of period |  | $— |
| Awarded (converted) | 426321 | 33.93 |
| Vested | (68433) | 33.93 |
| Cancelled |  |  |
| Nonvested at end of period | 357888 | $33.93 |

---

During the nine months ended September 30, 2025, the Company reissued 209,869 shares from treasury in connection with awards of restricted stock. The Company recorded total stock-based compensation expense of $5,443 and $3,273 for the three months ended September 30, 2025 and 2024, respectively, and $13,527 and $10,639 for the nine months ended September 30, 2025 and 2024, respectively.

There were no stock options granted or outstanding, nor compensation expense associated with options recorded, during the nine months ended September 30, 2025 or 2024.

**Note 10 – Derivative Instruments**

*(In Thousands)*

The Company uses certain derivative instruments to meet the needs of customers as well as to manage the interest rate risk associated with certain transactions.

*Non-hedge derivatives*

The Company enters into derivative instruments that are not designated as hedging instruments to help its commercial customers manage their exposure to interest rate fluctuations (which are included within the "interest rate contracts" line items in the tables below). To mitigate the interest rate risk associated with these customer contracts, the Company enters into an offsetting derivative contract position. The Company manages its credit risk, or potential risk of default by its commercial customers, through credit limit approval and monitoring procedures.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

The Company enters into interest rate lock commitments with its customers to mitigate the interest rate risk associated with the commitments to fund fixed-rate and adjustable-rate residential mortgage loans. The Company also enters into forward commitments to sell residential mortgage loans to secondary market investors.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

The following table provides a summary of the Company's derivatives not designated as hedging instruments as of the dates presented:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| | **Balance Sheet**<br>**Location** | **Notional Amount** | **Fair Value** | **Notional Amount** | **Fair Value** |
| **Derivative assets:** | | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate contracts | Other Assets | $1602805 | $30131 | $877051 | $14071 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate lock commitments | Other Assets | 126983 | 1722 | 64365 | 861 |
| &nbsp;&nbsp;&nbsp;Forward commitments | Other Assets | 106000 | 330 | 174000 | 1242 |
| Totals |  | $1835788 | $32183 | $1115416 | $16174 |
| **Derivative liabilities:** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate contracts | Other Liabilities | $1603104 | $30178 | $880371 | $14094 |
| &nbsp;&nbsp;&nbsp;Interest rate lock commitments | Other Liabilities | 13528 | 39 | 1829 | 122 |
| &nbsp;&nbsp;&nbsp;&nbsp;Forward commitments | Other Liabilities | 189000 | 1304 | 52000 | 86 |
| Totals |  | $1805632 | $31521 | $934200 | $14302 |

---

Gains and losses included in the Consolidated Statements of Income related to the Company's derivative financial instruments were as follows as of the dates presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Interest rate contracts: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Included in interest income on loans | $8784 | $3958 | $17765 | $10388 |
| Interest rate lock commitments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Included in mortgage banking income | (1029) | (261) | 944 | 127 |
| Forward commitments |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Included in mortgage banking income | 2423 | (1167) | (2129) | 1184 |
| Total | $10178 | $2530 | $16580 | $11699 |

---

*Derivatives designated as cash flow hedges*

Cash flow hedge relationships mitigate exposure to the variability of future cash flows or other forecasted transactions. The Company uses both interest rate swap contracts and interest rate collars in an effort to manage future interest rate exposure on borrowings and loans, respectively. The swap hedging strategy converts the variable interest rate on the forecasted borrowings to a fixed interest rate. The collar hedging strategy limits the benefit to interest income when rates exceed the cap but protects interest income from interest rate fluctuations below the floor strike rate.

The following table provides a summary of the Company's derivatives designated as cash flow hedges as of the dates presented:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| | **Balance Sheet**<br>**Location** | **Notional Amount** | **Fair Value** | **Notional Amount** | **Fair Value** |
| **Derivative assets:** | | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate swaps | Other Assets | $130000 | $17043 | $130000 | $22780 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate collars | Other Assets | 450000 | 206 |  |  |
| Total |  | $580000 | $17249 | $130000 | $22780 |
| **Derivative liabilities:** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate collars | Other Liabilities | $— | $— | $450000 | $598 |
| Totals |  | $— | $— | $450000 | $598 |

---

Changes in fair value of cash flow hedges are, to the extent that the hedging relationship is effective, recorded as other comprehensive income and are subsequently recognized in earnings at the same time that the hedged item is recognized in

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

earnings. The assessment of the effectiveness of the hedging relationship is evaluated under the hypothetical derivative method. The impact on other comprehensive income for the nine months ended September 30, 2025 and 2024 is discussed in Note 13, "Other Comprehensive Income."

*Derivatives designated as fair value hedges*

Fair value hedges protect against changes in the fair value of an asset, liability, or firm commitment. Gains and losses on the derivative instrument and the offsetting gains and losses on the hedged item are recognized in current earnings. The Company enters into interest rate swap agreements to manage interest rate exposure on certain of the Company's fixed-rate subordinated notes. The agreements convert a fixed rate of interest to a variable rate of interest based on SOFR. The Company also utilizes fair value hedges to manage interest rate exposure on certain fixed rate available-for-sale securities. The agreements convert the fixed interest rates to variable interest rates based on SOFR.

The following table provides a summary of the Company's derivatives designated as fair value hedges as of the dates presented:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| | **Balance Sheet**<br>**Location** | **Notional Amount** | **Fair Value** | **Notional Amount** | **Fair Value** |
| **Derivative liabilities:** | | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate swaps - subordinated notes | Other Liabilities | $100000 | $12597 | $100000 | $17369 |
| &nbsp;&nbsp;Interest rate swaps - securities | Other Liabilities | $22410 | $56 | $— | $— |
| Totals |  | $122410 | $12653 | $100000 | $17369 |

---

The following table presents the effects of the Company's fair value hedge relationships on the Consolidated Statements of Income for the periods presented:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Amount of Gain (Loss) Recognized in Income** | **Amount of Gain (Loss) Recognized in Income** | **Amount of Gain (Loss) Recognized in Income** | **Amount of Gain (Loss) Recognized in Income** |
| | | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| |<br>**Income Statement**<br>**Location** | **2025** | **2024** | **2025** | **2024** |
| **Derivative liabilities:** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate swaps - subordinated notes | Interest Expense | $842 | $4042 | $4771 | $2705 |
| &nbsp;&nbsp;Interest rate swaps - securities | Interest Income | (56) |  | (56) |  |
| **Derivative liabilities - hedged items:** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate swaps - subordinated notes | Interest Expense | $(842) | $(4042) | $(4771) | $(2705) |
| &nbsp;&nbsp;Interest rate swaps - securities | Interest Income | 56 |  | 56 |  |

---

The following table presents the amounts that were recorded in the Consolidated Balance Sheets related to cumulative basis adjustments for fair value hedges as of the dates presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Carrying Amount of the Hedged Item** | **Carrying Amount of the Hedged Item** | **Cumulative Amount of Fair Value Hedging Adjustments Included in the Carrying Amount of the Hedged Item** | **Cumulative Amount of Fair Value Hedging Adjustments Included in the Carrying Amount of the Hedged Item** |
|<br>**Balance Sheet Location** | **September 30, 2025** | **December 31, 2024** | **September 30, 2025** | **December 31, 2024** |
| Long-term debt | $86549 | $81648 | $12597 | $17369 |
| Securities available for sale | 17081 |  | 56 |  |

---

*Credit Derivatives*

The Company has both bought and sold credit protection in the form of risk participation agreements. These risk participations, which meet the definition of credit derivatives, were entered into in the ordinary course of business to help the Company's commercial customers manage their exposure to interest rate fluctuations. Risk participations in which credit protection has been purchased entitle the Company to receive a payment from the counterparty if the customer fails to make payment on any amounts due to the Company upon early termination of the swap transaction. The Company's bought risk participation agreements have maturities between 2028 and 2032. For contracts where the Company sold credit protection, it would be required to make payment to the counterparty if the customer fails to make payment on any amounts due to the counterparty

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

upon early termination of the swap transaction. The Company's sold risk participation agreements have maturities between 2025 and 2032.

The maximum potential amount of future payments under these risk participation agreements as of September 30, 2025 was approximately $2,306. This scenario occurs if variable interest rates were at zero percent and all counterparties defaulted with zero recovery. The fair value of risk participation agreements at September 30, 2025 and 2024 was immaterial.

*Offsetting*

Certain financial instruments, including derivatives, may be eligible for offset in the consolidated balance sheet when the "right of offset" exists or when the instruments are subject to an enforceable master netting agreement, which includes the right of the non-defaulting party or non-affected party to offset recognized amounts, including collateral posted with the counterparty, to determine a net receivable or net payable upon early termination of the agreement. Certain of the Company's derivative instruments are subject to master netting agreements; however, the Company has not elected to offset such financial instruments in the Consolidated Balance Sheets. The following table presents the Company's gross derivative positions as recognized in the Consolidated Balance Sheets as well as the net derivative positions, including collateral pledged to the extent the application of such collateral did not reduce the net derivative liability position below zero, had the Company elected to offset those instruments subject to an enforceable master netting agreement as of the dates presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Offsetting Derivative Assets** | **Offsetting Derivative Assets** | **Offsetting Derivative Liabilities** | **Offsetting Derivative Liabilities** |
| | **September 30,<br>2025** | **December 31, 2024** | **September 30,<br>2025** | **December 31, 2024** |
| Gross amounts recognized | $22128 | $34505 | $18503 | $28550 |
| Gross amounts offset in the Consolidated Balance Sheets |  |  |  |  |
| Net amounts presented in the Consolidated Balance Sheets | 22128 | 34505 | 18503 | 28550 |
| Gross amounts not offset in the Consolidated Balance Sheets |  |  |  |  |
| Financial instruments - derivative assets available for offset | 17530 | 27939 | 17530 | 27939 |
| Financial collateral (cash) pledged |  |  | 520 | 611 |
| Net amounts | $4598 | $6566 | $453 | $— |

---

**Note 11 – Income Taxes**

For the nine months ended September 30, 2025 and 2024, the effective tax rate was 21.23% and 22.80%, respectively. The Company's sale of its insurance business in the third quarter of 2024 resulted in a significant discrete tax expense during such period, which contributed to the year-over-year decrease in the Company's effective tax rate. The Company calculated the provision for income taxes by applying the estimated annual effective tax rate to year-to-date pre-tax income, and adjusting for discrete items that occurred during the period.

**Note 12 – Fair Value Measurements**

*(In Thousands)*

*Fair Value Measurements and the Fair Level Hierarchy*

Accounting Standards Codification ("ASC") 820, *"Fair Value Measurements and Disclosures,"* provides guidance for using fair value to measure assets and liabilities and establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to a valuation based on quoted prices in active markets for identical assets and liabilities (Level 1), next priority to a valuation based on quoted prices in active markets for similar assets and liabilities and/or based on assumptions that are observable in the market (Level 2), and the lowest priority to a valuation based on assumptions that are not observable in the market (Level 3).

*Recurring Fair Value Measurements*

The Company carries certain assets and liabilities at fair value on a recurring basis in accordance with applicable standards. The Company's recurring fair value measurements are based on the requirement to carry such assets and liabilities at fair value or the Company's election to carry certain eligible assets at fair value. Assets and liabilities that are required to be carried at fair value on a recurring basis include securities available for sale and derivative instruments. The Company has elected to carry

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

mortgage loans held for sale at fair value on a recurring basis as permitted under the guidance in ASC 825, *"Financial Instruments"* ("ASC 825").

The following methods and assumptions are used by the Company to estimate the fair values of the Company's financial assets and liabilities that are measured on a recurring basis:

<u>Securities available for sale</u>: Securities available for sale consist primarily of debt securities, such as obligations of U.S. Government agencies and corporations, obligations of states and political subdivisions and mortgage-backed securities. Where quoted market prices in active markets are available, securities are classified within Level 1 of the fair value hierarchy. If quoted prices from active markets are not available, fair values are based on quoted market prices for similar instruments traded in active markets, quoted market prices for identical or similar instruments traded in markets that are not active, or model-based valuation techniques where all significant assumptions are observable in the market. Such instruments are classified within Level 2 of the fair value hierarchy. When assumptions used in model-based valuation techniques are not observable in the market, the assumptions used by management reflect estimates of assumptions used by other market participants in determining fair value. When there is limited transparency around the inputs to the valuation, the instruments are classified within Level 3 of the fair value hierarchy.

<u>Derivative instruments</u>: Most of the Company's derivative contracts are extensively traded in over-the-counter markets and are valued using discounted cash flow models which incorporate observable market-based inputs including current market interest rates, credit spreads, and other factors. Such instruments are categorized within Level 2 of the fair value hierarchy and include interest rate swaps, interest rate collars and other interest rate contracts such as risk participations, interest rate caps and/or floors. The Company's interest rate lock commitments are valued using current market prices for mortgage-backed securities with similar characteristics, adjusted for certain factors including servicing and risk. The value of the Company's forward commitments is based on current prices for securities backed by similar types of loans. Because these assumptions are observable in active markets, the Company's interest rate lock commitments and forward commitments are categorized within Level 2 of the fair value hierarchy.

<u>Mortgage loans held for sale in loans held for sale</u>: The Company has elected to carry mortgage loans held for sale at fair value on a recurring basis under the fair value option. Mortgage loans held for sale are loans intended to be sold on the secondary market to investors or other financial institutions. The fair value of these instruments is derived from current market pricing for similar loans, adjusted for differences in loan characteristics, including servicing and risk. Because the valuation is based on external pricing of similar instruments, mortgage loans held for sale are classified within Level 2 of the fair value hierarchy.

The following tables present assets and liabilities that are measured at fair value on a recurring basis as of the dates presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Level 1** | **Level 2** | **Level 3** | **Totals** |
| **September 30, 2025** | | | | |
| Financial assets: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Securities available for sale | $— | $2512650 | $— | $2512650 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Derivative instruments |  | 49432 |  | 49432 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage loans held for sale in loans held for sale |  | 286779 |  | 286779 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total financial assets | $— | $2848861 | $— | $2848861 |
| Financial liabilities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Derivative instruments: | $— | $44174 | $— | $44174 |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Level 1** | **Level 2** | **Level 3** | **Totals** |
| **December 31, 2024** | | | | |
| Financial assets: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Securities available for sale | $— | $831013 | $— | $831013 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Derivative instruments |  | 38954 |  | 38954 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage loans held for sale in loans held for sale |  | 246171 |  | 246171 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total financial assets | $— | $1116138 | $— | $1116138 |
| Financial liabilities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Derivative instruments | $— | $32268 | $— | $32268 |

---

The Company reviews fair value hierarchy classifications on a quarterly basis. Changes in the Company's ability to observe inputs to the valuation may cause reclassification of certain assets or liabilities within the fair value hierarchy. Transfers between levels of the hierarchy are deemed to have occurred at the end of period. There were no such transfers between levels of the fair value hierarchy during the nine months ended September 30, 2025.

For the nine months ended September 30, 2025 and 2024, respectively, there were no gains or losses included in earnings that were attributable to the change in unrealized gains or losses related to assets or liabilities held at the end of each respective period that were measured on a recurring basis using significant unobservable inputs.

*Nonrecurring Fair Value Measurements*

Certain assets and liabilities may be recorded at fair value on a nonrecurring basis. These nonrecurring fair value adjustments typically are a result of the application of the lower of cost or market accounting or a write-down occurring during the period. The following tables provide the fair value measurement for assets measured at fair value on a nonrecurring basis that were still held on the Consolidated Balance Sheets as of the dates presented and the level within the fair value hierarchy each is classified:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>September 30, 2025</u>** | **Level 1** | **Level 2** | **Level 3** | **Totals** |
| Collateral dependent loans | $— | $— | $82144 | $82144 |
| OREO |  |  | 3307 | 3307 |
| Total | $— | $— | $85451 | $85451 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>December 31, 2024</u>** | **Level 1** | **Level 2** | **Level 3** | **Totals** |
| Collateral dependent loans | $— | $— | $38374 | $38374 |
| OREO |  |  | $3666 | 3666 |
| Total | $— | $— | $42040 | $42040 |

---

The following methods and assumptions are used by the Company to estimate the fair values of the Company's financial assets measured on a nonrecurring basis:

<u>Collateral dependent loans</u>: Collateral dependent loans are reviewed and evaluated for credit losses on at least a quarterly basis for additional impairment and adjusted accordingly, taking into account the fair value of the collateral less estimated selling costs. Collateral may be real estate and/or business assets including but not limited to equipment, inventory and accounts receivable. The fair value of real estate is determined based on appraisals by qualified licensed appraisers. The fair value of the business assets is generally based on amounts reported on the business's financial statements. Appraised and reported values may be adjusted based on changes in market conditions from the time of valuation and management's knowledge of the client and the client's business. Since not all valuation inputs are observable, these nonrecurring fair value determinations are classified as Level 3. Collateral dependent loans that were measured or re-measured at fair value had a carrying value of $104,716 and $53,157 at September 30, 2025 and December 31, 2024, respectively, and a specific reserve for these loans of $22,572 and $14,782 was included in the allowance for credit losses as of such dates.

<u>Other real estate owned</u>: OREO is comprised of commercial and residential real estate obtained in partial or total satisfaction of loan obligations. OREO acquired in settlement of indebtedness is recorded at the fair value of the real estate less estimated costs to sell. Subsequently, it may be necessary to record nonrecurring fair value adjustments for declines in fair value. Fair value,

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

when recorded, is determined based on appraisals by qualified licensed appraisers and adjusted for management's estimates of costs to sell. Accordingly, values for OREO are classified as Level 3.

The following table presents, as of the dates presented, OREO measured at fair value on a nonrecurring basis that was still held on the Consolidated Balance Sheets at period-end:

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31, 2024** |
| Carrying amount prior to remeasurement | $3980 | $4038 |
| Impairment recognized in results of operations | (673) | (372) |
| Fair value | $3307 | $3666 |

---

<u>Mortgage servicing rights</u>: Mortgage servicing rights are carried at the lower of amortized cost or fair value. Fair value is determined using an income approach with various assumptions including expected cash flows, market discount rates, prepayment speeds, servicing costs, and other factors. Because these factors are not all observable and include management's assumptions, mortgage servicing rights are classified within Level 3 of the fair value hierarchy. Mortgage servicing rights were carried at amortized cost at September 30, 2025 and December 31, 2024. There were no valuation adjustments on MSRs during the nine months ended September 30, 2025 or 2024.

The following table presents information as of September 30, 2025 about significant unobservable inputs (Level 3) used in the valuation of assets measured at fair value on a nonrecurring basis:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>Financial instrument</u>** | **Fair<br>Value** | **Valuation Technique** | **Significant<br>Unobservable Inputs** | **Range of Inputs** |
| Collateral dependent loans, net of allowance for credit losses | $82144 | Appraised value of collateral less estimated costs to sell | Estimated costs to sell | 4-10% |
| OREO | $3307 | Appraised value of property less estimated costs to sell | Estimated costs to sell | 4-10% |

---

*Fair Value Option*

The Company has elected to measure all mortgage loans held for sale at fair value under the fair value option as permitted under ASC 825. Electing to measure these assets at fair value reduces certain timing differences and better matches the changes in fair value of the loans with changes in the fair value of derivative instruments used to economically hedge them.

A net gain of $4,503 and $1,826 resulting from fair value changes of these mortgage loans were recorded in income during the nine months ended September 30, 2025 and 2024, respectively. These amounts do not reflect changes in fair values of related derivative instruments used to economically hedge exposure to market-related risks associated with these mortgage loans. The change in fair value of both mortgage loans held for sale and the related derivative instruments are recorded in "Mortgage banking income" in the Consolidated Statements of Income.

The Company's valuation of mortgage loans held for sale incorporates an assumption for credit risk; however, given the short-term period that the Company holds these loans, valuation adjustments attributable to instrument-specific credit risk is nominal. Interest income on mortgage loans held for sale measured at fair value is accrued as it is earned based on contractual rates and is reflected in loan interest income on the Consolidated Statements of Income.

The following table summarizes the differences between the fair value and the principal balance for mortgage loans held for sale measured at fair value as of September 30, 2025 and December 31, 2024:

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | | |
|:---|:---|:---|:---|
| | **Aggregate<br>Fair Value** | **Aggregate<br>Unpaid<br>Principal<br>Balance** | **Difference** |
| **September 30, 2025** | | | |
| Mortgage loans held for sale measured at fair value | $286779 | $280323 | $6456 |
| **December 31, 2024** |  |  |  |
| Mortgage loans held for sale measured at fair value | $246171 | $244218 | $1953 |

---

*Fair Value of Financial Instruments*

The carrying amounts and estimated fair values of the Company's financial instruments, including those assets and liabilities that are not measured and reported at fair value on a recurring basis or nonrecurring basis, were as follows as of the dates presented:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Fair Value** | **Fair Value** | **Fair Value** | **Fair Value** |
| **<u>As of September 30, 2025</u>** |<br>**Carrying<br>Value** | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Financial assets** | | | | | |
| Cash and cash equivalents | $1083785 | $1083785 | $— | $— | $1083785 |
| Securities held to maturity | 1051884 |  | 976690 |  | 976690 |
| Securities available for sale | 2512650 |  | 2512650 |  | 2512650 |
| Loans held for sale | 286779 |  | 286779 |  | 286779 |
| Loans, net | 18727930 |  |  | 18619999 | 18619999 |
| Mortgage servicing rights | 65466 |  |  | 81796 | 81796 |
| Derivative instruments | 49432 |  | 49432 |  | 49432 |
| **Financial liabilities** |  |  |  |  |  |
| Deposits | $21424555 |  | $21413437 | $— | $21413437 |
| Short-term borrowings | 606063 |  | 606063 |  | 606063 |
| Junior subordinated debentures | 140355 |  | 125831 |  | 125831 |
| Subordinated notes | 418523 |  | 409075 |  | 409075 |
| Derivative instruments | 44174 |  | 44174 |  | 44174 |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Fair Value** | **Fair Value** | **Fair Value** | **Fair Value** |
| **<u>As of December 31, 2024</u>** |<br>**Carrying<br>Value** | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Financial assets** | | | | | |
| Cash and cash equivalents | $1092032 | $1092032 | $— | $— | $1092032 |
| Securities held to maturity | 1126112 |  | 1002544 |  | 1002544 |
| Securities available for sale | 831013 |  | 831013 |  | 831013 |
| Loans held for sale | 246171 |  | 246171 |  | 246171 |
| Loans, net | 12683264 |  |  | 12340638 | 12340638 |
| Mortgage servicing rights | 72991 |  |  | 96290 | 96290 |
| Derivative instruments | 38954 |  | 38954 |  | 38954 |
| **Financial liabilities** |  |  |  |  |  |
| Deposits | $14572612 | $— | $14570304 | $— | $14570304 |
| Short-term borrowings | 108018 |  | 108018 |  | 108018 |
| Junior subordinated debentures | 113916 |  | 100668 |  | 100668 |
| Subordinated notes | 316698 |  | 295868 |  | 295868 |
| Derivative instruments | 32268 |  | 32268 |  | 32268 |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

**Note 13 – Other Comprehensive Income**

*(In Thousands)*

Changes in the components of other comprehensive income, net of tax, were as follows for the periods presented:

---

| | | | |
|:---|:---|:---|:---|
| | **Pre-Tax** | **Tax Expense<br>(Benefit)** | **Net of Tax** |
| **Three months ended September 30, 2025** | | | |
| Securities available for sale: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized holding gains on securities | $15440 | $3855 | $11585 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of unrealized holding losses on securities transferred to the held to maturity category | 3005 | 768 | 2237 |
| Total securities available for sale | 18445 | 4623 | 13822 |
| Derivative instruments: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized holding losses on derivative instruments | (1376) | (350) | (1026) |
| Total derivative instruments | (1376) | (350) | (1026) |
| Defined benefit pension and post-retirement benefit plans: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of net actuarial loss recognized in net periodic pension cost | 99 | 24 | 75 |
| Total defined benefit pension and post-retirement benefit plans | 99 | 24 | 75 |
| Total other comprehensive income | $17168 | $4297 | $12871 |
| **Three months ended September 30, 2024** |  |  |  |
| Securities available for sale: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized holding gains on securities | $31313 | $7872 | $23441 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of unrealized holding losses on securities transferred to the held to maturity category | 3131 | 800 | 2331 |
| Total securities available for sale | 34444 | 8672 | 25772 |
| Derivative instruments: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized holding losses on derivative instruments | (1116) | (288) | (828) |
| Total derivative instruments | (1116) | (288) | (828) |
| Defined benefit pension and post-retirement benefit plans: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of net actuarial loss recognized in net periodic pension cost | 106 | 28 | 78 |
| Total defined benefit pension and post-retirement benefit plans | 106 | 28 | 78 |
| Total other comprehensive income | $33434 | $8412 | $25022 |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | | |
|:---|:---|:---|:---|
| | **Pre-Tax** | **Tax Expense<br>(Benefit)** | **Net of Tax** |
| **Nine months ended September 30, 2025** | | | |
| Securities available for sale: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized holding gains on securities | $51167 | $12854 | $38313 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of unrealized holding losses on securities transferred to the held to maturity category | 8889 | 2274 | 6615 |
| Total securities available for sale | 60056 | 15128 | 44928 |
| Derivative instruments: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized holding losses on derivative instruments | (4988) | (1275) | (3713) |
| Total derivative instruments | (4988) | (1275) | (3713) |
| Defined benefit pension and post-retirement benefit plans: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of net actuarial loss recognized in net periodic pension cost | 298 | 75 | 223 |
| Total defined benefit pension and post-retirement benefit plans | 298 | 75 | 223 |
| Total other comprehensive income | $55366 | $13928 | $41438 |
| **Nine months ended September 30, 2024** |  |  |  |
| Securities available for sale: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized holding losses on securities | $25769 | $6494 | $19275 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of unrealized holding losses on securities transferred to the held to maturity category | 9658 | 2468 | 7190 |
| Total securities available for sale | 35427 | 8962 | 26465 |
| Derivative instruments: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized holding losses on derivative instruments | (2069) | (530) | (1539) |
| Total derivative instruments | (2069) | (530) | (1539) |
| Defined benefit pension and post-retirement benefit plans: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of net actuarial loss recognized in net periodic pension cost | 317 | 81 | 236 |
| Total defined benefit pension and post-retirement benefit plans | 317 | 81 | 236 |
| Total other comprehensive income | $33675 | $8513 | $25162 |

---

The accumulated balances for each component of other comprehensive loss, net of tax, were as follows as of the dates presented:

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31, 2024** |
| Unrealized losses on securities | $(108006) | $(152934) |
| Unrealized gains on derivative instruments | 13716 | 17429 |
| Unrecognized losses on defined benefit pension and post-retirement benefit plans obligations | (6880) | (7103) |
| Total accumulated other comprehensive loss | $(101170) | $(142608) |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

**Note 14 – Net Income Per Common Share**

*(In Thousands, Except Share and Per Share Data)*

Basic net income per common share is calculated by dividing net income by the weighted-average number of common shares outstanding for the period. Diluted net income per common share reflects the pro forma dilution of shares outstanding, assuming outstanding service-based restricted stock awards fully vested, calculated in accordance with the treasury method. Basic and diluted net income per common share calculations are as follows for the periods presented:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **September 30,** | **September 30,** |
| | **2025** | **2024** |
| **Basic** |  |  |
| Net income applicable to common stock | $59788 | $72455 |
| Average common shares outstanding | 94623551 | 61217094 |
| Net income per common share - basic | $0.63 | $1.18 |
| **Diluted** |  |  |
| Net income applicable to common stock | $59788 | $72455 |
| Average common shares outstanding | 94623551 | 61217094 |
| Effect of dilutive stock-based compensation | 661052 | 415354 |
| Average common shares outstanding - diluted | 95284603 | 61632448 |
| Net income per common share - diluted | $0.63 | $1.18 |

---

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended** | **Nine Months Ended** |
| | **September 30,** | **September 30,** |
| | **2025** | **2024** |
| **Basic** |  |  |
| Net income applicable to common stock | $102324 | $150711 |
| Average common shares outstanding | 84403694 | 57934806 |
| Net income per common share - basic | $1.21 | $2.60 |
| **Diluted** |  |  |
| Net income applicable to common stock | $102324 | $150711 |
| Average common shares outstanding | 84403694 | 57934806 |
| Effect of dilutive stock-based compensation | 530696 | 362748 |
| Average common shares outstanding - diluted | 84934390 | 58297554 |
| Net income per common share - diluted | $1.20 | $2.59 |

---

Stock-based compensation awards that could potentially dilute basic net income per common share in the future that were not included in the computation of diluted net income per common share due to their anti-dilutive effect were as follows for the periods presented:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **September 30,** | **September 30,** |
| | **2025** | **2024** |
| Number of shares | 1000 | 1000 |

---

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended** | **Nine Months Ended** |
| | **September 30,** | **September 30,** |
| | **2025** | **2024** |
| Number of shares | 1794 | 1000 |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

**Note 15 – Regulatory Matters**

*(In Thousands)*

The Company and the Bank are subject to various regulatory capital requirements administered by the federal banking agencies. Failure to meet minimum capital requirements can initiate certain mandatory, and possibly additional discretionary, actions by regulators that, if undertaken, could have a material effect on the Company's financial statements. Under capital adequacy guidelines and the regulatory framework for prompt corrective action, the Company and the Bank must meet specific capital guidelines that involve quantitative measures of assets, liabilities and certain off-balance sheet items as calculated under regulatory accounting practices. Capital amounts and classification are also subject to qualitative judgments by the regulators about components, risk weightings, and other factors.

The Federal Reserve, the FDIC and the Office of the Comptroller of the Currency have issued guidelines governing the levels of capital that bank holding companies and banks must maintain. Those guidelines specify capital tiers, which include the following classifications:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>Capital Tiers</u>** | **Tier 1 Capital to<br>Average Assets<br>(Leverage)** | **Common Equity Tier 1 to<br>Risk - Weighted Assets** | **Tier 1 Capital to<br>Risk - Weighted<br>Assets** | **Total Capital to<br>Risk - Weighted<br>Assets** |
| Well capitalized | 5% or above | 6.5% or above | 8% or above | 10% or above |
| Adequately capitalized | 4% or above | 4.5% or above | 6% or above | 8% or above |
| Undercapitalized | Less than 4% | Less than 4.5% | Less than 6% | Less than 8% |
| Significantly undercapitalized | Less than 3% | Less than 3% | Less than 4% | Less than 6% |
| Critically undercapitalized | Tangible Equity / Total Assets less than 2% | Tangible Equity / Total Assets less than 2% | Tangible Equity / Total Assets less than 2% | Tangible Equity / Total Assets less than 2% |

---

The following table provides the capital, risk-based capital and leverage ratios for the Company and for the Bank as of the dates presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| | **Amount** | **Ratio** | **Amount** | **Ratio** |
| **Renasant Corporation** | | | | |
| Tier 1 Capital to Average Assets (Leverage) | $2364465 | 9.46% | $1935522 | 11.34% |
| Common Equity Tier 1 Capital to Risk-Weighted Assets | 2364465 | 11.04% | 1825197 | 12.73% |
| Tier 1 Capital to Risk-Weighted Assets | 2364465 | 11.04% | 1935522 | 13.50% |
| Total Capital to Risk-Weighted Assets | 3187027 | 14.88% | 2449129 | 17.08% |
| **Renasant Bank** |  |  |  |  |
| Tier 1 Capital to Average Assets (Leverage) | $2526336 | 10.12% | $1843123 | 10.80% |
| Common Equity Tier 1 Capital to Risk-Weighted Assets | 2526336 | 11.80% | 1843123 | 12.85% |
| Tier 1 Capital to Risk-Weighted Assets | 2526336 | 11.80% | 1843123 | 12.85% |
| Total Capital to Risk-Weighted Assets | 2794398 | 13.05% | 2022737 | 14.10% |

---

**Note 16 – Segment Reporting**

*(In Thousands)*

The operations of the Company's reportable segments are described as follows:

• The Community Banks segment delivers a complete range of banking and financial services to individuals and small to medium-sized businesses including checking and savings accounts, business and personal loans, asset-based lending, factoring, equipment leasing and treasury management services, as well as safe deposit and night depository facilities.

• The Wealth Management segment, through the Trust division, offers a broad range of fiduciary services including the administration (as trustee or in other fiduciary or representative capacities) of benefit plans, management of trust accounts, inclusive of personal and corporate benefit accounts, and custodial accounts, as well as accounting and money management for trust accounts. In addition, the Wealth Management segment, through the Financial Services division, provides specialized products and services to customers, which include fixed and variable annuities, mutual funds and other

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

investment services through a third party broker-dealer. The Financial Services division also provides administrative and compliance services for certain mutual funds.

For periods prior to the third quarter of 2024, the Company maintained an Insurance segment that included a full service insurance agency. Effective July 1, 2024, the Bank sold substantially all of the assets of its Insurance segment.

The Company's reportable segments are determined by the Chief Executive Officer, who is the designated chief operating decision maker ("CODM"), based upon information provided about the Company's products and services. The CODM evaluates the financial performance of the segments by evaluating revenue streams, significant expenses and budget to actual results, and provides guidance in strategy and the allocation of resources.

In order to give the CODM a more precise indication of the income and expenses controlled by each segment, the results of operations for each segment reflect its own direct revenues and expenses. Indirect revenues and expenses, including but not limited to income from the Company's investment portfolio, as well as certain costs associated with data processing and back office functions, primarily support the operations of the community banks and, therefore, are included in the results of the Community Banks segment. Included in "Other" are the operations of the holding company and other eliminations that are necessary for purposes of reconciling to the consolidated amounts. Accounting policies for each segment are the same as those described in Note 1, "Significant Accounting Policies," in the Notes to the Consolidated Financial Statements in Item 8, Financial Statements and Supplementary Data, in the Company's Annual Report on Form 10-K for the year ended December 31, 2024.

The following tables provide financial information for the Company's operating segments as of and for the periods presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Community<br>Banks** | **Wealth<br>Management** | **Other** | **Consolidated** |
| **Three months ended September 30, 2025** | | | | |
| Total interest income | $351075 | $— | $23 | $351098 |
| Total interest expense | 119100 |  | 8478 | 127578 |
| Net interest income (loss) | $231975 | $— | $(8455) | $223520 |
| Provision for credit losses | 10450 |  |  | 10450 |
| Noninterest income (loss) | 35656 | 10861 | (491) | 46026 |
| Salaries and employee benefits | 94288 | 4694 |  | 98982 |
| Net occupancy and equipment | 18132 | 249 | 34 | 18415 |
| Other segment expenses<sup>(1)</sup> | 62834 | 3144 | 455 | 66433 |
| Income (loss) before income taxes | $81927 | $2774 | $(9435) | $75266 |
| Income tax expense (benefit) | 17698 | 198 | (2418) | 15478 |
| Net income (loss) | $64229 | $2576 | $(7017) | $59788 |
| Total assets | $26715563 | $7031 | $3571 | $26726165 |
| Goodwill | 1411711 |  |  | 1411711 |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Community<br>Banks** | **Wealth<br>Management** | **Other** | **Consolidated** |
| **Three months ended September 30, 2024** | | | | |
| Total interest income | $229028 | $15 | $— | $229043 |
| Total interest expense | 91168 |  | 6877 | 98045 |
| Net interest income (loss) | $137860 | $15 | $(6877) | $130998 |
| Provision for credit losses | 935 |  |  | 935 |
| Noninterest income (loss) | 83244 | 6447 | (392) | 89299 |
| Salaries and employee benefits | 67852 | 3455 |  | 71307 |
| Net occupancy and equipment | 11227 | 188 |  | 11415 |
| Other segment expenses<sup>(1)</sup> | 37956 | 868 | 437 | 39261 |
| Income (loss) before income taxes | $103134 | $1951 | $(7706) | $97379 |
| Income tax expense (benefit) | 26867 | 47 | (1990) | 24924 |
| Net income (loss) | $76267 | $1904 | $(5716) | $72455 |
| Total assets (liabilities) | $17959839 | $1163 | $(2162) | $17958840 |
| Goodwill | 988898 |  |  | 988898 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Community<br>Banks** | **Wealth<br>Management** | **Other** | **Consolidated** |
| **Nine months ended September 30, 2025** | | | | |
| Total interest income | $915257 | $— | $69 | $915326 |
| Total interest expense | 314976 |  | 23774 | 338750 |
| Net interest income (loss) | $600281 | $— | $(23705) | $576576 |
| Provision for credit losses | 96522 |  |  | 96522 |
| Noninterest income (loss) | 106441 | 25742 | (1428) | 130755 |
| Salaries and employee benefits | 258427 | 12054 |  | 270481 |
| Net occupancy and equipment | 46794 | 667 | 67 | 47528 |
| Other segment expenses<sup>(1)</sup> | 156796 | 5248 | 857 | 162901 |
| Income (loss) before income taxes | $148183 | $7773 | $(26057) | $129899 |
| Income tax expense (benefit) | 33818 | 435 | (6678) | 27575 |
| Net income (loss) | $114365 | $7338 | $(19379) | $102324 |
| Total assets | $26715563 | $7031 | $3571 | $26726165 |
| Goodwill | 1411711 |  |  | 1411711 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Community<br>Banks** | **Insurance** | **Wealth<br>Management** | **Other** | **Consolidated** |
| **Nine months ended September 30, 2024** | | | | | |
| Total interest income | $661444 | $942 | $47 |  | $662433 |
| Total interest expense | 262474 |  |  | 20645 | 283119 |
| Net interest income (loss) | $398970 | $942 | $47 | $(20645) | $379314 |
| Provision for credit losses | 6673 |  |  |  | 6673 |
| Noninterest income (loss) | 145179 | 6473 | 18933 | (1143) | 169442 |
| Salaries and employee benefits | 199969 | 3626 | 9913 |  | 213508 |
| Net occupancy and equipment | 33875 | 189 | 584 |  | 34648 |
| Other segment expenses<sup>(2)</sup> | 93697 | 577 | 3228 | 1213 | 98715 |
| Income (loss) before income taxes | $209935 | $3023 | $5255 | $(23001) | $195212 |
| Income tax expense (benefit) | 49507 | 785 | 147 | (5937) | 44502 |
| Net income (loss) | $160428 | $2238 | $5108 | $(17064) | $150710 |
| Total assets (liabilities) | $17959839 | $— | $1163 | $(2162) | $17958840 |
| Goodwill | 988898 |  |  |  | 988898 |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Renasant Corporation and Subsidiaries

Notes to Consolidated Financial Statements (Unaudited)

<sup>(1)&nbsp;&nbsp;&nbsp;&nbsp;</sup>Other segment expenses for Community Banks include data processing, other real estate owned, legal and professional fees, advertising and public relations, intangible amortization, communications, merger and conversion related expenses and other miscellaneous expenses. Other segment expenses for Wealth Management include data processing, legal and professional fees, advertising and public relations, intangible amortization, communications and other miscellaneous expenses.

<sup>(2)&nbsp;&nbsp;&nbsp;&nbsp;</sup>Other segment expenses for Community Banks include data processing, other real estate owned, legal and professional fees, advertising and public relations, intangible amortization, communications, merger and conversion related expenses and other miscellaneous expenses. Other segment expenses for Insurance included data processing, legal and professional fees, advertising and public relations, communications and other miscellaneous expenses. Other segment expenses for Wealth Management include data processing, legal and professional fees, advertising and public relations, intangible amortization, communications and other miscellaneous expenses.

**Note 17 – Subsequent Events**

*(In Thousands, Except Share Amounts)*

*Subordinated Debt Redemption*

On October 1, 2025, the Company redeemed $60,000 in subordinated notes assumed in connection with its merger with The First.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

*(In Thousands, Except Share Data)*

This Form 10-Q may contain or incorporate by reference statements regarding Renasant Corporation (referred to herein as the "Company", "Renasant", "we", "our", or "us") that constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements preceded by, followed by or that otherwise include the words "believes," "expects", "projects," "anticipates," "intends," "estimates," "plans," "potential," "focus," "possible," "may increase," "may fluctuate," "will likely result," and similar expressions, or future or conditional verbs such as "will," "should," "would" and "could," are generally forward-looking in nature and not historical facts. Forward-looking statements include information about the Company's future financial performance, business strategy, projected plans and objectives and are based on the current beliefs and expectations of management. The Company's management believes these forward-looking statements are reasonable, but they are all inherently subject to significant business, economic and competitive risks and uncertainties, many of which are beyond the Company's control. In addition, these forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Actual results may differ from those indicated or implied in the forward-looking statements, and such differences may be material. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and, accordingly, investors should not place undue reliance on these forward-looking statements, which speak only as of the date they are made.

Important factors currently known to management that could cause our actual results to differ materially from those in forward-looking statements include the following: (i) the Company's ability to efficiently integrate acquisitions (including its merger with The First Bancshares, Inc. ("The First")) into its operations, retain the customers of these businesses, grow the acquired operations and realize the cost savings expected from an acquisition to the extent and in the timeframe anticipated by management (including the possibility that such cost savings will not be realized when expected, or at all, as a result of the impact of, or challenges arising from, the integration of the acquired assets and assumed liabilities into the Company, potential adverse reactions or changes to business or employee relationships, or as a result of other unexpected factors or events); (ii) potential exposure to unknown or contingent risks and liabilities we have acquired, or may acquire, or target for acquisition, including in connection with the Company's merger with The First; (iii) the effect of economic conditions and interest rates on a national, regional or international basis; (iv) timing and success of the implementation of changes in operations to achieve enhanced earnings or effect cost savings; (v) competitive pressures in the consumer finance, commercial finance, financial services, asset management, retail banking, factoring, mortgage lending and auto lending industries; (vi) the financial resources of, and products available from, competitors; (vii) changes in laws and regulations as well as changes in accounting standards; (viii) changes in governmental and regulatory policy, whether applicable specifically to financial institutions or impacting the United States generally (such as, for example, changes in trade policy); (ix) increased scrutiny by, and/or additional regulatory requirements of, regulatory agencies as a result of the Company's merger with The First; (x) changes in the securities and foreign exchange markets; (xi) the Company's potential growth, including its entrance or expansion into new markets, and the need for sufficient capital to support that growth; (xii) changes in the quality or composition of the Company's loan or investment securities portfolios, including adverse developments in borrower industries or in the repayment ability of individual borrowers or issuers of investment securities, or the impact of interest rates on the value of our investment portfolio; (xiii) an insufficient allowance for credit losses as a result of inaccurate assumptions; (xiv) changes in the sources and costs of the capital we use to make loans and otherwise fund our operations, due to deposit outflows, changes in the mix of deposits and the cost and availability of borrowings; (xv) general economic, market or business conditions, including the impact of inflation; (xvi) changes in demand for loan and deposit products and other financial services; (xvii) concentrations of credit or deposit exposure; (xviii) changes or the lack of changes in interest rates, yield curves and interest rate spread relationships; (xix) increased cybersecurity risk, including potential network breaches, business disruptions or financial losses; (xx) civil unrest, natural disasters, epidemics and other catastrophic events in the Company's geographic area; (xxi) geopolitical conditions, including acts or threats of terrorism and actions taken by the United States or other governments in response to acts or threats of terrorism and/or military conflicts, which could impact business and economic conditions in the United States and abroad; (xxii) the impact, extent and timing of technological changes; and (xxiii) other circumstances, many of which are beyond management's control. Management believes that the assumptions underlying the Company's forward-looking statements are reasonable, but any of the assumptions could prove to be inaccurate.

The Company undertakes no obligation, and specifically disclaims any obligation, to update or revise forward-looking statements, whether as a result of new information or to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time, except as required by federal securities laws.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

**Financial Condition**

The following discussion provides details regarding the changes in significant balance sheet accounts at September 30, 2025 compared to December 31, 2024.

*Mergers and Acquisitions*

On April 1, 2025 the Company completed its merger with The First. At closing, The First merged with and into the Company, with the Company the surviving corporation in the merger; immediately thereafter, The First Bank merged with and into Renasant Bank, with Renasant Bank the surviving banking corporation in the merger. For more information, including the fair value of assets acquired and liabilities assumed, see Note 2, "Mergers and Acquisitions," in the Notes to Consolidated Financial Statements of the Company in Item 1, Financial Statements, in this report.

*Assets*

Total assets were $26,726,165 at September 30, 2025, compared to $18,034,868 at December 31, 2024. The acquisition of The First increased total assets $7,979,299 at April 1, 2025.

*Investments*

The securities portfolio is used to provide a source for meeting liquidity needs and to supply securities to be used in collateralizing certain deposits and certain types of borrowings. The securities portfolio also serves as an outlet to deploy excess liquidity and generate interest income rather than hold excess funds as cash. The following table shows the carrying value of our securities portfolio by investment type and the percentage of such investment type relative to the entire securities portfolio as of the dates presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| | **Balance** | **Percentage of<br>Portfolio** | **Balance** | **Percentage of<br>Portfolio** |
| Obligations of states and political subdivisions | $554185 | 15.55% | $302596 | 15.46% |
| Mortgage-backed securities | 2600186 | 72.94 | 1472918 | 75.26 |
| Other debt securities | 410195 | 11.51 | 181643 | 9.28 |
|  | $3564566 | 100.00% | $1957157 | 100.00% |
| Allowance for credit losses - held to maturity securities | (32) |  | (32) |  |
| Securities, net of allowance for credit losses | $3564534 |  | $1957125 |  |

---

The Company purchased $1,058,969 and $60,656 in investment securities during the nine months ended September 30, 2025 and 2024, respectively. The merger with The First contributed approximately $1,457,377 to the securities portfolio at April 1, 2025.

Proceeds from maturities, calls and principal payments on securities during the first nine months of 2025 totaled $282,347. Shortly after the merger with The First, certain securities from the acquired portfolio were sold at carrying value, resulting in net proceeds of $686,485. No gain or loss on sales of securities was recorded in the first nine months of 2025. Proceeds from the maturities, calls and principal payments on securities during the first nine months of 2024 totaled $142,480. During the first nine months of 2024, the Company sold from the available for sale portfolio municipal securities, residential mortgage backed securities and commercial mortgage backed securities for net proceeds of $177,185. The Company intended to sell these securities as of December 31, 2023; therefore, the Company impaired the securities and recognized the loss in net income as of December 31, 2023. The carrying value of the securities immediately prior to the impairment was $196,537, and the impairment charge was $19,352. No gain or loss on sales of securities was recorded in the first nine months of 2024.

During the third quarter of 2022, the Company transferred, at fair value, $882,927 of securities from the available for sale portfolio to the held to maturity portfolio as the Company has the intent and ability to hold these securities until their maturity. The related net unrealized losses of $99,675 (after tax losses of $74,307) remained in accumulated other comprehensive income (loss) and will be amortized over the remaining life of the securities, offsetting the related amortization of discount on the transferred securities. At September 30, 2025, the net unrealized after tax losses remaining to be amortized in accumulated other comprehensive income (loss) was $42,430. No gains or losses were recognized at the time of transfer.

For more information about the Company's security portfolio, see Note 3, "Securities," in the Notes to Consolidated Financial Statements of the Company in Item 1, Financial Statements, in this report.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

*Loans Held for Sale*

Loans held for sale, which consist of residential mortgage loans being held until they are sold in the secondary market, were $286,779 at September 30, 2025, as compared to $246,171 at December 31, 2024. Mortgage loans to be sold are sold either on a "best efforts" basis or under a mandatory delivery sales agreement. Under a "best efforts" sales agreement, residential real estate originations are locked in at a contractual rate with third party private investors or directly with government sponsored agencies, and the Company is obligated to sell the mortgages to such investors only if the mortgages are closed and funded. The risk we assume is conditioned upon loan underwriting and market conditions in the national mortgage market. Under a mandatory delivery sales agreement, the Company commits to deliver a certain principal amount of mortgage loans to an investor at a specified price and delivery date. Penalties are paid to the investor if we fail to satisfy the contract. Gains and losses are realized at the time consideration is received and all other criteria for sales treatment have been met. Our standard practice is to sell the loans within approximately 45 days after the loan is funded. Although loan fees and some interest income are derived from mortgage loans held for sale, the main source of income is gains from the sale of these loans in the secondary market.

*Loans*

Total loans, excluding loans held for sale, were $19,025,521 at September 30, 2025 and $12,885,020 at December 31, 2024. The acquisition of The First increased total loans $5,171,236, excluding loans held for sale, at April 1, 2025.

The table below sets forth the balance of loans outstanding, net of unearned income and excluding loans held for sale, by loan type and the percentage of each loan type to total loans as of the dates presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| | **Total<br>Loans** | **Percentage of Total Loans** | **Total<br>Loans** | **Percentage of Total Loans** |
| Commercial, financial, agricultural | $2760490 | 14.51% | $1885817 | 14.64% |
| Lease financing, net of unearned income | 74179 | 0.39 | 90591 | 0.70 |
| Real estate – construction: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Residential | 404651 | 2.13 | 256655 | 1.99 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commercial | 1122839 | 5.90 | 836998 | 6.50 |
| Total real estate – construction | 1527490 | 8.03 | 1093653 | 8.49 |
| Real estate – 1-4 family mortgage: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primary | 3061356 | 16.09 | 2428076 | 18.84 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Home equity | 739786 | 3.89 | 544158 | 4.22 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rental/investment | 841515 | 4.42 | 402938 | 3.13 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development | 239955 | 1.26 | 113705 | 0.88 |
| Total real estate – 1-4 family mortgage | 4882612 | 25.66 | 3488877 | 27.07 |
| Real estate – commercial mortgage: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Owner-occupied | 3321186 | 17.46 | 1894679 | 14.70 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-owner occupied | 6120677 | 32.17 | 4226937 | 32.81 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development | 223212 | 1.17 | 114452 | 0.89 |
| Total real estate – commercial mortgage | 9665075 | 50.80 | 6236068 | 48.40 |
| Installment loans to individuals | 115675 | 0.61 | 90014 | 0.70 |
| Total loans, net of unearned income | $19025521 | 100.00% | $12885020 | 100.00% |

---

Loan concentrations are considered to exist when there are loans to a number of borrowers engaged in similar activities that would cause them to be similarly impacted by economic or other conditions. At September 30, 2025, there were no concentrations of loans exceeding 10% of total loans other than loans disclosed in the table above. Non-owner occupied commercial mortgage term loans was the largest concentration and comprised 32.17% of total loans at September 30, 2025. The following table provides additional detail, broken down by collateral type, about loan segments within the non-owner occupied commercial mortgage loan category as of the date presented.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Balance** | **Average Loan Size** | **Percentage of Total Loans** | **Weighted-Average Loan-to-Value** | **Percentage 30-89 Days Past Due** | **Percentage<br>Non-performing** |
| Hotels | $735666 | $4459 | 3.87% | 53% | —% | —% |
| Self Storage | 587550 | 3013 | 3.09 | 54 | 0.04 |  |
| Multi-Family | 1365217 | 2630 | 7.18 | 53 |  | 0.10 |
| Office - Medical | 387581 | 1919 | 2.04 | 52 |  |  |
| Office - Non-Medical | 450674 | 870 | 2.37 | 55 |  | 7.12 |
| Retail | 1229189 | 1284 | 6.46 | 54 |  | 0.02 |
| Senior Housing | 326086 | 5823 | 1.71 | 60 |  | 3.52 |
| Warehouse/Industrial | 894911 | 2337 | 4.70 | 53 |  |  |
| Other | 143803 | 952 | 0.75 | 54 | 0.31 |  |
| Total non-owner occupied commercial mortgage term loans | $6120677 | $1946 | 32.17% | 54% | 0.01% | 0.74% |

---

Note: Weighted-average loan-to-value is calculated using the most recent appraisal available.

*Bank-owned life insurance*

The Company holds bank-owned life insurance policies ("BOLI") on certain employees. The carrying value of these policies was $488,920 and $391,810 at September 30, 2025 and December 31, 2024, respectively. The Company acquired $146,601 of BOLI as a result of its merger with The First. The Company elected to surrender $56,255 of BOLI with below market yields during the first quarter of 2025. The proceeds were deployed into higher yielding assets.

*Deposits*

The Company relies on deposits as its primary source of funds. Total deposits were $21,424,555 and $14,572,612 at September 30, 2025 and December 31, 2024, respectively. Noninterest-bearing deposits were $5,238,431 and $3,403,981 at September 30, 2025 and December 31, 2024, respectively, while interest-bearing deposits were $16,186,124 and $11,168,631 at September 30, 2025 and December 31, 2024, respectively. The merger with The First increased total deposits at April 1, 2025 by $6,449,394, which consisted of $1,787,866 and $4,661,527 of noninterest-bearing deposit and interest-bearing deposits, respectively.

Management continues to focus on growing and maintaining a stable source of funding, specifically noninterest-bearing deposits and other core deposits (that is, deposits excluding brokered deposits). Noninterest-bearing deposits represented 24.45% of total deposits at September 30, 2025, as compared to 23.36% of total deposits at December 31, 2024. The increase in noninterest-bearing deposits as a percentage of total deposits was primarily driven by the acquisition of The First during the second quarter, as its noninterest-bearing deposits represented 27.72% of its total deposits on the date of acquisition. Under certain circumstances, management may elect to acquire non-core deposits (in the form of brokered deposits) or public fund deposits (which are deposits of counties, municipalities or other political subdivisions). The source of funds that we select depends on the terms of the deposits and how those terms assist us in mitigating interest rate risk, maintaining our liquidity position and managing our net interest margin; business factors, described in the following paragraph, may lead us to obtain public deposits. Accordingly, funds are acquired to meet anticipated funding needs at the rate and with other terms that, in management's view, best address our interest rate risk, liquidity and net interest margin parameters.

Public fund deposits may be readily obtained based on the Company's pricing bid in comparison with competitors. Because public fund deposits are obtained through a bid process, these deposit balances may fluctuate as competitive and market forces change. Although the Company has focused on growing stable sources of deposits to reduce reliance on public fund deposits, it participates in the bidding process for public fund deposits when pricing and other terms make it reasonable given market conditions or when management perceives that other factors, such as the public entity's use of our treasury management or other products and services, make such participation advisable. Our public fund transaction accounts are principally obtained from public universities and municipalities, including school boards and utilities. Public fund deposits were $3,742,390 and $2,256,461 at September 30, 2025 and December 31, 2024, respectively, and represented 17.47% and 15.48% of total deposits as of September 30, 2025 and December 31, 2024, respectively.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

*Borrowed Funds*

Total borrowings may include federal funds purchased, securities sold under agreements to repurchase, advances from the Federal Home Loan Bank of Dallas (the "FHLB"), borrowings from the Federal Reserve Discount Window, subordinated notes and junior subordinated debentures and are classified on the Consolidated Balance Sheets as either short-term borrowings or long-term debt. Short-term borrowings have original maturities less than one year and typically consist of federal funds purchased, securities sold under agreements to repurchase, and short-term FHLB advances. The Company assumed $298,250 of FHLB advances as a result of its merger with The First. We also increased short-term FHLB borrowings in the first nine months of 2025 primarily to fund loan growth, particularly in the second and third quarters of 2025. The following table presents our short-term borrowings by type as of the dates presented:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| Security repurchase agreements | $6063 | $8018 |
| Short-term borrowings from the FHLB | 600000 | 100000 |
|  | $606063 | $108018 |

---

Long-term debt typically consists of long-term FHLB advances, our junior subordinated debentures and our subordinated notes. The Company assumed $95,262 of subordinated notes and $25,653 of junior subordinated debentures as a result of its merger with The First. The following table presents our long-term debt by type as of the dates presented:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| Junior subordinated debentures | $140355 | $113916 |
| Subordinated notes | 418523 | 316698 |
|  | $558878 | $430614 |

---

Long-term funds obtained from the FHLB are used to match-fund fixed rate loans in order to minimize interest rate risk and to meet day-to-day liquidity needs, particularly when the cost of such borrowing compares favorably to the rates that we would be required to pay to attract deposits (which has not been the case in recent periods). Advances from the FHLB are collateralized by a blanket lien on the Bank's loans. The Company had $5,011,339 of availability on unused lines of credit with the FHLB at September 30, 2025, as compared to $4,004,630 at December 31, 2024. The Company also had credit available at the Federal Reserve Discount Window in the amount of $657,277.

The Company has issued subordinated notes (and assumed subordinated notes in connection with its merger with The First), and the Company owns the outstanding common securities of business trusts that issued corporation-obligated mandatorily redeemable preferred capital securities to third-party investors, the proceeds of which were used to buy floating rate junior subordinated debentures issued by the Company (or by companies that the Company subsequently acquired). The proceeds generated by the Company's subordinated notes and trust preferred securities transactions have been used for general corporate purposes, including providing capital to support the Company's growth organically or through strategic acquisitions, repaying indebtedness and financing investments and capital expenditures, and for investments in Renasant Bank as regulatory capital. On October 1, 2025, the Company redeemed $60,000 in subordinated notes assumed in connection with its merger with The First. The subordinated notes and trust preferred securities qualify as Tier 2 capital under current regulatory guidelines.

**Results of Operations**

*Net Income*

Net income for the third quarter of 2025 was $59,788 compared to net income of $72,455 for the third quarter of 2024. Basic and diluted earnings per share ("EPS") for the third quarter of 2025 were $0.63, as compared to basic and diluted EPS of $1.18 for the third quarter of 2024. Net income for the nine months ended September 30, 2025, was $102,324 compared to net income of $150,710 for the same period in 2024. Basic and diluted EPS were $1.21 and $1.20, respectively, for the first nine months of 2025 as compared to $2.60 and $2.59, respectively, for the first nine months of 2024.

From time to time, the Company incurs expenses and charges or recognizes valuation adjustments in connection with certain transactions with respect to which management is unable to accurately predict when these items will be incurred or, when incurred, the amount of such items. The following table presents the impact of these items on reported EPS for the dates presented.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2024** | **September 30, 2024** | **September 30, 2024** |
| | **Pre-tax** | **After-tax** | **Impact to Diluted EPS** | **Pre-tax** | **After-tax** | **Impact to Diluted EPS** |
| Merger and conversion related expenses | $(17494) | $(13129) | $(0.14) | $(11273) | $(9456) | $(0.15) |
| Gain on sale of insurance agency |  |  |  | 53349 | 38951 | 0.63 |
|  | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
|  | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2024** | **September 30, 2024** | **September 30, 2024** |
|  | **Pre-tax** | **After-tax** | **Impact to Diluted EPS** | **Pre-tax** | **After-tax** | **Impact to Diluted EPS** |
| Merger and conversion related expenses | $(38764) | $(29561) | $(0.35) | $(11273) | $(9456) | $(0.16) |
| Day 1 acquisition provision | (66612) | (50026) | (0.59) |  |  |  |
| Gain on sale of MSR | 1467 | 1102 | 0.01 |  |  |  |
| Gain on sale of insurance agency |  |  |  | 53349 | 38951 | 0.67 |

---

*Net Interest Income*

Net interest income, the difference between interest earned on assets and the cost of interest-bearing liabilities, is the largest component of our net income, comprising 83.21% of total revenue (i.e., net interest income on a fully taxable equivalent basis and noninterest income) for the third quarter of 2025. Changes in net interest income are driven by fluctuations in the volume, mix and repricing of assets and liabilities.

Net interest income was $223,520 and $576,576 for the three and nine months ended September 30, 2025, as compared to $130,998 and $379,314 for the same periods in 2024. On a tax equivalent basis, net interest income was $228,131 and $588,280 for the three and nine months ended September 30, 2025, as compared to $133,576 and $387,024 for the same periods in 2024.

The following tables set forth average balance sheet data, including all major categories of interest-earning assets and interest-bearing liabilities, together with the interest earned or interest paid and the average yield or average rate paid on each such category on a tax-equivalent basis for the periods presented:

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| | **Average<br>Balance** | **Interest<br>Income/<br>Expense** | **Yield/<br>Rate** | **Average<br>Balance** | **Interest<br>Income/<br>Expense** | **Yield/<br>Rate** |
| Assets |  |  |  |  |  |  |
| Interest-earning assets: |  |  |  |  |  |  |
| Loans held for investment | $18750715 | $311903 | 6.60% | $12584104 | $204935 | 6.47% |
| Loans held for sale | 290756 | 4675 | 6.43 | 272110 | 4212 | 6.19 |
| Securities: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Taxable | 3243693 | 27107 | 3.34 | 1794421 | 9212 | 2.05 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tax-exempt<sup>(1)</sup> | 428252 | 3928 | 3.67 | 262621 | 1390 | 2.12 |
| Interest-bearing balances with banks | 814103 | 8096 | 3.95 | 894313 | 11872 | 5.28 |
| Total interest-earning assets | 23527519 | 355709 | 6.01 | 15807569 | 231621 | 5.82 |
| Cash and due from banks | 306847 |  |  | 189425 |  |  |
| Intangible assets | 1578846 |  |  | 1004701 |  |  |
| Other assets | 1043384 |  |  | 679901 |  |  |
| Total assets | $26456596 |  |  | $17681596 |  |  |
| Liabilities and shareholders' equity |  |  |  |  |  |  |
| Interest-bearing liabilities: |  |  |  |  |  |  |
| Deposits: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest-bearing demand<sup>(2)</sup> | $11521433 | $82080 | 2.83% | $7333508 | $60326 | 3.26% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Savings deposits | 1299396 | 943 | 0.29 | 815545 | 729 | 0.36 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Brokered deposits |  |  |  | 150991 | 1998 | 5.25 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Time deposits | 3398402 | 32550 | 3.80 | 2546860 | 27734 | 4.33 |
| Total interest-bearing deposits | 16219231 | 115573 | 2.83 | 10846904 | 90787 | 3.32 |
| Borrowed funds | 961980 | 12005 | 4.97 | 562146 | 7258 | 5.14 |
| Total interest-bearing liabilities | 17181211 | 127578 | 2.95 | 11409050 | 98045 | 3.41 |
| Noninterest-bearing deposits | 5226588 |  |  | 3509266 |  |  |
| Other liabilities | 253801 |  |  | 209763 |  |  |
| Shareholders' equity | 3794996 |  |  | 2553517 |  |  |
| Total liabilities and shareholders' equity | $26456596 |  |  | $17681596 |  |  |
| Net interest income/net interest margin |  | $228131 | 3.85% |  | $133576 | 3.36% |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup>U.S. Government and some U.S. Government Agency securities are tax-exempt in the states in which the Company operates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(2)</sup>Interest-bearing demand deposits include interest-bearing transactional accounts and money market deposits.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| | **Average<br>Balance** | **Interest<br>Income/<br>Expense** | **Yield/<br>Rate** | **Average<br>Balance** | **Interest<br>Income/<br>Expense** | **Yield/<br>Rate** |
| Assets |  |  |  |  |  |  |
| Interest-earning assets: |  |  |  |  |  |  |
| Loans held for investment | $16743048 | $816241 | 6.52% | $12522802 | $600245 | 6.39% |
| Loans held for sale | 260172 | 12322 | 6.32 | 215978 | 10050 | 6.20 |
| Securities: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Taxable | 2749580 | 62995 | 3.05 | 1839249 | 27975 | 2.03 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tax-exempt<sup>(1)</sup> | 384212 | 9680 | 3.36 | 265601 | 4346 | 2.18 |
| Interest-bearing balances with banks | 846844 | 25792 | 4.07 | 687318 | 27527 | 5.35 |
| Total interest-earning assets | 20983856 | 927030 | 5.90 | 15530948 | 670143 | 5.75 |
| Cash and due from banks | 282476 |  |  | 188485 |  |  |
| Intangible assets | 1392393 |  |  | 1007710 |  |  |
| Other assets | 915322 |  |  | 694427 |  |  |
| Total assets | $23574047 |  |  | $17421570 |  |  |
| Liabilities and shareholders' equity |  |  |  |  |  |  |
| Interest-bearing liabilities: |  |  |  |  |  |  |
| Deposits: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest-bearing demand<sup>(2)</sup> | $10196332 | $213332 | 2.80% | $7128721 | $168958 | 3.16% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Savings deposits | 1146732 | 2686 | 0.31 | 838443 | 2188 | 0.35 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Brokered deposits |  |  |  | 296550 | 11929 | 5.36 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Time deposits | 3095753 | 90862 | 3.92 | 2451733 | 77946 | 4.25 |
| Total interest-bearing deposits | 14438817 | 306880 | 2.84 | 10715447 | 261021 | 3.25 |
| Borrowed funds | 853071 | 31870 | 4.99 | 569476 | 22098 | 5.17 |
| Total interest-bearing liabilities | 15291888 | 338750 | 2.96 | 11284923 | 283119 | 3.35 |
| Noninterest-bearing deposits | 4629790 |  |  | 3512318 |  |  |
| Other liabilities | 237417 |  |  | 221932 |  |  |
| Shareholders' equity | 3414952 |  |  | 2402397 |  |  |
| Total liabilities and shareholders' equity | $23574047 |  |  | $17421570 |  |  |
| Net interest income/net interest margin |  | $588280 | 3.75% |  | $387024 | 3.32% |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup>U.S. Government and some U.S. Government Agency securities are tax-exempt in the states in which the Company operates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(2)</sup>Interest-bearing demand deposits include interest-bearing transactional accounts and money market deposits.

The average balances of nonaccruing assets are included in the tables above. Interest income and weighted average yields on tax-exempt loans and securities have been computed on a fully tax equivalent basis assuming a federal tax rate of 21%.

Net interest margin and net interest income are influenced by internal and external factors. Internal factors include balance sheet changes in volume and mix and pricing decisions. External factors include changes in market interest rates, competition and other factors affecting the banking industry in general, and the shape of the interest rate yield curve. The addition of The First's loan portfolio, strong organic loan growth in 2025 and the Federal Reserve lowering the federal funds rate by 100 basis points in the second half of 2024 were the largest contributing factors to the increase in net interest income for the three and nine months ended September 30, 2025, as compared to the same periods in 2024. (The Federal Reserve lowered the federal funds rate by 25 basis points in September 2025, but it did not have a significant impact on the Company's results because it occurred late in the quarter.) Lower interest rates and the addition of The First's deposits generated a positive impact to both the cost and mix of our funding sources. The Company has continued its efforts to mitigate increases in the cost of funding due to competition or otherwise through maintaining noninterest-bearing deposits and staying disciplined yet competitive in pricing on interest-bearing deposits in the current rate environment.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

The following tables set forth a summary of the changes in interest earned, on a tax equivalent basis, and interest paid resulting from changes in volume and rates for the Company for the three and nine months ended September 30, 2025, as compared to the same periods in 2024 (the changes attributable to the combined impact of yield/rate and volume have been allocated on a pro-rata basis using the absolute value of amounts calculated):

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025 Compared to the Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2025 Compared to the Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2025 Compared to the Three Months Ended September 30, 2024** |
| | **Volume** | **Rate** | **Net** |
| **Interest income:** | | | |
| Loans held for investment | $102755 | $4213 | $106968 |
| Loans held for sale | 296 | 167 | 463 |
| Securities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Taxable | 10058 | 7837 | 17895 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tax-exempt | 1175 | 1363 | 2538 |
| Interest-bearing balances with banks | (991) | (2785) | (3776) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest-earning assets | 113293 | 10795 | 124088 |
| **Interest expense:** |  |  |  |
| Interest-bearing demand deposits | 30586 | (8832) | 21754 |
| Savings deposits | 378 | (164) | 214 |
| Brokered deposits | (1998) |  | (1998) |
| Time deposits | 8507 | (3691) | 4816 |
| Borrowed funds | 4996 | (249) | 4747 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest-bearing liabilities | 42469 | (12936) | 29533 |
| Change in net interest income | $70824 | $23731 | $94555 |
|  | **Nine months ended September 30, 2025 Compared to the Nine Months Ended September 30, 2024** | **Nine months ended September 30, 2025 Compared to the Nine Months Ended September 30, 2024** | **Nine months ended September 30, 2025 Compared to the Nine Months Ended September 30, 2024** |
|  | **Volume** | **Rate** | **Net** |
| **Interest income:** |  |  |  |
| Loans held for investment | $203699 | $12297 | $215996 |
| Loans held for sale | 2076 | 196 | 2272 |
| Securities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Taxable | 17378 | 17642 | 35020 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tax-exempt | 2411 | 2923 | 5334 |
| Interest-bearing balances with banks | 7810 | (9545) | (1735) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest-earning assets | 233374 | 23513 | 256887 |
| **Interest expense:** |  |  |  |
| Interest-bearing demand deposits | 75668 | (31294) | 44374 |
| Savings deposits | 892 | (394) | 498 |
| Brokered deposits | (11929) |  | (11929) |
| Time deposits | 22459 | (9543) | 12916 |
| Borrowed funds | 11050 | (1278) | 9772 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest-bearing liabilities | 98140 | (42509) | 55631 |
| Change in net interest income | $135234 | $66022 | $201256 |

---

Interest income, on a tax equivalent basis, was $355,709 and $927,030 for the three and nine months ended September 30, 2025, as compared to $231,621 and $670,143 for the same period in 2024. The increase in interest income, on a tax equivalent basis, for the three and nine months ended September 30, 2025, as compared to the same time periods in 2024 is due primarily to the addition of The First's earning assets.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

The following tables present the percentage of total average earning assets, by type and yield, for the periods presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Percentage of Total Average Earning Assets** | **Percentage of Total Average Earning Assets** | **Yield** | **Yield** |
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Loans held for investment | 79.70% | 79.61% | 6.60% | 6.47% |
| Loans held for sale | 1.24 | 1.72 | 6.43 | 6.19 |
| Securities | 15.61 | 13.01 | 3.38 | 2.06 |
| Interest-bearing balances with banks | 3.45 | 5.66 | 3.95 | 5.28 |
| Total earning assets | 100.00% | 100.00% | 6.01% | 5.82% |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Percentage of Total Average Earning Assets** | **Percentage of Total Average Earning Assets** | **Yield** | **Yield** |
| | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Loans held for investment | 79.79% | 80.63% | 6.52% | 6.39% |
| Loans held for sale | 1.24 | 1.39 | 6.32 | 6.20 |
| Securities | 14.93 | 13.55 | 3.09 | 2.05 |
| Interest-bearing balances with banks | 4.04 | 4.43 | 4.07 | 5.35 |
| Total earning assets | 100.00% | 100.00% | 5.90% | 5.75% |

---

For the third quarter of 2025, interest income on loans held for investment, on a tax equivalent basis, increased $106,968 to $311,903 from $204,935 for the same period in 2024. For the nine months ended September 30, 2025, interest income on loans held for investment, on a tax equivalent basis, increased $215,996 to $816,241 from $600,245 in the same period of 2024. Driven largely by the addition of $5,171,236 in loans held for investment through our merger with The First on April l, 2025, the year-to-date average balance of loans held for investment increased $4,220,246 from September 2024, thereby resulting in the increase in interest income on loans held for investment for the three and nine months ended September 30, 2025, as compared to the same periods in 2024.

The impact from interest income collected on problem loans and purchase accounting adjustments on loans to total interest income on loans held for investment, loan yield and net interest margin is shown in the following table for the periods presented.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Net interest income collected on problem loans | $664 | $642 | $4469 | $619 |
| Accretable yield recognized on purchased loans | 16862 | 1089 | 35254 | 2786 |
| Total impact to interest income on loans | $17526 | $1731 | $39723 | $3405 |
| Impact to loan yield | 0.37% | 0.05% | 0.32% | 0.04% |
| Impact to net interest margin | 0.23% | 0.04% | 0.20% | 0.03% |

---

Interest income on loans held for sale (consisting of mortgage loans held for sale) increased $463 to $4,675 for the third quarter of 2025 from $4,212 for the same period in 2024. Interest income on loans held for sale (consisting of mortgage loans held for sale) for the nine months ended September 30, 2025 was $12,322 as compared to $10,050 for the same period in 2024.

Investment income, on a tax equivalent basis, increased $20,433 to $31,035 for the third quarter of 2025 from $10,602 for the third quarter of 2024. Investment income, on a tax equivalent basis, increased $40,354 to $72,675 for the nine months ended September 30, 2025 from $32,321 for the same period in 2024. The increase in investment income, on a tax equivalent basis, was primarily due to the acquisition of The First's investment portfolio. The tax equivalent yield on the investment portfolio for the third quarter of 2025 was 3.38%, up 132 basis points from 2.06% for the same period in 2024. The tax equivalent yield on

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

the investment portfolio for the nine months ended September 30, 2025 was 3.09%, up 104 basis points from 2.05% for the same period in 2024.

Interest expense was $127,578 for the third quarter of 2025 as compared to $98,045 for the same period in 2024. Interest expense for the nine months ended September 30, 2025 was $338,750 as compared to $283,119 for the same period in 2024. The increase in interest expense was primarily due to the assumption of The First's deposits and borrowed funds.

The following table presents, by type, the Company's funding sources, which consist of total average deposits and borrowed funds, and the total cost of each funding source for the periods presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Percentage of Total Average Deposits and Borrowed Funds** | **Percentage of Total Average Deposits and Borrowed Funds** | **Cost of Funds** | **Cost of Funds** |
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Noninterest-bearing demand | 23.32% | 23.52% | —% | —% |
| Interest-bearing demand | 51.42 | 49.16 | 2.83 | 3.26 |
| Savings | 5.80 | 5.47 | 0.29 | 0.36 |
| Brokered deposits |  | 1.01 |  | 5.25 |
| Time deposits | 15.17 | 17.07 | 3.80 | 4.33 |
| Short term borrowings | 1.75 | 0.77 | 3.55 | 1.11 |
| Subordinated notes | 1.92 | 2.24 | 5.72 | 5.50 |
| Other borrowed funds | 0.62 | 0.76 | 6.63 | 8.17 |
| Total deposits and borrowed funds | 100.00% | 100.00% | 2.26% | 2.61% |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Percentage of Total Average Deposits and Borrowed Funds** | **Percentage of Total Average Deposits and Borrowed Funds** | **Cost of Funds** | **Cost of Funds** |
| | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Noninterest-bearing demand | 23.24% | 23.74% | —% | —% |
| Interest-bearing demand | 51.18 | 48.18 | 2.80 | 3.16 |
| Savings | 5.76 | 5.67 | 0.31 | 0.35 |
| Brokered deposits |  | 2.00 |  | 5.36 |
| Time deposits | 15.54 | 16.57 | 3.92 | 4.25 |
| Short-term borrowings | 1.62 | 0.83 | 3.33 | 1.44 |
| Subordinated notes | 2.00 | 2.25 | 5.55 | 5.51 |
| Other long term borrowings | 0.66 | 0.76 | 7.36 | 8.23 |
| Total deposits and borrowed funds | 100.00% | 100.00% | 2.27% | 2.55% |

---

Interest expense on deposits was $115,573 and $90,787 for the three months ended September 30, 2025 and 2024, respectively, and the cost of total deposits was 2.14% and 2.51% for the same respective periods. Interest expense on deposits was $306,880 and $261,021 for the nine months ended September 30, 2025 and 2024, respectively, and the cost of total deposits was 2.15% and 2.45% for the same respective periods. The increase in deposit expense and decrease in cost is attributable to the acquisition of The First's deposits. The cost of total deposits was also affected by the Federal Reserve's rate cuts during the second half of 2024, with minor impact from the rate cut in September 2025. The payoff of higher costing brokered deposits has also helped lower our total deposit cost. The Company has continued its efforts to maintain non-interest bearing deposits. Low cost deposits continue to be the preferred choice of funding; however, the Company may rely on brokered deposits or wholesale borrowings when advantageous, to address liquidity needs or as otherwise deemed advisable due to market conditions.

Interest expense on total borrowings was $12,005 and $7,258 for the three months ended September 30, 2025 and 2024, respectively. Interest expense on total borrowings was $31,870 and $22,098 for the nine months ended September 30, 2025 and 2024, respectively. The increase in interest expense on borrowings is due to higher average short-term borrowings and the additional subordinated notes and other long-term borrowings added as a result of the merger with The First.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

A more detailed discussion of the cost of our funding sources is set forth below under the heading "Liquidity and Capital Resources" in this Item.

*Noninterest Income*

---

| | | | |
|:---|:---|:---|:---|
| **Noninterest Income to Average Assets** | **Noninterest Income to Average Assets** | **Noninterest Income to Average Assets** | **Noninterest Income to Average Assets** |
| **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| **2025** | **2024** | **2025** | **2024** |
| 0.69% | 2.01% | 0.74% | 1.30% |

---

Total noninterest income includes fees generated from deposit services and other fees and commissions, income from our wealth management and mortgage banking operations, realized gains and losses on the sale of securities and all other noninterest income. Our focus is to develop and enhance our products that generate noninterest income in order to diversify revenue sources. Noninterest income was $46,026 for the third quarter of 2025 as compared to $89,299 for the same period in 2024. Noninterest income was $130,755 for the nine months ended September 30, 2025 as compared to $169,442 for the same period in 2024. The decrease in noninterest income for both the three and nine months ended September 30, 2025 was primarily driven by the elevated level of noninterest income in the third quarter of 2024 resulting from the gain on sale of the Company's insurance agency that occurred in such period, somewhat offset by additional income associated with the acquisition of The First's operations.

Service charges on deposit accounts include maintenance fees on accounts, per item charges, account enhancement charges for additional packaged benefits and overdraft fees (which encompasses traditional overdraft fees as well as non-sufficient funds fees). Service charges on deposit accounts were $13,416 and $10,438 for the third quarter of 2025 and 2024, respectively, and $37,398 and $31,230 for the nine months ended September 30, 2025 and 2024, respectively. Overdraft fees, the largest component of service charges on deposits, were $6,772 for the three months ended September 30, 2025, as compared to $5,122 for the same period in 2024. These fees were $18,672 for the nine months ended September 30, 2025 compared to $15,380 for the same period in 2024.

Fees and commissions were $4,167 during the third quarter of 2025 as compared to $4,116 for the same period in 2024, and were $14,604 for the first nine months of 2025 as compared to $12,009 for the same period in 2024. Fees and commissions include fees related to deposit services, such as ATM fees and interchange fees on debit card transactions, and lending services, such as collateral management fees and unused commitment fees. For the third quarter of 2025, interchange fees were $1,841 as compared to $2,246 for the same period in 2024. Interchange fees were $8,048 for the nine months ended September 30, 2025 as compared to $6,697 for the same period in 2024. The decrease in interchange fees for the third quarter of 2025 as compared to the same period in 2024 is due to higher debit card expenses that offset the increase of debit card income associated with the acquisition of The First.

Our Wealth Management segment has two divisions: Trust and Financial Services. The Trust division operates on a custodial basis, which includes administration of benefit plans, as well as accounting and money management for trust accounts. The division manages a number of trust accounts inclusive of personal and corporate benefit accounts, IRAs, and custodial accounts. Fees for managing these accounts are based on changes in market values of the assets under management in the account, with the amount of the fee depending on the type of account. The Financial Services division provides specialized products and services to our customers, which include fixed and variable annuities, mutual funds, and stocks offered through a third party provider. Wealth Management revenue was $8,217 for the third quarter of 2025 compared to $5,835 for the same period in 2024, and was $22,629 for the nine months ended September 30, 2025 compared to $17,188 for the same period in 2024. The market value of assets under management or administration was $6,847,724 and $5,694,433 at September 30, 2025 and September 30, 2024, respectively. The Company acquired approximately $471,000 of assets under management through its merger with The First.

Mortgage banking income is derived from the origination and sale of mortgage loans and the servicing of mortgage loans that the Company has sold but retained the right to service. Although loan fees and some interest income are derived from mortgage loans held for sale, the main source of income is gains from the sale of these loans in the secondary market. Interest rate lock commitments and originations of mortgage loans to be sold totaled $590,160 and $425,482, respectively, in the third quarter of 2025 compared to $543,597 and $412,059, respectively, for the same period in 2024. The increase in interest rate lock commitments for the three months ended September 30, 2025 as compared to the same period in 2024 was due to the slight decrease in mortgage interest rates during the third quarter of 2025 as compared to the same period in 2024. Interest rate lock commitments and originations of mortgage loans to be sold totaled $1,901,918 and $1,220,267 in the nine months ended September 30, 2025 compared to $1,548,198 and $1,053,190 for the same period in 2024. The high rates in 2024 significantly dampened demand for mortgages nationwide. In the second quarter of 2025 and the first quarter of 2024, the Company sold a portion of its mortgage servicing rights portfolio with a carrying value of $7,886 and $19,539, respectively, for a pre-tax gain of

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

$1,467 and $3,472, respectively. The table below presents the components of mortgage banking income included in noninterest income for the periods presented.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Gain on sales of loans, net <sup>(1)</sup> | $5270 | $4499 | $15086 | $14233 |
| Fees, net | 3050 | 2646 | 9107 | 7366 |
| Mortgage servicing income, net<sup>(2)</sup> | 697 | 1302 | 4234 | 7916 |
| Mortgage banking income, net | $9017 | $8447 | $28427 | $29515 |

---

<sup>(1)</sup> Gain on sales of loans, net includes pipeline fair value adjustments

<sup>(2)</sup> Mortgage servicing income, net includes gain on sale of MSR

BOLI income is derived from changes in the cash surrender value of the bank-owned life insurance policies and proceeds received upon the death of covered individuals. BOLI income was $4,235 for the three months ended September 30, 2025 as compared to $2,858 for the same period in 2024, and $10,547 for the nine months ended September 30, 2025 as compared to $8,250 for the same period in 2024. The increase in BOLI income is primarily due to the acquisition of BOLI from The First with a cash surrender value of $146,601.

Other noninterest income was $6,974 and $4,256 for the three months ended September 30, 2025 and 2024, respectively, and was $17,150 and $12,371 for the nine months ended September 30, 2025 and 2024, respectively. Other noninterest income includes income from our SBA banking division, our capital markets division and other miscellaneous income and can fluctuate based on production in our SBA banking and capital markets divisions and recognition of other seasonal income items.

*Noninterest Expense*

---

| | | | |
|:---|:---|:---|:---|
| **Noninterest Expense to Average Assets** | **Noninterest Expense to Average Assets** | **Noninterest Expense to Average Assets** | **Noninterest Expense to Average Assets** |
| **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| **2025** | **2024** | **2025** | **2024** |
| 2.76% | 2.74% | 2.73% | 2.66% |

---

Noninterest expense was $183,830 and $121,983 for the third quarter of 2025 and 2024, respectively, and was $480,910 and $346,871 for the nine months ended September 30, 2025 and 2024, respectively. The increase is primarily due to $38,764 in expenses relating to the merger with The First and additional expenses associated with the operations of The First.

Salaries and employee benefits increased $27,675 to $98,982 for the third quarter of 2025 as compared to $71,307 for the same period in 2024. Salaries and employee benefits increased $56,973 to $270,481 for the nine months ended September 30, 2025 as compared to $213,508 for the same period in 2024. The increase in salaries and employee benefits is primarily attributable to the addition of The First employees, and to a lesser extent to annual merit increases implemented in April 2025.

Data processing costs were $5,541 in the third quarter of 2025 as compared to $4,133 for the same period in 2024 and were $15,068 for the nine months ended September 30, 2025 as compared to $11,885 for the same period in 2024. The increase in data processing costs is attributable to the acquisition of The First and the cost associated with operating two core systems. Core systems were converted during the third quarter of 2025. The Company continues to examine new and existing contracts to negotiate favorable terms to offset the increased variable cost components of our data processing costs, such as new accounts and increased transaction volume.

Net occupancy and equipment expense for the third quarter of 2025 was $18,415, as compared to $11,415 for the same period in 2024. These expenses for the first nine months of 2025 were $47,528, as compared to $34,648 for the same period in 2024. The increase in net occupancy and equipment expense is primarily due to the additional locations and assets attributable to the merger with The First.

Professional fees include fees for legal and accounting services, such as routine litigation matters, external audit services as well as assistance in complying with banking and other governmental regulations. Professional fees were $3,435 for the third quarter of 2025 as compared to $3,189 for the same period in 2024 and were $10,542 for the nine months ended September 30, 2025 as compared to $9,732 for the same period in 2024.

Advertising and public relations expense was $5,254 for the third quarter of 2025 as compared to $3,677 for the same period in 2024 and was $14,041 for the nine months ended September 30, 2025 as compared to $12,370 for the same period in 2024. During the nine months ended September 30, 2025 and 2024, the Company contributed approximately $1,125 and $1,305,

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

respectively, to charitable organizations and government economic development programs, which contributions are included in our advertising and public relations expense, and for which the Company received a dollar-for-dollar tax credit.

Amortization of intangible assets totaled $8,674 and $1,160 for the third quarter of 2025 and 2024, respectively, and $18,638 and $3,558 for the nine months ended September 30, 2025 and 2024, respectively. This amortization relates to finite-lived intangible assets which are being amortized over the useful lives as determined at acquisition. The increase for the three and nine months ended September 30, 2025 is primarily due to the addition of the core deposit intangible associated with our merger with The First. These finite-lived intangible assets have remaining estimated useful lives ranging from approximately 1 year to 10 years.

Communication expenses, those expenses incurred for communication to clients and between employees, were $3,955 for the third quarter of 2025 as compared to $2,176 for the same period in 2024. Communication expenses were $9,172 for the nine months ended September 30, 2025 as compared to $6,312 for the same period in 2024.

Other noninterest expense includes business development and travel expenses, other discretionary expenses, loan fees expense and other miscellaneous fees and operating expenses. Other noninterest expense was $21,752 for the third quarter of 2025 as compared to $13,597 for the same period in 2024 and was $55,506 for the nine months ended September 30, 2025 as compared to $43,317 for the same period in 2024.

*Efficiency Ratio*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Efficiency Ratio** | **Efficiency Ratio** | **Efficiency Ratio** | **Efficiency Ratio** |
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Efficiency ratio | 67.05% | 54.73% | 66.88% | 62.33% |

---

The efficiency ratio is a measure of productivity in the banking industry. (This ratio is a measure of our ability to turn expenses into revenue. That is, the ratio is designed to reflect the percentage of one dollar that we must expend to generate a dollar of revenue.) The Company calculates this ratio by dividing noninterest expense by the sum of net interest income on a fully tax equivalent basis and noninterest income. The gain on sale of the insurance agency that occurred in the third quarter of 2024 resulted in a significant enhancement to our efficiency ratio for the three and nine months ended September 30, 2024, which contributed to the change in our efficiency ratio for the three and nine months ended September 30, 2025 as compared to the same periods in 2024. Our goal is to improve the efficiency ratio over time from currently reported levels as a result of revenue growth while at the same time controlling noninterest expenses and eliminating duplicative expenses as we continue to integrate The First into our business model throughout the remainder of 2025.

*Income Taxes*

Income tax expense for the third quarter of 2025 and 2024 was $15,478 and $24,924, respectively, and $27,575 and $44,502 for the nine months ended September 30, 2025 and 2024, respectively. The Company's sale of its insurance business in the third quarter of 2024 resulted in a significant discrete tax expense during such period, which contributed to the year-over-year decrease in the Company's effective tax rate.

**Risk Management**

The management of risk is an on-going process. Primary risks that are associated with the Company include credit, interest rate and liquidity risk. Credit risk and interest rate risk are discussed below, while liquidity risk is discussed in the next subsection under the heading "Liquidity and Capital Resources."

*Credit Risk and the Allowance for Credit Losses on Loans and Unfunded Commitments*

<u>Management of Credit Risk – Roles and Responsibilities.</u> Inherent in any lending activity is credit risk related to asset quality deterioration and its impact on capital should a borrower default. Credit risk is monitored and managed on an ongoing basis using a cross-functional and multi-layered approach that includes the Company's loan production, credit administration (including appraisal review), and internal loan review functions. The Board of Directors, and specifically its Credit Review Committee, provide oversight and governance of the Company's credit risk management process.

The first line of defense against credit risk is embedded within our lending function. An integral part of a lending officer's responsibilities is to assess credit risk at the inception of the lending relationship, monitor ongoing risk over the life of the loan, and report any changes in asset quality or other components of credit risk to the appropriate parties within the Company. The

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

Company's policies and procedures governing our lending function provide guidelines for assigning lending limits based on a lending officer's knowledge and experience. These lending limits are monitored on an ongoing basis for appropriateness based on evaluations of the credit quality and compliance with the approved terms of the loan agreements within such lending officer's loan portfolio. Based on the Company's risk appetite and procedures for the management of loan concentrations (by geography, collateral type and other criteria), a lending officer may be subject to additional levels of approval for new loan originations, so that more technical expertise and greater oversight are allocated to such portfolio.

The Company's credit administration function is considered the second line of defense against credit risk. Oversight of the Company's lending operations (including adherence to our policies and procedures governing the loan underwriting and monitoring process), ongoing credit quality monitoring and loss mitigation are the primary focus areas of credit administration. This includes monitoring the loan portfolio to ensure it is properly underwritten, evaluating credit quality metrics to identify indicators of potential loss and assigning risk rating grades which appropriately reflect the potential risk of loss.

To verify the value of real estate collateral, the Company maintains a central appraisal review department, within credit administration. This department engages, reviews and approves third-party appraisals obtained by the Company on real estate collateral in accordance with banking regulations. This department is managed by a State Certified General Real Estate Appraiser and employs other trained appraisers and evaluators.

The internal loan review function is considered the third line of defense and operates independently of credit administration to monitor the Company's lending practices and loan quality. Loan review personnel evaluate and, if necessary, adjust the risk rating grades assigned to loans through periodic examination, focusing their review on commercial and real estate loans, and the consumer loan portfolio.

Finally, the Company's internal audit department provides oversight of all of the above functions. Internal audit staff reviews, among other things, whether these units are operating in adherence to their respective policies, processes and procedures. The internal audit department reports independently to the Board's Audit Committee.

<u>Management of Credit Risk – Risk Measurement Practices</u>. For commercial and commercial real estate secured loans, internal risk-rating grades are assigned based on an analysis of the financial and collateral strength and other credit attributes underlying each loan. Risk rating grades are evaluated on an ongoing basis over the life of the loan. The Company maintains an internal risk rating scale that aligns with regulatory risk classifications. For more information about the Company's risk rating grades, see the information under the heading "Credit Quality" in Note 4, "Loans," in the Notes to Consolidated Financial Statements in Item 1, Financial Statements, in this report.

In response to changes in the economic, geopolitical, or operating environments impacting the Company's loan portfolio, the Company may implement additional or enhanced risk management practices. The Company adjusts its processes to the current environment and evaluates the sensitivity of industry sectors, loan types and underlying collateral to changes in macroeconomic factors. Such factors include, but are not limited to, changes in interest rates, inflation on goods, labor costs, and supply chain disruptions. When such factors indicate that a heightened level of credit risk may impact our portfolio, risk management procedures are expanded to include enhanced oversight of past due loans, documented plans for resolving problem loans, enhanced exception monitoring as well as targeted reviews of loans within certain risk classifications. The Company uses information from these risk measurement processes to formulate its credit risk appetite statement, which is used to manage production activity and concentrations within the portfolio, whether by collateral type, industry, geography, relationship size or others factors, such that the Company's loan mix is consistent with its risk tolerance and does not expose the Company to undue risk. For more information about the Company's evaluation of loan concentrations, see the information under the heading "Loans" in the Financial Condition section above.

<u>Management of Credit Risk – Loss Identification</u>. Loans that are past due or not in compliance with financial or performance covenants, or that are otherwise adversely rated are subject to enhanced scrutiny and monitoring through a variety of processes within our special assets department, which is a division of credit administration. Results and findings are reported to management's problem asset resolution committee and the Board of Directors Credit Review Committee. When the ultimate collectability of a loan's principal becomes doubtful, the loan is placed on nonaccrual.

The Company's practice is to charge off estimated losses as soon as such loss is identified and reasonably quantifiable. If the value of the collateral after consideration of disposition costs is less than the loan balance, a charge off is recorded to reduce the allowance for credit losses on loans. Charge-offs reflect the realization of losses in the portfolio that were recognized previously through the provision for credit losses on loans. After collection efforts have been exhausted or a settlement agreement is reached with the borrower, underlying collateral is liquidated.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

<u>Allowance for Credit Losses on Loans; Provision for Credit Losses on Loans</u>. The allowance for credit losses is available to absorb credit losses inherent in the loans held for investment portfolio. Management evaluates the adequacy of the allowance on a quarterly basis.

The appropriate level of the allowance is based on an ongoing analysis of the loan portfolio and represents an amount that management deems adequate to provide for inherent losses, including loans evaluated on a collective (pooled) basis and those evaluated on an individual basis as set forth in Accounting Standards Codification Topic 326, "Financial Instruments - Credit Losses," often referred to as CECL. The credit loss estimation process involves procedures to appropriately consider the unique characteristics of the Company's loan portfolio segments. Credit quality is assessed and monitored by evaluating various attributes, and the results of those evaluations are utilized in underwriting new loans and in the Company's process for the estimation of expected credit losses. Credit quality monitoring procedures and indicators can include an assessment of problem loans, the types of loans, historical loss experience, new lending products, emerging credit trends, changes in the size and character of loan categories, and other factors, including our risk rating system, regulatory guidance and economic conditions, such as the unemployment rate and change in GDP in the national and local economies as well as trends in the market values of underlying collateral securing loans, all as determined based on input from management, loan review staff and other sources. This evaluation is complex and inherently subjective, as it requires estimates by management that are inherently uncertain and therefore susceptible to significant revision as more information becomes available. In future periods, evaluations of the overall loan portfolio, in light of the factors and forecasts then prevailing, may result in significant changes in the allowance and provision for credit loss in those future periods.

The methodology for estimating the amount of expected credit losses reported in the allowance for credit losses has two basic components: first, a collective or pooled component for estimated expected credit losses for pools of loans that share similar risk characteristics; and second, an asset-specific component involving individual loans that do not share risk characteristics with other loans and the measurement of expected credit losses for such individual loans.

• The allowance for credit losses for loans that share similar risk characteristics with other loans is calculated on a collective (or pooled) basis, where such loans are segregated into loan portfolio segments. In determining the allowance for credit losses on loans evaluated on a collective basis, the Company further categorizes the loan segments based on risk rating. The Company uses two CECL models: (1) for the Real Estate - 1-4 Family Mortgage, Real Estate - Construction and the Installment Loans to Individuals portfolio segments, the Company uses a loss rate model, based on average historical life-of-loan loss rates, and (2) for the Commercial, Real Estate - Commercial Mortgage and Lease Financing portfolio segments, the Company uses a probability of default/loss given default model, which calculates an expected loss percentage for each loan pool by considering (a) the probability of default, based on the migration of loans from performing (using risk ratings) to default using life-of-loan analysis periods, and (b) the historical severity of loss, based on the aggregate net lifetime losses incurred per loan pool.

The historical loss rates calculated as described above are adjusted, as necessary, for both internal and external qualitative factors where there are differences in the historical loss data of the Company and current or projected future conditions. Internal factors include loss history, changes in credit quality (including movement between risk ratings) and/or credit concentration and the nature and volume of the respective loan portfolio segments. External factors include current and reasonable and supportable forecasted economic conditions and changes in collateral values. These factors are used to adjust the historical loss rates (as described above) to ensure that they reflect management's expectation of future conditions based on a reasonable and supportable forecast period. To the extent the lives of the loans in the portfolio extend beyond the period for which a reasonable and supportable forecast can be made, when necessary, the models immediately revert to the historical loss rates adjusted for qualitative factors related to current conditions.

• For loans that do not share similar risk characteristics with other loans, an individual analysis is performed to determine the expected credit loss. If the respective loan is collateral dependent (that is, when the borrower is experiencing financial difficulty and repayment is expected to be provided substantially through the operation or sale of the collateral), the expected credit loss is measured as the difference between the amortized cost basis of the loan and the fair value of the collateral. The fair value of collateral is initially based on external appraisals. Generally, collateral values for loans for which measurement of expected losses is dependent on the fair value of such collateral are updated every twelve months, either from external third parties or in-house certified appraisers. Third-party appraisals are obtained from a pre-approved list of independent, third-party, local appraisal firms. The fair value of the collateral derived from the external appraisal is then adjusted for the estimated cost to sell if repayment or satisfaction of a loan is dependent on the sale (rather than only on the operation) of the collateral. Other acceptable methods for determining the expected credit losses for collateral dependent loans is a discounted cash flow approach or, if applicable, an observable market price. Once the expected credit loss amount is determined, an allowance equal to such expected credit loss is included in the allowance for credit losses.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

In addition to its quarterly analysis of the allowance for credit losses, management and the Board of Directors review loan ratios on a regular basis. These ratios include the allowance for credit losses as a percentage of total loans, net charge-offs as a percentage of average loans, nonperforming loans as a percentage of total loans and the allowance coverage on nonperforming loans, among others. Also, management reviews past due ratios by officer, community bank and the Company as a whole.

The following table presents the allocation of the allowance for credit losses on loans by loan category and the percentage of loans in each category to total loans as of the dates presented:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **September 30, 2024** | **September 30, 2024** |
| | **Balance** | **% of Total** | **Balance** | **% of Total** | **Balance** | **% of Total** |
| Commercial, financial, agricultural | $60526 | 20.34% | $38527 | 14.64% | $43053 | 14.29% |
| Lease financing | 1480 | 0.50 | 3368 | 0.70 | 2384 | 0.78 |
| Real estate – construction | 23953 | 8.05 | 15126 | 8.49 | 16656 | 9.50 |
| Real estate – 1-4 family mortgage | 66826 | 22.46 | 47761 | 27.07 | 47219 | 27.24 |
| Real estate – commercial mortgage | 139342 | 46.81 | 90204 | 48.40 | 82087 | 47.47 |
| Installment loans to individuals | 5464 | 1.84 | 6770 | 0.70 | 8979 | 0.72 |
| Total | $297591 | 100.00% | $201756 | 100.00% | $200378 | 100.00% |

---

The provision for credit losses on loans charged to operating expense is an amount which, in the judgment of management, is necessary to maintain the allowance for credit losses on loans at a level that is believed to be adequate to meet the inherent risks of losses in our loan portfolio. The Company's allowance for credit losses model considers economic projections, primarily the national unemployment rate and GDP, over a reasonable and supportable period of two years.

The table below reflects the activity in the allowance for credit losses on loans, including the provision for credit losses, for the periods presented:

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Balance at beginning of period | $290770 | $199871 | $201756 | $198578 |
| Impact of purchased credit deteriorated loans acquired during the period | 1510 |  | 25003 |  |
| Charge-offs |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commercial, financial, agricultural | 2557 | 347 | 8474 | 882 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lease financing | 42 | 642 | 2436 | 642 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate – construction | 8 |  | 113 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate – 1-4 family mortgage | 612 | 256 | 1240 | 546 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate – commercial mortgage | 1296 | 10 | 5701 | 5737 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Installment loans to individuals | 539 | 649 | 1198 | 1379 |
| Total charge-offs | 5054 | 1904 | 19162 | 9186 |
| Recoveries |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commercial, financial, agricultural | 51 | 514 | 1636 | 1385 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lease financing | 90 | 8 | 103 | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate – construction | 6 |  | 6 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate – 1-4 family mortgage | 84 | 57 | 154 | 130 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate – commercial mortgage | 429 | 11 | 551 | 116 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Installment loans to individuals | 55 | 611 | 444 | 1181 |
| Total recoveries | 715 | 1201 | 2894 | 2838 |
| Net charge-offs | 4339 | 703 | 16268 | 6348 |
| Provision for credit losses on loans | 9650 | 1210 | 87100 | 8148 |
| Balance at end of period | $297591 | $200378 | $297591 | $200378 |
| Net charge-offs (annualized) to average loans | 0.09% | 0.02% | 0.14% | 0.07% |
| Net charge-offs to allowance for credit losses on loans | 1.46% | 0.35% | 5.47% | 3.17% |
| Allowance for credit losses on loans to: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total loans |  |  | 1.56% | 1.59% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonperforming loans |  |  | 173.47% | 168.07% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonaccrual loans |  |  | 174.28% | 175.97% |

---

Loan growth, including the addition of loans acquired in the merger with The First, as well as changes in credit metrics that influenced our expectations of future credit losses, considered in the context of the existing balance of the allowance for credit losses, resulted in the Company's model indicating that the provision for credit losses on loans during the first nine months of 2025 in the table above was appropriate. Included in the first nine months of 2025 provision for credit losses on loans is a Day 1 acquisition provision of $62,190 associated with the merger with The First.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

The table below reflects annualized net charge-offs (recoveries) to daily average loans outstanding, by loan category, for the periods presented:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2024** | **September 30, 2024** | **September 30, 2024** |
| | **Net Charge-offs** | **Average Loans** | **Annualized Net Charge-offs to Average Loans** | **Net Charge-offs (Recoveries)** | **Average Loans** | **Annualized Net Charge-offs (Recoveries) to Average Loans** |
| &nbsp;&nbsp;&nbsp;Commercial, financial, agricultural | $6838 | $2313531 | 0.40% | $(503) | $1850707 | (0.04)% |
| &nbsp;&nbsp;&nbsp;Lease financing | 2333 | 90605 | 3.44% | 616 | 103954 | 0.79% |
| &nbsp;&nbsp;&nbsp;Real estate – construction | 107 | 1310487 | 0.01% |  | 1297036 | —% |
| &nbsp;&nbsp;&nbsp;Real estate – 1-4 family mortgage | 1086 | 4435847 | 0.03% | 416 | 3422711 | 0.02% |
| &nbsp;&nbsp;&nbsp;Real estate – commercial mortgage | 5150 | 8482010 | 0.08% | 5621 | 5752206 | 0.13% |
| &nbsp;&nbsp;&nbsp;Installment loans to individuals | 754 | 110567 | 0.91% | 198 | 96188 | 0.27% |
| &nbsp;&nbsp;&nbsp;Total | $16268 | $16743047 | 0.13% | $6348 | $12522802 | 0.07% |

---

The following table provides further details of the Company's net charge-offs (recoveries) of loans secured by real estate for the periods presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Real estate – construction: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Residential | $2 | $— | $107 | $— |
| Total real estate – construction | 2 |  | 107 |  |
| Real estate – 1-4 family mortgage: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primary | 384 | 167 | 775 | 327 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Home equity | 125 | 74 | 315 | 93 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rental/investment | (6) | (41) | (29) | (3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development | 25 |  | 25 | (1) |
| Total real estate – 1-4 family mortgage | 528 | 200 | 1086 | 416 |
| Real estate – commercial mortgage: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Owner-occupied | 857 | (9) | 5198 | (68) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-owner occupied | (4) | (1) | (61) | 5682 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development | 14 | 7 | 13 | 7 |
| Total real estate – commercial mortgage | 867 | (3) | 5150 | 5621 |
| Total net charge-offs of loans secured by real estate | $1397 | $197 | $6343 | $6037 |

---

<u>Allowance for Credit Losses on Unfunded Commitments; Provision for Credit Losses on Unfunded Commitments</u>. The Company maintains a separate allowance for credit losses on unfunded loan commitments, which is included in the "Other liabilities" line item on the Consolidated Balance Sheets. Management estimates the amount of expected losses on unfunded loan commitments by calculating a likelihood of funding over the contractual period for exposures that are not unconditionally cancellable by the Company and applying the loss factors used in the allowance for credit losses on loans methodology described above to unfunded commitments for each loan type. No credit loss estimate is reported for off-balance-sheet credit exposures that are unconditionally cancellable by the Company. A roll-forward of the allowance for credit losses on unfunded commitments is shown in the tables below.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

---

| | | |
|:---|:---|:---|
| **Three Months Ended September 30,** | **2025** | **2024** |
| Allowance for credit losses on unfunded loan commitments: |  |  |
| Beginning balance | $23565 | $17618 |
| Provision for (recovery of) credit losses on unfunded loan commitments | 800 | (700) |
| Ending balance | $24365 | $16918 |
| **Nine Months Ended September 30,** | **2025** | **2024** |
| Allowance for credit losses on unfunded loan commitments: |  |  |
| Beginning balance | $14943 | $20118 |
| Provision for (recovery of) credit losses on unfunded loan commitments | 9422 | (3200) |
| Ending balance | $24365 | $16918 |

---

The increase in the provision for credit losses on unfunded commitments during the three and nine months ended September 30, 2025, as compared to the same periods in 2024 was largely driven by the Day 1 acquisition provision of $4,422 associated with our merger with The First as well as growth in the balance of unfunded loan commitments.

<u>Nonperforming Assets</u>. Nonperforming assets consist of nonperforming loans and other real estate owned. Nonperforming loans are those on which the accrual of interest has stopped or loans which are contractually 90 days past due on which interest continues to accrue. Generally, the accrual of interest is discontinued when the full collection of principal or interest is in doubt or when the payment of principal or interest has been contractually 90 days past due, unless the obligation is both well secured and in the process of collection. Management, the problem asset resolution committee and our loan review staff closely monitor loans that are considered to be nonperforming.

Other real estate owned consists of properties acquired through foreclosure or acceptance of a deed in lieu of foreclosure. These properties are carried at the lower of cost or fair market value based on appraised value less estimated selling costs. Losses arising at the time of foreclosure of properties are charged against the allowance for credit losses on loans. Reductions in the carrying value subsequent to acquisition are charged to earnings and are included in "Other real estate owned" in the Consolidated Statements of Income.

The following table provides details of the Company's nonperforming assets as of the dates presented.

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| Nonaccruing loans | $170756 | $110811 |
| Accruing loans past due 90 days or more | 792 | 2464 |
| Total nonperforming loans | 171548 | 113275 |
| Other real estate owned | 10578 | 8673 |
| Total nonperforming assets | $182126 | $121948 |
| Nonperforming loans to total loans | 0.90% | 0.88% |
| Nonaccruing loans to total loans | 0.89% | 0.88% |
| Nonperforming assets to total assets | 0.68% | 0.68% |

---

The following table presents nonperforming loans by loan category as of the dates presented:

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

---

| | | | |
|:---|:---|:---|:---|
| | **September 30,<br>2025** | **December 31, 2024** | **September 30,<br>2024** |
| Commercial, financial, agricultural | $32829 | $2000 | $5024 |
| Lease financing | 638 | 4083 | 614 |
| Real estate – construction: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Residential | 2525 | 1223 | 1307 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commercial | 2123 | 16 |  |
| Total real estate – construction | 4648 | 1239 | 1307 |
| Real estate – 1-4 family mortgage: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primary | 52155 | 55037 | 55076 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Home equity | 2560 | 3404 | 3296 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rental/investment | 2690 | 388 | 927 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development | 49 | 1760 | 22 |
| Total real estate – 1-4 family mortgage | 57454 | 60589 | 59321 |
| Real estate – commercial mortgage: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Owner-occupied | 29877 | 12679 | 9610 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-owner occupied | 45144 | 29280 | 39944 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development | 719 | 3291 | 3169 |
| Total real estate – commercial mortgage | 75740 | 45250 | 52723 |
| Installment loans to individuals | 239 | 114 | 234 |
| Total nonperforming loans | $171548 | $113275 | $119223 |

---

Total nonperforming loans as a percentage of total loans were 0.90% as of September 30, 2025 as compared to 0.88% and 0.94% as of December 31, 2024 and September 30, 2024, respectively. The Company's coverage ratio, or its allowance for credit losses on loans as a percentage of nonperforming loans, was 173.47% as of September 30, 2025 as compared to 178.11% as of December 31, 2024 and 168.07% as of September 30, 2024.

Management has evaluated loans classified as nonperforming and believes that all nonperforming loans have been adequately reserved for in the allowance for credit losses at September 30, 2025. Management also continually monitors past due loans for potential credit quality deterioration. Total loans 30-89 days past due but still accruing interest were $48,654, or 0.26% of total loans, at September 30, 2025 as compared to $39,842, or 0.31% of total loans, at December 31, 2024 and $17,523, or 0.14% of total loans, at September 30, 2024.

Certain modifications of loans made to borrowers experiencing financial difficulty in the form of principal forgiveness, an interest rate reduction, an other-than-insignificant payment delay (including an extension of the amortization period), or a term extension, but excluding covenant waivers and modification of contingent acceleration clauses, are required to be disclosed in accordance with ASU 2022-02, "*Financial Instruments - Credit Losses (Topic326): Troubled Debt Restructurings and Vintage Disclosures*" ("ASU 2022-02"). All modifications for the three and nine months ended September 30, 2025 and 2024 and which met the disclosure criteria in ASU 2022-02 were performing in accordance with their modified terms at September 30, 2025 and 2024, respectively. The total amortized cost basis of loans that were modified during the three and nine months ended September 30, 2025 due to borrowers experiencing financial difficulty was $29,148 and $31,551, respectively, as compared to $3,887, and $15,747, respectively, for the same periods in 2024. Unused commitments with respect to these loans were $647 and $464 at September 30, 2025 and September 30, 2024, respectively. Upon the Company's determination that a modified loan has subsequently become uncollectible, the loan, or portion of the loan, is charged off, the amortized cost basis of the loan is reduced by the uncollectible amount and the allowance for credit losses is adjusted accordingly. For more information about loan modifications made to borrowers experiencing financial difficulty, see the information under the heading "Certain Modifications to Borrowers Experiencing Financial Difficulty" in Note 4, "Loans," in the Notes to Consolidated Financial Statements of the Company in Item 1, Financial Statements.

The following table provides details of the Company's other real estate owned, net of valuation allowance and direct write-downs, as of the dates presented:

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

---

| | | | |
|:---|:---|:---|:---|
| | **September 30,<br>2025** | **December 31, 2024** | **September 30,<br>2024** |
| Residential real estate | $5179 | $2966 | $1004 |
| Commercial real estate | 3711 | 5681 | 6336 |
| Residential land development | 15 | 19 | 19 |
| Commercial land development | 1673 | 7 | 7 |
| Total other real estate owned | $10578 | $8673 | $7366 |

---

Changes in the Company's other real estate owned were as follows:

---

| | | |
|:---|:---|:---|
| | **2025** | **2024** |
| Balance at January 1 | $8673 | $9622 |
| Acquired OREO | 11109 |  |
| Transfers of loans | 3971 | 3286 |
| Impairments | (623) | (67) |
| Dispositions | (12552) | (1323) |
| Other |  | (2382) |
| Balance at June 30 | $10578 | $9136 |

---

Other real estate owned with a cost basis of $12,552 was sold during the nine months ended September 30, 2025, resulting in a net gain of $53, while other real estate owned with a cost basis of $1,323 was sold during the nine months ended September 30, 2024, resulting in a net gain of $143.

*Interest Rate Risk*

Market risk is the risk of loss from adverse changes in market prices and rates. The majority of assets and liabilities of a financial institution are monetary in nature and therefore differ greatly from most commercial and industrial companies that have significant investments in fixed assets and inventories. Our market risk arises primarily from interest rate risk inherent in lending, investing and deposit-taking activities. Management believes a significant impact on the Company's financial results stems from our ability to react to changes in interest rates. A sudden and substantial change in interest rates may adversely impact our earnings because the interest rates borne by assets and liabilities do not change at the same speed, to the same extent or on the same basis. Changes in rates may also limit our liquidity, making it more costly for the Company to generate funds to make loans and to satisfy customers wishing to withdraw deposits.

Because of the impact of interest rate fluctuations on our profitability and liquidity, we actively monitor and manage our interest rate risk exposure. We have an Asset/Liability Committee ("ALCO"), which is comprised of various members of senior management and is authorized by the Board of Directors to monitor interest rate sensitivity and liquidity risk, over the short-, medium-, and long-term, and to make decisions relating to these processes. The ALCO's goal is to structure our asset/liability composition to maximize net interest income while managing interest rate risk and preserving adequate liquidity so as to minimize the adverse impact of changes in interest rates on net interest income, liquidity and capital. We regularly monitor liquidity and stress our liquidity position in various simulated scenarios, which are incorporated in our contingency funding plan outlining different potential liquidity environments. The ALCO uses an asset/liability model as the primary quantitative tool in measuring the amount of interest rate risk associated with changing market rates. The model is used to perform both net interest income forecast simulations for multiple year horizons and economic value of equity ("EVE") analyses, each under various interest rate scenarios.

Net interest income forecast simulations measure the short- and medium-term earnings exposure from changes in market interest rates in a rigorous and explicit fashion. Our current financial position is combined with assumptions regarding future business to calculate future net interest income under various hypothetical rate scenarios. EVE measures our long-term earnings exposure from changes in market rates of interest. EVE is defined as the present value of assets minus the present value of liabilities at a point in time for a given set of market rate assumptions. An increase in EVE due to a specified rate change indicates an improvement in the long-term earnings capacity of the balance sheet assuming that the rate change remains in effect over the life of the current balance sheet.

The following table presents the projected impact of a change in interest rates on (1) static EVE and (2) earnings at risk (that is, net interest income) for the 1-12 and 13-24 month periods commencing October 1, 2025, in each case as compared to the result

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

under rates present in the market on September 30, 2025. The changes in interest rates assume an instantaneous and parallel shift in the yield curve and do not account for changes in the slope of the yield curve.

---

| | | | |
|:---|:---|:---|:---|
| | **Percentage Change In:** | **Percentage Change In:** | **Percentage Change In:** |
| **Immediate Change in Rates of (in basis points):** | **Economic Value Equity (EVE)** | **Earning at Risk (Net Interest Income)** | **Earning at Risk (Net Interest Income)** |
| **Immediate Change in Rates of (in basis points):** | **Static** | **1-12 Months** | **13-24 Months** |
| +100 | 2.53% | 2.47% | 4.56% |
| -100 | (3.75)% | (2.82)% | (5.04)% |
| -200 | (8.33)% | (4.68)% | (9.83)% |

---

The rate shock results for the net interest income simulations for the next 24 months produce an asset sensitive position at September 30, 2025. The preceding measures assume no change in the size or asset/liability compositions of the balance sheet, and they do not reflect future actions the ALCO may undertake in response to such changes in interest rates.

The scenarios assume instantaneous movements in interest rates in increments described in the table above. As interest rates are adjusted over a period of time, it is our strategy to proactively change the volume and mix of our balance sheet in order to mitigate our interest rate risk. The computation of the prospective effects of hypothetical interest rate changes requires numerous assumptions, including asset prepayment speeds, the impact of competitive factors on our pricing of loans and deposits, the impact of market conditions on the securities yields and interest rates of our borrowings, how responsive our deposit repricing is to the change in market rates and the expected life of non-maturity deposits. These business assumptions are based upon our experience, business plans and published industry experience; however, such assumptions may not necessarily reflect the manner or timing in which cash flows, asset yields and liability costs respond to changes in market rates. Because these assumptions are inherently uncertain, actual results will differ from simulated results.

The Company utilizes derivative financial instruments, including interest rate contracts such as swaps, collars, caps and/or floors, risk participations, forward commitments, and interest rate lock commitments, as part of its ongoing efforts to mitigate its interest rate risk exposure. For more information about the Company's derivatives, see the information under the heading "Loan Commitments and Other Off-Balance Sheet Arrangements" in the Liquidity and Capital Resources section below and Note 10, "Derivative Instruments," in the Notes to Consolidated Financial Statements of the Company in Item 1, Financial Statements. The next section also details our available sources of liquidity, both on and off-balance sheet.

**Liquidity and Capital Resources**

Liquidity management is the ability to meet the cash flow requirements of customers who may be either depositors wishing to withdraw funds or borrowers needing assurance that sufficient funds will be available to meet their credit needs.

Core deposits, which are deposits excluding brokered deposits, are the major source of funds used by the Bank to meet cash flow needs. Maintaining the ability to acquire these funds as needed in a variety of markets is the key to assuring the Bank's liquidity. We may also access the brokered deposit market where rates are favorable to other sources of liquidity (especially in light of collateral requirements for certain borrowings) and core deposits are not sufficient for meeting our current and anticipated short- or long-term liquidity needs. We did not hold any brokered deposits at September 30, 2025 or December 31, 2024. Management continually monitors the Bank's liquidity and non-core dependency ratios to ensure compliance with targets established by the ALCO.

Our investment portfolio is another alternative for meeting liquidity needs. These assets generally have readily available markets that offer conversions to cash as needed. Within the next twelve months the securities portfolio is forecasted to generate cash flow through principal payments and maturities equal to approximately 13.72% of the carrying value of the total securities portfolio. Securities within our investment portfolio are also used to secure certain deposit types, short-term borrowings and derivative instruments. At September 30, 2025, securities with a carrying value of $1,241,138 were pledged to secure government, public fund and trust deposits and as collateral for short-term borrowings and derivative instruments as compared to securities with a carrying value of $843,870 similarly pledged at December 31, 2024.

Other sources available for meeting liquidity needs include federal funds purchased, short-term and long-term advances from the FHLB and borrowings from the Federal Reserve Discount Window. Interest is charged at the prevailing market rate on federal funds purchased, FHLB advances and borrowings from the Federal Reserve Discount Window. There were $600,000 and $400,000 in short-term borrowings from the FHLB at September 30, 2025 and December 31, 2024, respectively. Long-term funds obtained from the FHLB are used to match-fund fixed rate loans in order to minimize interest rate risk and also are used to meet day-to-day liquidity needs, particularly when the cost of such borrowing compares favorably to the rates that we would

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

be required to pay to attract deposits. There were no outstanding long-term advances with the FHLB at September 30, 2025 or December 31, 2024. The total amount of the remaining credit available to us from the FHLB at September 30, 2025 was $5,011,339. The credit available at the Federal Reserve Discount Window at September 30, 2025 was $657,277 with no borrowings outstanding as of such date. We also maintain lines of credit with other commercial banks totaling $140,000. These are unsecured lines of credit with the majority maturing at various times within the next twelve months. There were no amounts outstanding under these lines of credit at September 30, 2025 or December 31, 2024.

Finally, we can access the capital markets to meet liquidity needs. The Company maintains a shelf registration statement with the Securities and Exchange Commission ("SEC"). The shelf registration statement, which was effective upon filing, allows the Company to raise capital from time to time through the sale of common stock, preferred stock, depositary shares, debt securities, rights, warrants and units, or a combination thereof, subject to market conditions. Specific terms and prices will be determined at the time of any offering under a separate prospectus supplement that the Company will file with the SEC at the time of the specific offering. The proceeds of the sale of securities, if and when offered, will be used for general corporate purposes or as otherwise described in the prospectus supplement applicable to the offering and could include the expansion of the Company's banking and wealth management operations as well as other business opportunities. Our common stock offering completed in July 2024 reflects our access of the capital markets as described in this paragraph. In addition, in previous years, we have accessed the capital markets to generate liquidity in the form of subordinated notes. We have also assumed subordinated notes as part of acquisitions. The carrying value of subordinated notes, net of unamortized debt issuance costs, was $418,523 at September 30, 2025. On October 1, 2025, the Company redeemed $60,000 in subordinated notes assumed as part of its merger with The First.

The following table presents, by type, the Company's funding sources, which consist of total average deposits and borrowed funds, and the total cost of each funding source for the periods presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Percentage of Total Average Deposits and Borrowed Funds** | **Percentage of Total Average Deposits and Borrowed Funds** | **Cost of Funds** | **Cost of Funds** |
| | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Noninterest-bearing demand | 23.24% | 23.74% | —% | —% |
| Interest-bearing demand | 51.18 | 48.18 | 2.80 | 3.16 |
| Savings | 5.76 | 5.67 | 0.31 | 0.35 |
| Brokered deposits |  | 2.00 |  | 5.36 |
| Time deposits | 15.54 | 16.57 | 3.92 | 4.25 |
| Short-term borrowings | 1.62 | 0.83 | 3.33 | 1.44 |
| Subordinated notes | 2.00 | 2.25 | 5.55 | 5.51 |
| Other borrowed funds | 0.66 | 0.76 | 7.36 | 8.23 |
| Total deposits and borrowed funds | 100.00% | 100.00% | 2.27% | 2.55% |

---

The estimated amount of uninsured and uncollateralized deposits at September 30, 2025 was $6,878,118. Collateralized public funds over FDIC insurance limits were $3,146,202 at September 30, 2025.

Our strategy in choosing funds is focused on minimizing cost in the context of our balance sheet composition, interest rate risk position and liquidity forecast. Accordingly, management targets growth of core deposits, focusing on noninterest-bearing deposits. While we do not control the types of deposit instruments our clients choose, we do influence those choices with the rates and the deposit specials we offer. We constantly monitor our funds position and evaluate the effect that various funding sources have on our financial position.

Cash and cash equivalents were $1,083,785 at September 30, 2025, as compared to $1,275,620 at September 30, 2024. The decrease is largely driven by the funding of loan growth and investing capital into the securities portfolio. We acquired $261,484 in cash and cash equivalents in connection with the merger with The First.

Cash used in investing activities for the nine months ended September 30, 2025 was $710,954, as compared to cash provided by investing activities of $48,583 for the nine months ended September 30, 2024. Proceeds from the sale, maturity or call of securities within our investment portfolio were $968,832 for the nine months ended September 30, 2025, as compared to $319,665 for the same period in 2024. Shortly after merger with The First, certain securities from the acquired portfolio were sold at carrying value, resulting in proceeds of $686,485. A portion of the securities portfolio was also sold during the first quarter of 2024, resulting in proceeds of $177,185 of which a portion were used to purchase higher yielding securities, while

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

the remainder was used to fund loan growth. Purchases of investment securities were $1,058,969 during the first nine months of 2025 and $60,656 for the same period in 2024. The Company received $261,483 in net cash from its acquisition of The First.

Cash provided by financing activities for the nine months ended September 30, 2025 was $538,376, as compared to $411,366 for the same period in 2024. Deposits increased $395,159 and $432,966 for the nine months ended September 30, 2025 and 2024, respectively.

*Restrictions on Bank Dividends, Loans and Advances*

The Company's liquidity and capital resources, as well as its ability to pay dividends to its shareholders, are substantially dependent on the ability of Renasant Bank to transfer funds to the Company in the form of dividends, loans and advances. Under Mississippi law, a Mississippi bank may not pay dividends unless its earned surplus is in excess of three times capital stock. A Mississippi bank with earned surplus in excess of three times capital stock may pay a dividend, subject to the approval of the Mississippi Department of Banking and Consumer Finance (the "DBCF"). In addition, the FDIC also has the authority to prohibit the Bank from engaging in business practices that the FDIC considers to be unsafe or unsound, which, depending on the financial condition of the bank, could include the payment of dividends. Accordingly, the approval of the DBCF is required prior to the Bank paying dividends to the Company, and under certain circumstances the approval of the FDIC may be required.

Federal Reserve regulations also limit the amount the Bank may loan to the Company unless such loans are collateralized by specific obligations. At September 30, 2025, the maximum amount available for transfer from the Bank to the Company in the form of loans was $279,440. The Company maintains a $3,000 line of credit collateralized by cash with the Bank. There were no amounts outstanding under this line of credit at September 30, 2025.

These restrictions did not have any impact on the Company's ability to meet its cash obligations in the nine months ended September 30, 2025, nor does management expect such restrictions to materially impact the Company's ability to meet its currently-anticipated cash obligations.

*Loan Commitments and Other Off-Balance Sheet Arrangements*

The Company enters into loan commitments and standby letters of credit in the normal course of its business. Loan commitments are made to accommodate the financial needs of the Company's customers. Standby letters of credit commit the Company to make payments on behalf of customers when certain specified future events occur. Both arrangements have credit risk essentially the same as that involved in extending loans to customers and are subject to the Company's normal credit policies, including establishing a provision for credit losses on unfunded commitments. Collateral (e.g., securities, receivables, inventory, equipment, etc.) is obtained based on management's credit assessment of the customer.

Loan commitments and standby letters of credit do not necessarily represent future cash requirements of the Company in that while the borrower has the ability to draw upon these commitments at any time, these commitments often expire without being drawn upon. The Company's unfunded loan commitments and standby letters of credit outstanding were as follows as of the dates presented:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| Loan commitments | $4425675 | $2856308 |
| Standby letters of credit | 115618 | 90267 |

---

The Company closely monitors the amount of remaining future commitments to borrowers in light of prevailing economic conditions and adjusts these commitments and the provision related thereto as necessary; the Company also reviews these commitments as part of its analysis of loan concentrations within the loan portfolio. The Company will continue this process as new commitments are entered into or existing commitments are renewed. For a more detailed discussion related to the allowance and provision for credit losses on unfunded loan commitments, refer to the "Risk Management" section above.

The Company utilizes derivative financial instruments, including interest rate contracts such as swaps, collars, risk participations, caps and/or floors, as part of its ongoing efforts to mitigate its interest rate risk exposure and to facilitate the needs of its customers. The Company enters into derivative instruments that are not designated as hedging instruments to help its commercial customers manage their exposure to interest rate fluctuations. To mitigate the interest rate risk associated with these customer contracts, the Company enters into an offsetting derivative contract position with other financial institutions. The Company manages its credit risk, or potential risk of default by its commercial customers, through credit limit approval and monitoring procedures. At September 30, 2025, the Company had notional amounts of $1,602,805 on interest rate contracts

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

with corporate customers and $1,603,104 in offsetting interest rate contracts with other financial institutions to mitigate the Company's rate exposure on its corporate customers' contracts and certain fixed rate loans.

Additionally, the Company enters into interest rate lock commitments with its customers to mitigate the interest rate risk associated with the commitments to fund fixed-rate and adjustable rate residential mortgage loans and also enters into forward commitments to sell residential mortgage loans to secondary market investors.

To mitigate future interest rate exposure on its FHLB borrowings and its junior subordinated debentures the Company enters into interest rate swap contracts that are accounted for as cash flow hedges. Under each of these contracts, the Company pays a fixed rate of interest and receives a variable rate of interest. The Company entered into an interest rate swap contract on its subordinated notes that is accounted for as a fair value hedge. Under this contract, the Company pays a variable rate of interest and receives a fixed rate of interest. The Company utilizes interest rate collars to protect against interest rate fluctuations on certain variable-rate loans. Under these contracts, interest income is limited to the interest rate cap; however, interest income is protected when market rates fall below the floor strike rate.

For more information about the Company's derivatives, see Note 10, "Derivative Instruments," in the Notes to Consolidated Financial Statements of the Company in Item 1, Financial Statements.

**Shareholders' Equity and Regulatory Matters**

Total shareholders' equity of the Company was $3,825,778 at September 30, 2025 compared to $2,678,318 at December 31, 2024. Book value per share was $40.26 and $42.13 at September 30, 2025 and December 31, 2024, respectively. The growth in shareholders' equity is attributable to the merger with The First, current period earnings and declines in accumulated other comprehensive loss, offset by dividends declared.

Effective October 28, 2025, the Company's Board of Directors approved a $150.0 million stock repurchase program under which the Company is authorized to repurchase outstanding shares of its common stock either in open market purchases or privately negotiated transactions. This plan, which will remain in effect until the earlier of October 2026 or the repurchase of the entire amount authorized under the plan, replaces the Company's $100.0 million stock repurchase program that expired October 2025.

The Company has junior subordinated debentures with a carrying value of $140,355 at September 30, 2025, of which $135,959 was included in the Company's Tier 2 capital.

The Company has subordinated notes with a par value of $433,400 at September 30, 2025, of which $418,523 is included in the Company's Tier 2 capital. On October 1, 2025, the Company redeemed $60,000 in subordinated notes assumed as part of its merger with The First.

The Federal Reserve, the FDIC and the Office of the Comptroller of the Currency have issued guidelines governing the levels of capital that bank holding companies and banks must maintain. Those guidelines specify capital tiers, which include the following classifications:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>Capital Tiers</u>** | **Tier 1 Capital to<br>Average Assets<br>(Leverage)** | **Common Equity Tier 1 to<br>Risk - Weighted Assets** | **Tier 1 Capital to<br>Risk - Weighted<br>Assets** | **Total Capital to<br>Risk - Weighted<br>Assets** |
| Well capitalized | 5% or above | 6.5% or above | 8% or above | 10% or above |
| Adequately capitalized | 4% or above | 4.5% or above | 6% or above | 8% or above |
| Undercapitalized | Less than 4% | Less than 4.5% | Less than 6% | Less than 8% |
| Significantly undercapitalized | Less than 3% | Less than 3% | Less than 4% | Less than 6% |
| Critically undercapitalized | Tangible Equity / Total Assets less than 2% | Tangible Equity / Total Assets less than 2% | Tangible Equity / Total Assets less than 2% | Tangible Equity / Total Assets less than 2% |

---

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

The following table provides the capital, risk-based capital and leverage ratios for the Company and for Renasant Bank as of the dates presented:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Actual** | **Actual** | **Minimum Capital<br>Requirement to be<br>Well Capitalized** | **Minimum Capital<br>Requirement to be<br>Well Capitalized** | **Minimum Capital<br>Requirement to be<br>Adequately<br>Capitalized (including the Capital Conservation Buffer)** | **Minimum Capital<br>Requirement to be<br>Adequately<br>Capitalized (including the Capital Conservation Buffer)** |
| | **Amount** | **Ratio** | **Amount** | **Ratio** | **Amount** | **Ratio** |
| **September 30, 2025** | | | | | | |
| **Renasant Corporation:** | | | | | | |
| &nbsp;&nbsp;&nbsp;*Risk-based capital ratios:* |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common equity tier 1 capital ratio | $2364465 | 11.04% | $1392167 | 6.50% | $1499257 | 7.00% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tier 1 risk-based capital ratio | 2364465 | 11.04 | 1713436 | 8.00 | 1820526 | 8.50 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total risk-based capital ratio | 3187027 | 14.88 | 2141795 | 10.00 | 2248885 | 10.50 |
| &nbsp;&nbsp;&nbsp;*Leverage capital ratios:* |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tier 1 leverage ratio | 2364465 | 9.46 | 1249829 | 5.00 | 999863 | 4.00 |
| **Renasant Bank:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;*Risk-based capital ratios:* |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common equity tier 1 capital ratio | $2526336 | 11.80% | $1392069 | 6.50% | $1499152 | 7.00% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tier 1 risk-based capital ratio | 2526336 | 11.80 | 1713316 | 8.00 | 1820398 | 8.50 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total risk-based capital ratio | 2794398 | 13.05 | 2141645 | 10.00 | 2248727 | 10.50 |
| &nbsp;&nbsp;&nbsp;*Leverage capital ratios:* |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tier 1 leverage ratio | 2526336 | 10.12 | 1248557 | 5.00 | 998846 | 4.00 |
| **December 31, 2024** |  |  |  |  |  |  |
| **Renasant Corporation:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;*Risk-based capital ratios:* |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common equity tier 1 capital ratio | $1825197 | 12.73% | $932162 | 6.50% | $1003867 | 7.00% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tier 1 risk-based capital ratio | 1935522 | 13.50 | 1147276 | 8.00 | 1218981 | 8.50 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total risk-based capital ratio | 2449129 | 17.08 | 1434095 | 10.00 | 1505800 | 10.50 |
| &nbsp;&nbsp;&nbsp;*Leverage capital ratios:* |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tier 1 leverage ratio | 1935522 | 11.34 | 853556 | 5.00 | 682845 | 4.00 |
| **Renasant Bank:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;*Risk-based capital ratios:* |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common equity tier 1 capital ratio | $1843123 | 12.85% | $932552 | 6.50% | $1004287 | 7.00% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tier 1 risk-based capital ratio | 1843123 | 12.85 | 1147756 | 8.00 | 1219491 | 8.50 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total risk-based capital ratio | 2022737 | 14.10 | 1434695 | 10.00 | 1506430 | 10.50 |
| &nbsp;&nbsp;&nbsp;*Leverage capital ratios:* |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tier 1 leverage ratio | 1843123 | 10.80 | 852933 | 5.00 | 682346 | 4.00 |

---

The Company elected to take advantage of transitional relief offered by the Federal Reserve and FDIC to delay for two years the estimated impact of CECL on regulatory capital, followed by a three-year transitional period to phase out the capital benefit provided by the two-year delay. The three-year transitional period began on January 1, 2022; the full impact of CECL is reflected in our capital ratios as of September 30, 2025.

For more information regarding the capital adequacy guidelines applicable to the Company and Renasant Bank, please refer to Note 15, "Regulatory Matters," in the Notes to the Consolidated Financial Statements of the Company in Item 1, Financial Statements.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

**Critical Accounting Estimates**

We have identified certain accounting estimates that involve significant judgment and estimates which can have a material impact on our financial condition or results of operations. Our accounting policies are more fully described in Note 1, "Significant Accounting Policies," in the Notes to Consolidated Financial Statements of the Company in Item 8, Financial Statements and Supplementary Data, in our Annual Report on Form 10-K for the year ended December 31, 2024. Actual amounts and values as of the balance sheet dates may be materially different from the amounts and values reported due to the inherent uncertainty in the estimation process. Also, future amounts and values could differ materially from those estimates due to changes in values and circumstances after the balance sheet date.

The accounting estimates that we believe to be the most critical in preparing our consolidated financial statements relate to the allowance for credit losses and acquisition accounting, which are described under "Critical Accounting Policies and Estimates" in Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, in our Annual Report on Form 10-K for the year ended December 31, 2024. Since December 31, 2024, there have been no material changes in these critical accounting estimates.

**Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

The Company's primary market risk exposure is to changes in interest rates. Interest rate risk is managed as part of the Company's broader risk management practices. See the information under the heading "Interest Rate Risk" in the "Risk Management" section of Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations, of this report for a description of the Company's governance structure and risk management processes. There have been no material changes in or market risk since December 31, 2024. For additional information regarding our market risk, see our Annual Report on Form 10-K for the year ended December 31, 2024.

**Item 4. CONTROLS AND PROCEDURES**

Based on their evaluation as of the end of the period covered by this quarterly report on Form 10-Q, our Principal Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) are effective for ensuring that information the Company is required to disclose in reports that it files or submits under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms and that such information is accumulated and communicated to the Company's management, including its Principal Executive and Principal Financial Officers, as appropriate to allow timely decisions regarding required disclosure. There was no change in the Company's internal control over financial reporting during the fiscal quarter covered by this quarterly report that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

**Part II. OTHER INFORMATION**

**Item 1A. RISK FACTORS**

When evaluating the risk of an investment in the Company's common stock, potential investors should carefully consider the risk factors appearing in Part I, Item 1A, Risk Factors, of the Company's Annual Report on Form 10-K for the year ended December 31, 2024. There have been no material changes from the risk factors set forth in our Annual Report on Form 10-K.

**Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

**Unregistered Sales of Equity Securities**

None.

**Issuer Purchases of Equity Securities**

During the three month period ended September 30, 2025, the Company repurchased shares of its common stock as indicated in the following table:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Total Number of Shares Purchased**<sup>(1)</sup> | **Average Price Paid per Share** | **Total Number of Shares Purchased as Part of Publicly Announced Share Repurchase Plans** | **Maximum Number or Approximate Dollar Value of Shares That May Yet Be Purchased Under Share Repurchase Plans**<sup>(2)(3)</sup> |
| July 1, 2025 to July 31, 2025 | 5285 | $37.51 |  | $100000 |
| August 1, 2025 to August 31, 2025 | 11574 | 37.49 |  | 100000 |
| September 1, 2025 to September 30, 2025 | 8122 | 37.29 |  | 100000 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total** | 24981 | $37.43 |  |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)All shares in this column represent shares of Renasant Corporation stock withheld to satisfy the federal and state tax liabilities related to the vesting of time-based restricted stock awards.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)The Company announced a $100.0 million stock repurchase program in October 2024 under which the Company was authorized to repurchase outstanding shares of its common stock either in open market purchases or privately-negotiated transactions. No shares were repurchased during the third quarter of 2025 under this plan, which expired in October 2025 and was replaced with a $150.0 million stock repurchase program approved in October 2025. This new plan will remain in effect through October 2026 or, if earlier, the repurchase of the entire amount of common stock authorized to be repurchased.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)Dollars in thousands

Please refer to the information discussing restrictions on the Company's ability to pay dividends under the heading "Liquidity and Capital Resources" in Part I, Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations, of this report, which is incorporated by reference herein.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

**Item 5. OTHER INFORMATION**

**Trading Plans**

During the quarter ended September 30, 2025, no director or officer (as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended) adopted or terminated any "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" (each as defined in Item 408(a) of Regulation S-K).

**Item 6. EXHIBITS**

---

| | |
|:---|:---|
| Exhibit<br>Number | Description |
| &nbsp;&nbsp;3.1 | <u>[Restated Articles of Incorporation of Renasant Corporation](https://www.sec.gov/Archives/edgar/data/715072/000071507225000211/ex31restatedarticlesofin.htm)</u><sup>(1)</sup> |
| &nbsp;&nbsp;3.2 | <u>[Amended and Restated Bylaws of Renasant Corporation](https://www.sec.gov/Archives/edgar/data/715072/000071507224000179/exhibit3ii_amendedandresta.htm)</u><sup>(2)</sup> |
| &nbsp;&nbsp;31.1 | <u>[Certification of the Principal Financial Officer, as required pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](rnst9302025ex311.htm)</u> |
| &nbsp;&nbsp;31.2 | <u>[Certification of the Principal Financial Officer, as required pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](rnst9302025ex312.htm)</u> |
| &nbsp;&nbsp;32.1 | <u>[Certification of the Principal Executive Officer, as required pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](rnst9302025ex321.htm)</u> |
| &nbsp;&nbsp;32.2 | <u>[Certification of the Principal Financial Officer, as required pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](rnst9302025ex322.htm)</u> |
| &nbsp;&nbsp;101 | The following materials from Renasant Corporation's Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 were formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Income, (iii) Consolidated Statements of Comprehensive Income, (iv) Consolidated Statements of Changes in Shareholders' Equity, (v) Consolidated Statements of Cash Flows and (vi) Notes to Consolidated Financial Statements (Unaudited). |
| &nbsp;&nbsp;104 | The cover page of Renasant Corporation's Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, formatted in Inline XBRL (included in Exhibit 101). |

---

(1)Filed as exhibit 3.1 to the Form 10-Q of the Company filed with the Securities and Exchange Commission (the "Commission") on August 6, 2025, and incorporated herein by reference.

(2)Filed as exhibit 3(ii) to the Form 8-K of the Company filed with the Commission on October 24, 2024, and incorporated herein by reference.

The Company does not have any long-term debt instruments under which securities are authorized exceeding ten percent of the total assets of the Company and its subsidiaries on a consolidated basis. The Company will furnish to the Commission, upon its request, a copy of all long-term debt instruments.

------

<u>[**Table of Contents**](#icd1fb2c5bace4247a2ab058bf222a535_7)</u>

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | | <u>RENASANT CORPORATION</u> |
| | | (Registrant) |
| Date: | November 7, 2025 | /s/ Kevin D. Chapman |
|  |  | Kevin D. Chapman |
|  |  | President and Chief Executive Officer |
|  |  | (Principal Executive Officer) |
| Date: | November 7, 2025 | /s/ James C. Mabry IV |
|  |  | James C. Mabry IV |
|  |  | Executive Vice President and |
|  |  | Chief Financial Officer |
|  |  | (Principal Financial Officer) |

---

## Exhibit 31.1

**Exhibit 31(i)**

**CERTIFICATIONS**

I, Kevin D. Chapman, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2025 of Renasant Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)), for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: | November 7, 2025 | /s/ Kevin D. Chapman |
| | | Kevin D. Chapman |
| | | President and Chief Executive Officer |
| | | (Principal Executive Officer) |

---

## Exhibit 31.2

**Exhibit 31(ii)**

**CERTIFICATIONS**

I, James C. Mabry IV, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2025 of Renasant Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)), for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: | November 7, 2025 | /s/ James C. Mabry IV |
| | | James C. Mabry IV |
| | | Executive Vice President and |
| | | Chief Financial Officer |
| | | (Principal Financial Officer) |

---

## Exhibit 32.1

**Exhibit 32(i)**

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report on Form 10-Q of Renasant Corporation (the "Company") for the period ended September 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Kevin D. Chapman, Chief Executive Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: | November 7, 2025 | /s/ Kevin D. Chapman |
| | | Kevin D. Chapman |
| | | President and Chief Executive Officer |
| | | (Principal Executive Officer) |

---

## Exhibit 32.2

**Exhibit 32(ii)**

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report on Form 10-Q of Renasant Corporation (the "Company") for the period ended September 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, James C. Mabry IV, Chief Financial Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: | November 7, 2025 | /s/ James C. Mabry IV |
| | | James C. Mabry IV |
| | | Executive Vice President and |
| | | Chief Financial Officer |
| | | (Principal Financial Officer) |

---

<br>